AlleleID,Type,Name,GeneID,GeneSymbol,HGNC_ID,ClinicalSignificance,ClinSigSimple,LastEvaluated,RS (dbSNP),RCVaccession,PhenotypeIDS,PhenotypeList,Origin,OriginSimple,Assembly,ChromosomeAccession,Chromosome,Start,Stop,ReferenceAllele,AlternateAllele,Cytogenetic,ReviewStatus,NumberSubmitters,Guidelines,TestedInGTR,OtherIDs,SubmitterCategories,VariationID,chr,pos,REF,ALT,AlleleID_1,variant_str,submitter_clinical_significance,submitter_date_last_evaluated,submitter_description,submitted_phenotype_info,reported_phenotype_info,clarification_unspecified_reported_phenotype,Correct_phenotype,Why_incorrect_phenotype,submitter_review_status,submitter_collection_method,submitter_origin_counts,submitter,submitterSCV,submitted_gene_symbol,ExplanationOfInterpretation,Traits,last_evaluated,n_called,n_not_called,AC,AF,n_het,submitterSCV_1,flag_HC_lab_unspecified_phenotype,high_confidence_lab_2017,high_confidence_lab_2017_any,high_confidence_lab_2017_clinical_significance
16561,single nucleotide variant,NM_000237.3(LPL):c.644G>A (p.Gly215Glu),4023,LPL,HGNC:6677,Pathogenic,1,31-Oct-18,118204057,RCV000763181;RCV000001586;RCV000763181;RCV000521241,"Human Phenotype Ontology:HP:0008158,MedGen:C0020474,OMIM:144250;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:CN517202","Hyperapobetalipoproteinemia;Hyperlipoproteinemia, type I;Hyperlipoproteinemia, type I;not provided",germline;unknown,germline,GRCh37,NC_000008.10,8,19811733,19811733,G,A,8p21.3,"criteria provided, multiple submitters, no conflicts",3,NA,N,"OMIM Allelic Variant:609708.0002,UniProtKB (protein):P06858#VAR_004225",3,1522,8,19811733,G,A,16561,8:19811733:G:A,Pathogenic,2018-10-31,-,OMIM:144250;OMIM:238600,"C0020474:Hyperapobetalipoproteinemia;C0023817:Hyperlipoproteinemia, type I",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000893780.1,-,-,High triglycerides,10/31/18,46963,0,13,"[0.9998615931690905,1.3840683090943933E-4]",13,SCV000893780,FALSE,FALSE,FALSE,
16589,single nucleotide variant,NM_000237.3(LPL):c.953A>G (p.Asn318Ser),4023,LPL,HGNC:6677,Pathogenic,1,3-Dec-17,268,RCV000001615,"Human Phenotype Ontology:HP:0008158,MedGen:C0020474,OMIM:144250",Hyperapobetalipoproteinemia,germline;inherited,germline,GRCh37,NC_000008.10,8,19813529,19813529,A,G,8p21.3,"criteria provided, single submitter",2,NA,N,"OMIM Allelic Variant:609708.0033,UniProtKB (protein):P06858#VAR_004239",3,1550,8,19813529,A,G,16589,8:19813529:A:G,Pathogenic,2017-12-03,-,MedGen:C0020474,C0020474:Hyperapobetalipoproteinemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:na,"Genomic Research Center,Shahid Beheshti University of Medical Sciences",SCV000746401.1,-,-,High triglycerides,12/3/17,46963,0,727,"[0.9922598641483721,0.007740135851627877]",721,SCV000746401,FALSE,FALSE,FALSE,
17915,single nucleotide variant,NM_174936.3(PCSK9):c.426C>G (p.Tyr142Ter),255738,PCSK9,HGNC:20001,Pathogenic,1,31-May-16,67608943,RCV000003010;RCV000588335,MedGen:C3276239;MedGen:CN517202,Low density lipoprotein cholesterol level quantitative trait locus 1;not provided,germline,germline,GRCh37,NC_000001.10,1,55512222,55512222,C,G,1p32.3,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:607786.0004,OMIM Allelic Variant:607786.0007",3,2876,1,55512222,C,G,17915,1:55512222:C:G,Pathogenic,2016-05-31,"Variant summary: The PCSK9 c.426C>G (p.Tyr142X) variant results in a premature termination codon, predicted to cause a truncated or absent PCSK9 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Functional studies showed that it leads to the nonsense mediated decay with no detectable protein (Cohen_2005, Zhao_2006). This variant was found in 33/121362 control chromosomes from ExAC, predominantly observed in the African subpopulation at a frequency of 0.0029813 (31/10398). However, it is unknown whether the individuals in ExAC were ruled out to be hypocholesterolemic. This variant is widely known to be a causative mutation for hypocholesterolemia predominantly in Africans including cosegregation data. In a large case-cohort study, this variant was found to be associated with 40% reduction in plasma levels of LDL cholesterol (Cohen_2006). Although this variant is likely to confer protection against coronary artery disease due to its LDLC reducing effect (Peloso_2014), other clinical conditions including cardiovascular effects are likely to manifest as result of the hypocholesterolemia amongst the individuals who carry this variant. Taken together, this variant is classified as Pathogenic.",MedGen:CN221809,CN517202:not provided,Hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000699995.1,PCSK9,-,Low LDL,5/31/16,46963,0,40,"[0.9995741328279709,4.2586717202904413E-4]",40,SCV000699995,FALSE,FALSE,FALSE,
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Pathogenic,2018-06-08,"This sequence change replaces tryptophan with glycine at codon 87 of the LDLR protein (p.Trp87Gly). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and glycine. This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 2318961, 12553167, 16542394). It is a founder mutation in the Dutch population, and is common in individuals of European ancestry. This variant is also known as p.W66G in the literature. ClinVar contains an entry for this variant (Variation ID: 3685). Experimental studies have shown that this missense change leads to an LDL receptor protein that is unable to properly bind LDL (PMID: 8098448). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285027.5,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000285027,FALSE,TRUE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:16,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583644.1,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583644,FALSE,FALSE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 9 , family members = 7 with co-segregation / frequently associated with c.1975A>C, p.Thr659Pro (2 index cases), Subnormal LDLR activity / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:9,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503120.1,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503120,FALSE,FALSE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:1,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540721.1,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000540721,FALSE,FALSE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Pathogenic,2016-01-11,"The p.Trp87Gly variant in LDLR is a well-established pathogenic variant for familial hypercholesterolemia (Leitersdorf 1990, Jensen 1996, Vohl 1997, Tybjaerg-Hansen 2005, Futema 2013), and is a known founder mutation in the French Canadian population where it has been reported in >400 individuals with FH, including >15 homozygous individuals (Vohl 1997). It has also been identified in 5/66740 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs121908025); however, this frequency is low enough to be consistent with the frequency of FH in the general population. Additionally, in vitro functional studies provide some evidence that the p.Trp87Gly variant may impact protein function (Leitersdorf 1990). In summary, this variant meets our criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon its identification in a large number of affected individuals and low frequency in controls.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271387.2,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000271387,FALSE,FALSE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Pathogenic,2008-12-18,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:6,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268547.1,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268547,FALSE,FALSE,TRUE,Pathogenic
18724,single nucleotide variant,NM_000527.4(LDLR):c.259T>G (p.Trp87Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,8-Jun-18,121908025,RCV000003870;RCV000622852,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11213408,11213408,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308",3,3685,19,11213408,T,G,18724,19:11213408:T:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Robarts Research Institute,Western University",SCV000484716.1,LDLR,-,High LDL,6/8/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484716,FALSE,FALSE,TRUE,Pathogenic
18729,single nucleotide variant,NM_000527.4(LDLR):c.681C>G (p.Asp227Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Jun-17,121908028,RCV000003876,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216263,11216263,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338",3,3690,19,11216263,C,G,18729,19:11216263:C:G,Pathogenic,2017-06-30,"The p.Asp227Glu variant in LDLR (also known as the FH Afrikaner 1 allele) is a founder variant in the Afrikan population and is thought to account for 65 - 75% of familial hypercholesterolemia in Afrikans (Leitersdorf 1989, Kotze 1990, Kotze 1994). This variant has also been identified in at least 7 Caucasian individuals with familial hypercholesterolemia (Gudnason 1993, Callis 1998, Fouchier 2001, Bertolini 2013, Sharifi 2016) and has been reported in ClinVar (Variation ID 3690). Additionally, in vitro functional studies provide some evidence that the p.Asp227Glu variant may impair receptor activity (Fourie 1988). This variant has been identified in 1/33548 Latino chromosomes by the Genome Aggregation Database (gnomAD; http://gnomad.broadinstitute.org; dbSNP rs121908028). This frequency is low enough to be consistent with the frequency of familial hypercholesterolemia (FH) in the general population. In summary, this variant meets criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon low frequency in controls, functional evidence, and presence in multiple affected individuals.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000731597.1,LDLR,-,High LDL,6/30/17,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000731597,FALSE,TRUE,TRUE,Pathogenic
18729,single nucleotide variant,NM_000527.4(LDLR):c.681C>G (p.Asp227Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Jun-17,121908028,RCV000003876,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216263,11216263,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338",3,3690,19,11216263,C,G,18729,19:11216263:C:G,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583721.1,LDLR,-,High LDL,6/30/17,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000583721,FALSE,FALSE,TRUE,Pathogenic
18729,single nucleotide variant,NM_000527.4(LDLR):c.681C>G (p.Asp227Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Jun-17,121908028,RCV000003876,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216263,11216263,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338",3,3690,19,11216263,C,G,18729,19:11216263:C:G,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 6 , family members = 3 with co-segregation / FH-Afrikaner-1 / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503215.1,LDLR,-,High LDL,6/30/17,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000503215,FALSE,FALSE,TRUE,Pathogenic
18729,single nucleotide variant,NM_000527.4(LDLR):c.681C>G (p.Asp227Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Jun-17,121908028,RCV000003876,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216263,11216263,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338",3,3690,19,11216263,C,G,18729,19:11216263:C:G,Pathogenic,2008-06-25,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:14,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268580.1,LDLR,-,High LDL,6/30/17,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000268580,FALSE,FALSE,TRUE,Pathogenic
18729,single nucleotide variant,NM_000527.4(LDLR):c.681C>G (p.Asp227Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Jun-17,121908028,RCV000003876,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216263,11216263,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338",3,3690,19,11216263,C,G,18729,19:11216263:C:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484734.1,LDLR,-,High LDL,6/30/17,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000484734,FALSE,FALSE,TRUE,Pathogenic
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894170.1,-,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000894170,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2018-01-19,"This sequence change replaces glutamic acid with lysine at codon 228 of the LDLR protein (p.Glu228Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is not present in population databases (rs121908029, ExAC no frequency). This variant has been reported in numerous individuals and families affected with familial hypercholesterolemia (PMID: 2318961, 21475731, 21722902, 22390909, 23375686). This variant is also known as p.Glu207Lys in the literature. ClinVar contains an entry for this variant (Variation ID: 3691). A different missense substitution at this codon (p.Glu228Gln) has been determined to be pathogenic (PMID: 1301956, 8882879, 16250003, 17094996). This suggests that the glutamic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense change causes impaired lipoprotein binding (PMID: 18677035). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544645.3,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000544645,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2017-09-20,"The p.Glu228Lys variant in LDLR is a common pathogenic variant that has been reported in a large number of individuals across several studies (Kusters 2011, Hujgen 2012, Bertolini 2013, Leitersdorf 1990). It is one of the 12 most common LDLR variants in the Dutch (Kusters 2011). This variant has been identified in 2/17176 East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121908029). In vitro functional studies support that the p.Glu228Lys impacts protein function (Leitersdorf 1990). In addition, several other variants at the same position (p.Glu228Gln, p.Glu228Ala, p.Glu228Gly) have been reported with evidence supporting a disease causing role (ClinVar ID: 251393, 251394, 375796), suggesting that a change at this position is not tolerated. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon functional studies, presence in multiple affected individuals, low frequency in controls and pathogenicity of other variants at the same amino acid position.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000731719.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000731719,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2017-07-28,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genome Diagnostics Laboratory,University Medical Center Utrecht",SCV000743851.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000743851,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:20,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583724.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000583724,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 9 , family members = 3 with co-segregation / FH-Canada-3, < 2% LDLR Activity / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:9,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503221.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000503221,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Likely pathogenic,2016-11-05,Disrupt SDE motif. SDE bind structural Ca2+.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540754.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000540754,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,2012-07-20,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268581.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000268581,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484738.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000484738,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18730,single nucleotide variant,NM_000527.4(LDLR):c.682G>A (p.Glu228Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885,"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202",Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",19,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341",3,3691,19,11216264,G,A,18730,19:11216264:G:A,Pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733815.1,LDLR,-,High LDL,10/31/18,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000733815,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18731,single nucleotide variant,NM_000527.4(LDLR):c.910G>A (p.Asp304Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,10-Apr-18,121908030,RCV000003880;RCV000148569;RCV000622705,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123",Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11218160,11218160,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355",3,3692,19,11218160,G,A,18731,19:11218160:G:A,Pathogenic,2018-04-10,"This c.910G>A (p.Asp304Asn) variant in the LDLR gene has been reported in multiple unrelated individuals with familial hypercholesterolemia (PMID: 1301956, 9664576, 11810272, 12436241, 21418584, 21310417) and is extremely rare in the general population. Functional studies have shown that the mutant LDLR protein retains only 5-15% of receptor activity compared with wildtype LDLR protein (PMID: 1301956). This c.910G>A (p.Asp304Asn) variant in the LDLR gene is classified as pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000840002.1,LDLR,-,High LDL,4/10/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000840002,FALSE,FALSE,TRUE,"Likely pathogenic, Pathogenic"
18731,single nucleotide variant,NM_000527.4(LDLR):c.910G>A (p.Asp304Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,10-Apr-18,121908030,RCV000003880;RCV000148569;RCV000622705,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123",Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11218160,11218160,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355",3,3692,19,11218160,G,A,18731,19:11218160:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583757.1,LDLR,-,High LDL,4/10/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583757,FALSE,FALSE,TRUE,"Likely pathogenic, Pathogenic"
18731,single nucleotide variant,NM_000527.4(LDLR):c.910G>A (p.Asp304Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,10-Apr-18,121908030,RCV000003880;RCV000148569;RCV000622705,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123",Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11218160,11218160,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355",3,3692,19,11218160,G,A,18731,19:11218160:G:A,Likely pathogenic,2017-03-03,Lines of evidence used in support of classification: LIKELY POSITIVE: Relevant Alteration(s) Detected,MeSH:D030342,C0950123:Inborn genetic diseases,Familial Hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,Ambry Genetics,SCV000741389.1,LDLR,-,High LDL,4/10/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000741389,FALSE,TRUE,TRUE,"Likely pathogenic, Pathogenic"
18731,single nucleotide variant,NM_000527.4(LDLR):c.910G>A (p.Asp304Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,10-Apr-18,121908030,RCV000003880;RCV000148569;RCV000622705,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123",Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11218160,11218160,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355",3,3692,19,11218160,G,A,18731,19:11218160:G:A,Pathogenic,2017-03-01,"This sequence change replaces aspartic acid with asparagine at codon 304 of the LDLR protein (p.Asp304Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs121908030, ExAC <0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 9664576, 11810272, 12436241, 2088165, 21418584, 22698793). This variant is also known as Denver-2 and D283N. ClinVar contains an entry for this variant (Variation ID: 3692). A different missense substitution at this codon (p.Asp304Glu) has been determined to be pathogenic (PMID: 1301956, 17094996). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense change reduces the LDLR receptor activity (PMID: 1301956). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544684.2,LDLR,-,High LDL,4/10/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000544684,FALSE,TRUE,TRUE,"Likely pathogenic, Pathogenic"
18731,single nucleotide variant,NM_000527.4(LDLR):c.910G>A (p.Asp304Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,10-Apr-18,121908030,RCV000003880;RCV000148569;RCV000622705,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123",Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11218160,11218160,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355",3,3692,19,11218160,G,A,18731,19:11218160:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:8,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540769.1,LDLR,-,High LDL,4/10/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000540769,FALSE,FALSE,TRUE,"Likely pathogenic, Pathogenic"
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894174.1,-,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000894174,FALSE,FALSE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Pathogenic,2018-04-06,"This sequence change replaces valine with methionine at codon 429 of the LDLR protein (p.Val429Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs28942078, ExAC 0.006%). This variant has been reported in the literature in the homozygous state segregating with disease in a single family (PMID: 21925660) and in several individuals both in the homozygous and heterozygous state affected with familial hypercholesterolemia (PMID: 11668627, 23375686, 2569482, 11196104, 19837725, 15256764, 11139254, 21475731). This variant is also known as p.Val408Met in the literature. ClinVar contains an entry for this variant (Variation ID: 3694). Experimental studies have shown that this missense change causes slower processing of precursor LDLR protein to the mature protein and faster degradation of the protein (PMID: 2569482). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627017.2,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000627017,FALSE,TRUE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:17,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583816.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583816,FALSE,FALSE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 12 , family members = 6 with co-segregation / FH-Afrikaner-2, < 2% LDLR Activity / Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:12,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503327.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503327,FALSE,FALSE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:3,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540808.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540808,FALSE,FALSE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Pathogenic,2011-11-07,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:7,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268609.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268609,FALSE,FALSE,TRUE,Pathogenic
18733,single nucleotide variant,NM_000527.4(LDLR):c.1285G>A (p.Val429Met),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942078,RCV000003882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited;unknown,germline,GRCh37,NC_000019.9,19,11224052,11224052,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383",3,3694,19,11224052,G,A,18733,19:11224052:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Robarts Research Institute,Western University",SCV000484726.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484726,FALSE,FALSE,TRUE,Pathogenic
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:16,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583817.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583817,FALSE,FALSE,FALSE,
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 4 , family members = 11 with co-segregation / FH-Algeria-2, 5 to 15% LDLR activity / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503329.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503329,FALSE,FALSE,FALSE,
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:6,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540810.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540810,FALSE,FALSE,FALSE,
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Likely pathogenic,2015-09-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Blueprint Genetics,",SCV000264001.2,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000264001,FALSE,FALSE,FALSE,
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"Robarts Research Institute,Western University",SCV000484702.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484702,FALSE,FALSE,FALSE,
18734,single nucleotide variant,NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,28942079,RCV000003883,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224058,11224058,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384",3,3695,19,11224058,G,A,18734,19:11224058:G:A,Pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733819.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000733819,FALSE,FALSE,FALSE,
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894178.1,-,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000894178,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2018-04-28,"This sequence change creates a premature translational stop signal at codon 681 (p.Cys681*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant is a known common cause of familial hypercholesterolemia in the Lebanese population (PMID: 19319977, 21145767), although it has been observed in individuals from other ethnicities (PMID: 11668627, 25461735). This variant is also known as p.Cys660* in the literature. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285024.5,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000285024,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2017-08-11,"The p.Cys681X variant in LDLR has been reported in >80 individuals with hypercholestrolemia across several studies and segregated with disease in >10 affected relatives (Abifadel 2009, Banares 2017, Fahed 2011, Jannes 2015, Lehrman 1987, Tichy 2012, Vandrovcova 2013). This variant is considered to be a founder variant in the Lebanese population (Fahed 2016). This variant has also been reported in Clinvar (Variation ID 3699) and identified in 1/33580 Latino and 1/111664 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121908031). This nonsense variant leads to a premature termination codon at position 681, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the LDLR gene is an established disease mechanism in familial hypercholestrolemia. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholestrolemia in an autosomal dominant manner based upon frequency in affected individuals and segregation studies.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000731826.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000731826,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:40,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583922.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000583922,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 31 (1 homozygote) , family members = 17 with co-segregation / FH-Libanon, < 2% LDLR Activity",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:31,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503452.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000503452,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540853.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000540853,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2016-11-02,"The C681X pathogenic variant in the LDLR gene (also reported as C660X due to alternate nomenclature) has been reported many times in both the heterozygous state and the homozygous state in individuals with FH (Lehrman et al., 1987; Day et al., 1997; Callis et al., 1998; Xenophontos et al., 2000; Wang et al., 2001; Bodamer et al., 2002; Dedoussis et al., 2004). The C681X variant is considered a Lebanese founder mutation and may account for greater than 80% of FH cases in this population (Abifadel et al., 2009). Furthermore, the C681X pathogenic variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project nor was it observed in the Exome Aggregation Consortium (ExAC) data set, indicating it is not a common benign variant in these populations. Located in the middle of a cysteine-rich sequence that is part of the epidermal growth factor precursor homology domain, C681X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay (Lehrman et al., 1987). In addition, other nonsense variants in the LDLR gene have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014). In summary, C681X in the LDLR gene is interpreted as a pathogenic variant.",Not Provided,CN517202:not provided,Familial Hypercholesterolemia - based on pubmed,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000568525.3,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000568525,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2016-10-26,"Variant summary: The LDLR c.2043C>A (p.Cys681X) variant results in a premature termination codon, predicted to cause a truncated or absent LDLR protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified in the pathogenic spectrum by our laboratory (e.g. p.Trp813X, p.Ser710fsX2 ). Mutation taster predicts a damaging outcome for this variant. This variant was found in 1/121136 control chromosomes at a frequency of 0.0000083, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). It was observed in several FH families and showed co-segregation with the disease indicating causality. Moreover, the variant was shown to result in lack of detectable high affinity binding and uptake of LDL, further supporting pathogenicity. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697220.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000697220,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2015-11-02,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Blueprint Genetics,",SCV000264002.2,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000264002,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Pathogenic,2012-05-04,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:5,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268655.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000268655,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18738,single nucleotide variant,NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908031,RCV000003887;RCV000590806;RCV000481771,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11231101,11231101,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",18,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016",3,3699,19,11231101,C,A,18738,19:11231101:C:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"Robarts Research Institute,Western University",SCV000484730.1,LDLR,-,High LDL,10/31/18,46958,5,1,"[0.9999893521870608,1.0647812939222283E-5]",1,SCV000484730,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894179.1,-,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000894179,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Pathogenic,2018-05-15,"This sequence change replaces proline with leucine at codon 685 of the LDLR protein (p.Pro685Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs28942084, ExAC 0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia and has been found to segregate with the disease in multiple families (PMID: 11031227, 15359125, 18718593, 21382890, 23155708, 23375686, 23669246, 2726768). This variant is also known as p.Pro664Leu in the literature. This variant has been reported in individuals in the Universal Mutation Database (PMID: 12124988) and has an entry in ClinVar (Variation ID: 3702). Experimental studies have shown that this missense change inhibits LDL-uptake in cultured lymphocytes (PMID: 19013141). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627025.2,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000627025,FALSE,TRUE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:69,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583924.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583924,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 25 (1 homozygote) , family members = 22 with co-segregation / previously described in association with FH/software prediction damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:25,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503454.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503454,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:9,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540854.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000540854,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Pathogenic,2016-01-11,"The p.Pro685Leu variant in LDLR has been reported in >40 individuals with familial hypercholesterolemia (FH), segregated with disease in >40 affected relatives from at least 4 families, and was identified in the homozygous state in at least 10 individuals with FH (Bertolini 2013, Sharifi 2016, Medeiros 2010,Rubinsztein 1992, Soutar 1989, Soutar 1991, Thormaehlen 2015, Van Der Graaf 2011). This variant has also been identified in 7/66600 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs28942084). However, this frequency is low enough to be consistent with the frequency of FH in the general population. In vitro functional studies provide some evidence that the p.Pro685Leu variant may impact protein function (Knight 1989, Rubinsztein 1992, Thormaehlen 2015). In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271386.2,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000271386,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Pathogenic,2010-04-13,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:6,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268656.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268656,FALSE,FALSE,TRUE,Pathogenic
18741,single nucleotide variant,NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,28942084,RCV000003891;RCV000162007,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11231112,11231112,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410",3,3702,19,11231112,C,T,18741,19:11231112:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484689.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484689,FALSE,FALSE,TRUE,Pathogenic
18765,single nucleotide variant,NM_000527.4(LDLR):c.523G>A (p.Asp175Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,2-Jan-18,121908033,RCV000003924,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216105,11216105,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326",3,3726,19,11216105,G,A,18765,19:11216105:G:A,Likely pathogenic,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782949.1,LDLR,-,High LDL,1/2/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000782949,FALSE,FALSE,FALSE,
18765,single nucleotide variant,NM_000527.4(LDLR):c.523G>A (p.Asp175Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,2-Jan-18,121908033,RCV000003924,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216105,11216105,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326",3,3726,19,11216105,G,A,18765,19:11216105:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:7,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583693.1,LDLR,-,High LDL,1/2/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583693,FALSE,FALSE,FALSE,
18765,single nucleotide variant,NM_000527.4(LDLR):c.523G>A (p.Asp175Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,2-Jan-18,121908033,RCV000003924,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216105,11216105,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326",3,3726,19,11216105,G,A,18765,19:11216105:G:A,Likely pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1, family member =1 /FH-Afrikaner-3 / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503175.1,LDLR,-,High LDL,1/2/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503175,FALSE,FALSE,FALSE,
18765,single nucleotide variant,NM_000527.4(LDLR):c.523G>A (p.Asp175Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,2-Jan-18,121908033,RCV000003924,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216105,11216105,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326",3,3726,19,11216105,G,A,18765,19:11216105:G:A,Pathogenic,2015-01-09,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268568.1,LDLR,-,High LDL,1/2/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268568,FALSE,FALSE,FALSE,
18779,single nucleotide variant,NM_000527.4(LDLR):c.782G>T (p.Cys261Phe),3949,LDLR,HGNC:6547,Likely pathogenic,1,12-Apr-17,121908040,RCV000003938;RCV000148568,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11217328,11217328,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000647,OMIM Allelic Variant:606945.0059,UniProtKB (protein):P01130#VAR_013953",3,3740,19,11217328,G,T,18779,19:11217328:G:T,Likely pathogenic,2017-04-12,"This c.782G>T (p.Cys261Phe) variant has previously been detected in several patients with familial hypercholesterolemia [legacy: 240 in PMID 9767373, 16542394]. The variant was also detected in a 13 y/o female, compound heterozygous for this variant and a loss of function variant [PMID 10422803]. Two siblings carried the same c.782G>T (p.Cys261Phe) heterozygous variant with only one clinically presenting hypercholesterolemia. In vitro assays showed that although the cells produced a detectable protein, cells expressing the mutant protein were unable to mediate uptake and degradation of LDL [PMID 10422803]. This variant has been reported in only one heterozygous individual from the ExAC database (http://exac.broadinstitute.org/variant/19-11217328-G-T). This variant is conserved in mammals and while not clinically validated, computer-based algorithms (SIFT and Polyphen-2) predict this p.Cys261Phe change to be deleterious. This variant is thus classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839987.1,LDLR,-,High LDL,4/12/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000839987,FALSE,FALSE,FALSE,
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2017-11-14,"This sequence change creates a premature translational stop signal at codon 44 (p.Trp44*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in multiple individuals affected with hypercholesterolemia (PMID: 1301956, 22390909, 21382890, 11668627, 22698793, 20145306, 16542394, 20506408). This variant is also known in the literature as p.W23X. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544649.3,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000544649,FALSE,TRUE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2017-09-19,"This c.131G>A (p.Trp44*) variant in the LDLR gene is predicted to is predicted to introduce a premature translation termination codon. This variant has been reported in multiple patients with familial hypercholesterolemia (PMID: 1301956, 8850176). The c.131G>A (p.Trp44*) variant in the LDLR gene is classified as pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839974.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000839974,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2017-03-30,ACMG Guidelines: Pathogenic (ii),Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583633.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583633,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 10 , family members = 2 with co-segregation / FH-Cincinnati-5, 2 to 5% LDLR activity",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503103.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503103,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:41,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540718.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540718,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2015-03-23,"The p.Trp44X variant in LDLR has been reported in a large number (>500) of individuals with hypercholesterolemia (Hobbs 1992, Huijgen 2010, Chmara 2010, Dukov 2011, Fouchier 2015). It was absent from large population studies. This nonsense variant leads to a premature termination codon at position 44, which is predicted to lead to a truncated or absent protein. Heterozygous loss of LDLR function is an established disease mechanism in familial hypercholesterolemia. In summary, this variant meets our criteria to be classified as pathogenic for hypercholesterolemia in an autosomal dominant manner (http://www.partners.org/personalizedmedicince/LMM) based upon the predicted impact to the protein, its presence in a large number of affected individuals, and absence from controls.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271381.2,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000271381,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,2008-07-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268535.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268535,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484698.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484698,FALSE,FALSE,TRUE,Pathogenic
18780,single nucleotide variant,NM_000527.4(LDLR):c.131G>A (p.Trp44Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,14-Nov-17,267607213,RCV000003939,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11210962,11210962,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060",3,3741,19,11210962,G,A,18780,19:11210962:G:A,Pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733811.1,LDLR,-,High LDL,11/14/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000733811,FALSE,FALSE,TRUE,Pathogenic
18783,single nucleotide variant,NM_000527.4(LDLR):c.2140+1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,11-Jun-18,145787161,RCV000003942,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231199,11231199,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063",3,3744,19,11231199,G,A,18783,19:11231199:G:A,Pathogenic,2018-06-11,"This sequence change affects a donor splice site in intron 14 of the LDLR gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in individuals affected with familial hypercholesterolemia and to segregate with the disease in a large multigenerational family (PMID: 12522687, 15241806,Ό20828696, 23054246). Experimental studies have shown that this splice site variant leads to an aberrant splicing that results in the loss of the protein (PMID: 12522687). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627027.3,LDLR,-,High LDL,6/11/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000627027,FALSE,TRUE,TRUE,Pathogenic
18783,single nucleotide variant,NM_000527.4(LDLR):c.2140+1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,11-Jun-18,145787161,RCV000003942,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231199,11231199,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063",3,3744,19,11231199,G,A,18783,19:11231199:G:A,Pathogenic,2016-12-16,subject mutated among 2600 FH index cases screened = 1,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503469.1,LDLR,-,High LDL,6/11/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000503469,FALSE,FALSE,TRUE,Pathogenic
18783,single nucleotide variant,NM_000527.4(LDLR):c.2140+1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,11-Jun-18,145787161,RCV000003942,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231199,11231199,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063",3,3744,19,11231199,G,A,18783,19:11231199:G:A,Pathogenic,2008-06-10,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268658.1,LDLR,-,High LDL,6/11/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000268658,FALSE,FALSE,TRUE,Pathogenic
18783,single nucleotide variant,NM_000527.4(LDLR):c.2140+1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,11-Jun-18,145787161,RCV000003942,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231199,11231199,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063",3,3744,19,11231199,G,A,18783,19:11231199:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484793.1,LDLR,-,High LDL,6/11/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000484793,FALSE,FALSE,TRUE,Pathogenic
18785,single nucleotide variant,NM_000527.4(LDLR):c.1216C>A (p.Arg406=),3949,LDLR,HGNC:6547,Pathogenic,1,13-Apr-18,121908043,RCV000003944;RCV000588218,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;not applicable,germline,GRCh37,NC_000019.9,19,11223983,11223983,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000813,OMIM Allelic Variant:606945.0065",3,3746,19,11223983,C,A,18785,19:11223983:C:A,Pathogenic,2018-04-13,"This sequence change affects codon 406 of the LDLR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the LDLR protein. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with familial hypercholesterolemia (PMID: 17335829, 19371225, 17094996, 21382890, 18400033) including an individual compound heterozygous with another LDLR variant affected with autosomal recessive hypercholesterolemia (PMID:Ό28028493). ClinVar contains an entry for this variant (Variation ID: 3746). Experimental studies have shown that this silent change causes aberrantly spliced transcripts that are degraded via nonsense-mediated decay (PMID: 17335829, 19371225). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000833922.1,LDLR,-,High LDL,4/13/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000833922,FALSE,TRUE,TRUE,Pathogenic
18785,single nucleotide variant,NM_000527.4(LDLR):c.1216C>A (p.Arg406=),3949,LDLR,HGNC:6547,Pathogenic,1,13-Apr-18,121908043,RCV000003944;RCV000588218,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;not applicable,germline,GRCh37,NC_000019.9,19,11223983,11223983,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000813,OMIM Allelic Variant:606945.0065",3,3746,19,11223983,C,A,18785,19:11223983:C:A,Pathogenic,2017-07-10,"Variant summary: The LDLR c.1216C>A (p.Arg406Arg) variant involves the alteration of a conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict a significant impact on normal splicing by the introduction of a cryptic splice site and ESE finder predicts that this variant may affect ESE sites at the locus. In support of these predictions, functional studies have shown that the variant splice site is used preferentially over the wild type splice site in patient cell lines and in vitro splicing assays (Tveten_Genet Test Molec Biomarkers_2009; Bourbon_Ather_2007). Additionally, the variant has been cited in numerous patients with hypercholesterolemia and segregates with disease in families (e.g., van der Graaf_Circ_2011; Du_SpringerPlus_2016; Tveten_Genet Test Molec Biomarkers_2009). This variant is absent from the large control database ExAC and control cohorts from the literature (0/120510 control chromosomes). In addition, two reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697190.1,LDLR,-,High LDL,4/13/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000697190,FALSE,FALSE,TRUE,Pathogenic
23175,single nucleotide variant,NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu),5468,PPARG,HGNC:9236,Conflicting interpretations of pathogenicity,1,14-Jun-16,121909244,RCV000288354;RCV000343316;RCV000008612;RCV000382908,"MedGen:C4016738;MedGen:C0271694,Orphanet:ORPHA98306,SNOMED CT:49292002;MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001","Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity",germline,germline,GRCh37,NC_000003.11,3,12475610,12475610,C,T,3p25,"criteria provided, conflicting interpretations",2,NA,N,"OMIM Allelic Variant:601487.0007,UniProtKB (protein):P37231#VAR_010728",3,8136,3,12475610,C,T,23175,3:12475610:C:T,Likely pathogenic,2016-06-14,"The c.1484C>T (p.Pro495Leu) variant, also known as p.Pro467Leu, is reported in a study by Barroso et al. (1999) in which it is found in a heterozygous state in one patient with familial partial lipodystrophy and her affected son. The variant was not found in any of the five unaffected family members tested, showing that the variant segregated with disease over two generations. The p.Pro495Leu variant was absent from 314 control chromosomes and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. The p.Pro495Leu variant is located in the PPARG ligand binding domain. Functional studies showed that the variant protein had severely impaired ligand binding ability, abnormal activation profile and inhibited the function of the wild-type protein (Barroso et al. 1999). Majithia et al. (2014) describe an in vitro assay wherein the p.Pro495Leu variant had a significantly reduced ability to rescue differentiation of adipocytes when compared to wild type PPARG. Modrick et al. (2012) showed that mice with the p.Pro495Leu variant had vascular dysfunction not seen in the wild-type mice. Tsai et al. (2004) demonstrated that homozygosity for the variant is lethal in utero for mice establishing that the mutant protein is functionally null. Mice who were heterozygous for the variant showed abnormal fat distribution and hypertension but not insulin resistance. Based on the evidence, the p.Pro495Leu variant is classified to be likely pathogenic for familial partial lipodystrophy.",Familial Partial Lipodystrophy,C0271694:Familial partial lipodystrophy,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000440531.2,PPARG,-,"Lipodystrophy, MonogenicDM_all",6/14/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000440531,FALSE,FALSE,FALSE,
23722,single nucleotide variant,NM_000525.3(KCNJ11):c.902G>A (p.Arg301His),3767,KCNJ11,HGNC:6257,Likely pathogenic,1,11-Dec-17,74339576,RCV000009220;RCV000671339;RCV000671339;RCV000671339,"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582",Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3,germline;unknown,germline,GRCh37,NC_000011.9,11,17408737,17408737,C,T,11p15.1,"criteria provided, single submitter",2,NA,N,OMIM Allelic Variant:600937.0019,3,8683,11,17408737,C,T,23722,11:17408737:C:T,Likely pathogenic,2017-12-11,-,OMIM:601820;OMIM:606176;OMIM:610582,C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,Counsyl,SCV000796303.1,KCNJ11,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",12/11/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000796303,FALSE,FALSE,FALSE,
23725,single nucleotide variant,NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys),3767,KCNJ11,HGNC:6257,Pathogenic/Likely pathogenic,1,31-Oct-18,267607196,RCV000763231;RCV000009223;RCV000763231;RCV000763231;RCV000763231;RCV000763231,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C4225365,OMIM:616329;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582","Diabetes mellitus type 2;Islet cell hyperplasia;Islet cell hyperplasia;Maturity-onset diabetes of the young, type 13;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3",germline;unknown,germline,GRCh37,NC_000011.9,11,17408795,17408795,C,T,11p15.1,"criteria provided, multiple submitters, no conflicts",3,NA,N,OMIM Allelic Variant:600937.0022,3,8686,11,17408795,C,T,23725,11:17408795:C:T,Likely pathogenic,2018-10-31,-,OMIM:125853;OMIM:601820;OMIM:606176;OMIM:610582;OMIM:616329,"C0011860:Diabetes mellitus type 2;C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia;C4225365:Maturity-onset diabetes of the young, type 13",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000893864.1,-,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000893864,FALSE,FALSE,FALSE,
23898,single nucleotide variant,NM_000209.3(PDX1):c.226G>A (p.Asp76Asn),3651,PDX1,HGNC:6107,"Conflicting interpretations of pathogenicity, risk factor",1,5-Feb-18,137852783,RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374","Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified",germline;inherited;unknown,germline,GRCh37,NC_000013.10,13,28494501,28494501,G,A,13q12.2,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311",3,8859,13,28494501,G,A,23898,13:28494501:G:A,Likely pathogenic,2017-12-18,-,MedGen:C0342276,C0342276:Maturity onset diabetes mellitus in young,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:na,"Genomic Research Center,Shahid Beheshti University of Medical Sciences",SCV000746953.1,-,-,"MODY, MODY Extended, MonogenicDM_all",2/5/18,42422,4541,98,"[0.998844938946773,0.0011550610532270991]",98,SCV000746953,TRUE,FALSE,FALSE,
23898,single nucleotide variant,NM_000209.3(PDX1):c.226G>A (p.Asp76Asn),3651,PDX1,HGNC:6107,"Conflicting interpretations of pathogenicity, risk factor",1,5-Feb-18,137852783,RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374","Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified",germline;inherited;unknown,germline,GRCh37,NC_000013.10,13,28494501,28494501,G,A,13q12.2,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311",3,8859,13,28494501,G,A,23898,13:28494501:G:A,not provided,2011-08-18,-,"Maturity-onset diabetes of the young, type 4","C1833382:Maturity-onset diabetes of the young, type 4",NA,TRUE,NA,no assertion provided,clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000052732.2,PDX1,-,"MODY, MODY Extended, MonogenicDM_all",2/5/18,42422,4541,98,"[0.998844938946773,0.0011550610532270991]",98,SCV000052732,TRUE,FALSE,FALSE,
23901,single nucleotide variant,NM_000209.3(PDX1):c.52T>C (p.Cys18Arg),3651,PDX1,HGNC:6107,Likely pathogenic,1,10-Oct-16,137852785,RCV000009412;RCV000439286,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:CN517202",Diabetes mellitus type 2;not provided,germline,germline,GRCh37,NC_000013.10,13,28494327,28494327,T,C,13q12.2,"criteria provided, single submitter",2,NA,N,"OMIM Allelic Variant:600733.0005,UniProtKB (protein):P52945#VAR_009309",3,8862,13,28494327,T,C,23901,13:28494327:T:C,Likely pathogenic,2016-10-10,"The C18R variant in the PDX1 gene has been reported previously in association with diabetes (Macfarlane et al., 1999; Flannick et al., 2013); however, the variant has been observed in unaffected family members by Macfarlane et al., and in a control subject in another study (Macfarlane et al., 1999; Edghill et al., 2011). The variant was not observed at any significant frequency in approximately 5,600 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. G18R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have shown that G18R results in a moderate reduction in insulin gene activation by the PDX1 protein (Macfarlane et al., 1999). Therefore, this variant is likely pathogenic.",Not Provided,CN517202:not provided,Type 2 diabetes,TRUE,Not trait of interest,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000521051.3,PDX1,-,"MODY, MODY Extended, MonogenicDM_all",10/10/16,41938,5025,3,"[0.9999642329152558,3.576708474414612E-5]",3,SCV000521051,FALSE,FALSE,FALSE,
24144,single nucleotide variant,NM_000352.4(ABCC8):c.4135C>T (p.Arg1379Cys),6833,ABCC8,HGNC:59,Pathogenic,1,1-Mar-16,137852673,RCV000009674;RCV000502425;RCV000009673,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1835887,OMIM:610374",Diabetes mellitus type 2;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 2,germline,germline,GRCh37,NC_000011.9,11,17417462,17417462,G,A,11p15.1,"criteria provided, single submitter",2,NA,N,OMIM Allelic Variant:600509.0019,3,9105,11,17417462,G,A,24144,11:17417462:G:A,Pathogenic,2016-03-01,-,"Diabetes mellitus, permanent neonatal",C1833104:Permanent neonatal diabetes mellitus,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000592981.1,ABCC8,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",3/1/16,46515,448,1,"[0.9999892507793186,1.0749220681500592E-5]",1,SCV000592981,FALSE,FALSE,FALSE,
24251,single nucleotide variant,NM_175914.4(HNF4A):c.340C>T (p.Arg114Trp),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,12-Dec-17,137853336,RCV000009792;RCV000711955;RCV000520726,"MedGen:C1852093,OMIM:125850;MedGen:CN517202;MedGen:CN169374","Maturity-onset diabetes of the young,  type 1;not provided;not specified",germline,germline,GRCh37,NC_000020.10,20,43042354,43042354,C,T,20q13.1,"criteria provided, conflicting interpretations",3,NA,N,"OMIM Allelic Variant:600281.0003,UniProtKB (protein):P41235#VAR_004668",3,9212,20,43042354,C,T,24251,20:43042354:C:T,Pathogenic,2017-12-12,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842366.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",12/12/17,46962,1,5,"[0.9999467654699544,5.3234530045568755E-5]",5,SCV000842366,TRUE,FALSE,FALSE,
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,2018-08-14,-,not provided,CN517202:not provided,Pubmed articles mention obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics",SCV000862775.1,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000862775,FALSE,TRUE,TRUE,Pathogenic
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,2016-06-14,"Across a selection of the available literature, the c.105C>A (p.Tyr35Ter) stop-gained variant has been identified in a heterozygous state in at least 38 individuals with obesity. In almost all of these reports, the variant was found in cis with another variant, p.Asp37Val (Hinney et al. 1999; Hinney et al. 2003; Farooqi et al. 2003; Stutzmann et al. 2008; Tan et al. 2009; Calton et al. 2009; Larsen et al. 2009; van den Berg et al. 2011). The p.Tyr35Ter variant was absent from over 4,000 controls and is reported at a frequency of 0.00009 in the European (Non-Finnish) population of the Exome Aggregation Consortium. Lubrano-Berthelier et al. (2006) demonstrated a complete lack of membrane expression of the p.Tyr35Ter variant protein as well as a significantly impaired basal receptor activity and reduced response to a receptor agonist, both to less than 10% of wild-type. It has been shown that the C-terminal tail of the receptor contains a signal for cell surface expression, hence any truncation of the protein upstream of this signal as is predicted for the p.Tyr35Ter variant would result in intracellular retention of the variant receptor (MacKenzie, 2006). Based on the collective evidence and the potential impact of stop-gained variants, the p.Tyr35Ter variant is classified as pathogenic for obesity.",Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000409981.2,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000409981,FALSE,FALSE,TRUE,Pathogenic
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,2016-05-27,"The Y35X pathogenic variant in the MC4R gene has been reported multiple times in association with obesity, seen on the same allele (in cis) with the D37V variant, which will not be translated since it is downstream of the premature stop codon created by Y35X (Hinney et al., 1999; Hinney et al., 2003; Larsen et al., 2005). Functional studies show Y35X leads to impaired cAMP responses and absent binding of NDP-alphaMSH (Hinney et al., 2003; Larsen et al., 2005). The Y35X variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret Y35X as a pathogenic variant.",Not Provided,CN517202:not provided,Obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000321871.6,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000321871,FALSE,FALSE,TRUE,Pathogenic
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,2013-11-06,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692294.1,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000692294,FALSE,FALSE,TRUE,Pathogenic
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,2011-08-18,-,Early Onset Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:26,Integrated Genetics/Laboratory Corporation of America,SCV000052811.1,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000052811,FALSE,FALSE,TRUE,Pathogenic
29357,single nucleotide variant,NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter),4160,MC4R,HGNC:6932,Pathogenic,1,14-Aug-18,13447324,RCV000015394;RCV000202583;RCV000255005,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202",Obesity;Schizophrenia;not provided,germline,germline,GRCh37,NC_000018.9,18,58039478,58039478,G,T,18q21.3,"criteria provided, multiple submitters, no conflicts",8,NA,N,OMIM Allelic Variant:155541.0003,3,14318,18,58039478,G,T,29357,18:58039478:G:T,Pathogenic,NA,-,OMIM:601665,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733802.1,MC4R,-,Obesity,8/14/18,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000733802,FALSE,FALSE,TRUE,Pathogenic
29369,single nucleotide variant,NM_005912.2(MC4R):c.523G>A (p.Ala175Thr),4160,MC4R,HGNC:6932,Pathogenic,1,16-Mar-11,121913563,RCV000015406,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Obesity,germline,germline,GRCh37,NC_000018.9,18,58039060,58039060,C,T,18q21.3,no assertion criteria provided,2,NA,N,"OMIM Allelic Variant:155541.0015,UniProtKB (protein):P32245#VAR_038646",3,14330,18,58039060,C,T,29369,18:58039060:C:T,Pathogenic,2011-03-16,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692300.1,MC4R,-,Obesity,3/16/11,46963,0,45,"[0.9995208994314674,4.7910056853267465E-4]",45,SCV000692300,FALSE,FALSE,FALSE,
29375,single nucleotide variant,NM_005912.2(MC4R):c.380C>T (p.Ser127Leu),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,25-May-17,13447331,RCV000015412;RCV000414065,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202",Obesity;not provided,germline,germline,GRCh37,NC_000018.9,18,58039203,58039203,G,A,18q21.3,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643",3,14336,18,58039203,G,A,29375,18:58039203:G:A,Likely pathogenic,2017-05-25,"This c.380C>T (p.Ser127Leu) variant in the MC4R gene has previously been reported in multiple patients presenting with obesity [PMID 12499395, 24385306, 18559663, 14764818, 26047380]. The variant was also detected in one lean individual, the mother of the obese proband, indicating possible incomplete penetrance [PMID 26047380]. Functional assays showed that the receptor displayed high constitutive activity [PMID 19298524, 12970296]. However, cell surface expression level of the p.Ser127Leu mutant was decreased by about half of wild type [PMID 19298524, 24385306]. Thus, the mechanism of pathogenicity for this variant in unclear at this time. Serine at amino acid position 127 of the MC4R protein is highly conserved in mammals. This variant has been observed in 20 heterozygous individuals from the ExAC database (http://exac.broadinstitute.org/variant/18-58039203-G-A). While not validated for clinical use, the computer-based algorithms SIFT and Polyphen2 predict this p.Ser127Leu change to be deleterious. It is thus interpreted as a likely pathogenic variant.",OMIM:601665,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000840007.1,MC4R,-,Obesity,5/25/17,46963,0,18,"[0.999808359772587,1.9164022741306988E-4]",18,SCV000840007,TRUE,FALSE,FALSE,
29375,single nucleotide variant,NM_005912.2(MC4R):c.380C>T (p.Ser127Leu),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,25-May-17,13447331,RCV000015412;RCV000414065,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202",Obesity;not provided,germline,germline,GRCh37,NC_000018.9,18,58039203,58039203,G,A,18q21.3,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643",3,14336,18,58039203,G,A,29375,18:58039203:G:A,Uncertain significance,2016-06-14,"Across a selection of the available literature, the c.380C>T (p.Ser127Leu) variant has been identified in a total of 15 obese patients, including nine patients in a compound heterozygous state with a known MC4R polymorphism and six patients in a heterozygous state (Hinney et al. 2003; Valli-Jaakola et al. 2004; Hainerova et al. 2007; Calton et al. 2009; Santoro et al. 2009; Nowacka-Woszuk et al. 2011; Albuquerque et al. 2014; Rovite et al. 2014). The variant was also found in five unaffected individuals, including two that carried the variant in a compound heterozygous state with the common MC4R polymorphism (Nowacka-Woszuk et al. 2011; Rouskas et al. 2012; Stanikova et al. 2015). Control data are unavailable for the p.Ser127eu variant, which is reported at a frequency of 0.00052 in the Latino population of the Exome Aggregation Consortium. Functional studies for the p.Ser127Leu variant revealed a constituitively active receptor (Hinney et al. 2003; Srinivasan et al. 2007; Mo et al. 2013), which conflicts with functional studies showing decreased cell surface expression (Rovite et al. 2014), impaired signaling (Valli-Jaakola et al. 2004), and altered alpha-MSH activation of the receptor (Lubrano-Berthelier et al. 2003). Based on the conflicting evidence from the literature, the p.Ser127Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for obesity.",Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000409978.2,MC4R,-,Obesity,5/25/17,46963,0,18,"[0.999808359772587,1.9164022741306988E-4]",18,SCV000409978,TRUE,FALSE,FALSE,
29375,single nucleotide variant,NM_005912.2(MC4R):c.380C>T (p.Ser127Leu),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,25-May-17,13447331,RCV000015412;RCV000414065,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202",Obesity;not provided,germline,germline,GRCh37,NC_000018.9,18,58039203,58039203,G,A,18q21.3,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643",3,14336,18,58039203,G,A,29375,18:58039203:G:A,Likely pathogenic,2016-01-07,"The S127L variant in the MC4R gene has been reported in individuals with obesity (Lubrano-Berthelier et al., 2003; Rovite et al., 2014). Functional assays showed S127L has decreased membrane trafficking and functional activity (Rovite et al., 2014). The S127L variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S127L variant is a non-conservative amino acid substitution, which occurs within the Transmembrane 3 domain at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in a nearby residue (D126Y) has been reported in the Human Gene Mutation Database in association with obesity (Stenson et al., 2014), supporting the functional importance of this region of the protein. The S127L variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.",Not Provided,CN517202:not provided,Obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000491324.1,MC4R,-,Obesity,5/25/17,46963,0,18,"[0.999808359772587,1.9164022741306988E-4]",18,SCV000491324,TRUE,FALSE,FALSE,
29375,single nucleotide variant,NM_005912.2(MC4R):c.380C>T (p.Ser127Leu),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,25-May-17,13447331,RCV000015412;RCV000414065,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202",Obesity;not provided,germline,germline,GRCh37,NC_000018.9,18,58039203,58039203,G,A,18q21.3,"criteria provided, conflicting interpretations",6,NA,N,"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643",3,14336,18,58039203,G,A,29375,18:58039203:G:A,Pathogenic,2013-06-18,-,not provided,CN517202:not provided,Obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842715.1,MC4R,-,Obesity,5/25/17,46963,0,18,"[0.999808359772587,1.9164022741306988E-4]",18,SCV000842715,TRUE,FALSE,FALSE,
29525,single nucleotide variant,NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln),4000,LMNA,HGNC:6636,Pathogenic,1,31-Oct-18,11575937,RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299,"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202","Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided",de novo;germline;unknown,germline,GRCh37,NC_000001.10,1,156106776,156106776,G,A,1q22,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992",3,14486,1,156106776,G,A,29525,1:156106776:G:A,Pathogenic,2018-10-31,-,OMIM:115200;OMIM:151660;OMIM:176670;OMIM:181350;OMIM:212112;OMIM:248370;OMIM:275210;OMIM:605588;OMIM:610140;OMIM:613205;OMIM:616516,"C0033300:Hutchinson-Gilford syndrome;C0406585:Lethal tight skin contracture syndrome;C0410190:Benign scapuloperoneal muscular dystrophy with cardiomyopathy;C0432291:Mandibuloacral dysostosis;C0796031:Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;C1449563:Dilated cardiomyopathy 1A;C1720860:Familial partial lipodystrophy 2;C1854154:Charcot-Marie-Tooth disease type 2B1;C1857829:Heart-hand syndrome, Slovenian type;C2750035:Emery-Dreifuss muscular dystrophy 3, autosomal recessive;C2750785:Congenital muscular dystrophy, LMNA-related",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000893895.1,-,-,"Lipodystrophy, MonogenicDM_all",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000893895,FALSE,FALSE,TRUE,Pathogenic
29525,single nucleotide variant,NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln),4000,LMNA,HGNC:6636,Pathogenic,1,31-Oct-18,11575937,RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299,"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202","Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided",de novo;germline;unknown,germline,GRCh37,NC_000001.10,1,156106776,156106776,G,A,1q22,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992",3,14486,1,156106776,G,A,29525,1:156106776:G:A,Pathogenic,2017-12-07,"The c.1445G>A variant in codon 482 (exon 8 of the RefSeq gene) of the Lamin A/C gene, LMNA, results in the substitution of Arginine to Glutamine. Mutations in the LMNA gene have been found to cause multiple disorders, collectively known as A-type laminopathies, that have overlapping signs and symptoms (23853504, 20074070, OMIM, 16364671). A-type laminopathies include familial partial lipodystrophy type 2 (FPLD2, also called familial partial lipodystrophy, Dunnigan type), Limb-Girdle muscular dystrophy type 1B, Emery-Dreifuss muscular dystrophy (EDMD), Charcot-Marie-Tooth type 2B1 disease, Hutchinson-Gilford progeria, Heart-hand syndrome, Slovenian type, mandibuloacral dysplasia, Malouf syndrome, and familial dilated cardiomyopathy (23853504, 20074070, OMIM). To date, no clear genotype-phenotype correlations have been identified (23853504, 20074070). The c.1445G>A variant has been identified in multiple individuals over multiple generations in families with clinical diagnoses of FPLD2 (22700598, 10868844, 10999845, 10587585, 10739751, 10655060). This variant was also found in the homozygous state in an individual with FPLD2 and autosomal recessive-EDMD (23313286). A different amino acid change at codon 482, Arg482Trp, has also been shown to segregate with FPLD2 (23853504, 22700598, 10999845, 10739751, 10655060). Approximately 75% of patients with FPLD2 have a mutation at Arg482, making it a mutational hotspot for FPLD2 (16364671). Multiple lines of computational evidence (SIFT, LRT, MutationTaster, FATHMM, MetaSVM, MetalR, GERP, CADD) predict the c.1445G>A variant is probably damaging to the protein structure, function, or protein-protein interaction. Indeed, functional studies of the Arg482Gln mutant protein, as well as the Arg482Trp protein, demonstrated a failure of adipocyte cell differentiation (16415042). A transgenic mouse harboring the Arg482Gln mutation recapitulates the FPLD2 phenotype and studies confirmed a lack of adipocyte renewal (19201734). ACMG criteria = PS3, PS4, PP1-strong, PM1, PM5, PP3",MedGen:C3888631,C3888631:Monogenic diabetes,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Translational Genomics Laboratory,University of Maryland School of Medicine",SCV000882464.1,LMNA,-,"Lipodystrophy, MonogenicDM_all",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000882464,FALSE,FALSE,TRUE,Pathogenic
29525,single nucleotide variant,NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln),4000,LMNA,HGNC:6636,Pathogenic,1,31-Oct-18,11575937,RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299,"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202","Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided",de novo;germline;unknown,germline,GRCh37,NC_000001.10,1,156106776,156106776,G,A,1q22,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992",3,14486,1,156106776,G,A,29525,1:156106776:G:A,Pathogenic,2017-12-01,"The p.Arg482Gln variant in LMNA has been reported in at least 20 individuals with Dunnigan-type familial partial lipodystrophy (FPLD) and segregated with disease in more than 40 affected family members from at least 8 families (Cao 2000, Hegel 2000, Speckman 2000, Vigouroux 2000, Ludtke 2005, Gambineri 2008, Mory 2012, Wiltshire 2013, Lewandowski 2015). Other clinical laboratories have reported this variant in ClinVar (Variation ID 14486). This variant has also been identified in 1/111632 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs11575937). Please note that for diseases with clinical variability, reduced penetrance, or recessive inheritance, pathogenic variants may be present at a low frequency in the general population. Transgenic mice with the p.Arg482Gln variant of LMNA have a phenotype consistent FPLD (Wojtanik 2009). In summary, this variant meets our criteria to be classified as pathogenic for FPLD in an autosomal dominant manner based on presence in multiple affected individuals, segregation studies, low frequency in the general population and in vivo functional studies. ACMG/AMP Criteria applied: PS4, PP1_strong, PM2, PS3_moderate (Richards 2015).",Orphanet:ORPHA98301,CN236383:Laminopathy,NA,TRUE,description from lab says lipodystrophy,"criteria provided, single submitter",clinical testing,germline:13,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000065011.5,LMNA,-,"Lipodystrophy, MonogenicDM_all",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000065011,FALSE,TRUE,TRUE,Pathogenic
29525,single nucleotide variant,NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln),4000,LMNA,HGNC:6636,Pathogenic,1,31-Oct-18,11575937,RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299,"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202","Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided",de novo;germline;unknown,germline,GRCh37,NC_000001.10,1,156106776,156106776,G,A,1q22,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992",3,14486,1,156106776,G,A,29525,1:156106776:G:A,Pathogenic,2017-08-11,"The LMNA c.1445G>A, p.Arg482Gln variant (rs11575937) has been reported in multiple families with familial partial lipodystrophy (Dunnigan-type) (Cao 2000, Drac 2010, Gamberini 2008, Hegele 2000, Hegele 2000b, Imachi 2009, Ludtke 2005, Shackleton 2000, Speckman 2000, Vigouroux 2000), and co-segregated with affected individuals (Cao 2000, Hegele 2000, Speckman 2000). Other missense variants at this position (p.Arg482Trp and p.Arg482Leu) have also been implicated in familial partial lipodystrophy (Hegele 2000b, Shackleton 2000, Speckman 2000, Vigouroux 2000). The variant protein appears to have no significant impact on the structural integrity of the nucleus, but appears to decrease Lamin B2 expression (Zwerger 2013). Transgenic mice expressing the human variant protein shows increase blood insulin levels, reduced insulin sensitivity, and impaired adipocyte differentiation, consistent with the clinical phenotypes in patients (Wojtanik 2009). The p.Arg482Gln variant is listed as pathogenic in ClinVar (Variation ID: 14486), and observed once in the Exome Variant Server (1/13006 alleles) and Genome Aggregation Database (1/246132 alleles). Based on the above information, the variant is classified as pathogenic. References: Cao H et al. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000; 9(1):109-12. Gambineri A et al. Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin. Eur J Endocrinol. 2008; 159(3):347-53. Hegele R et al. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 2000; 10(5):652-8. Hegele R et al. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab. 2000b; 85(9):3431-5. Imachi H et al. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease. Endocrine. 2009; 35(1):18-21. Ludtke A et al. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. Am J Gastroenterol. 2005; 100(10):2218-24. Shackleton S et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000; 24(2):153-6. Speckman R et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 2000; 66(4):1192-8. Vigouroux C et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000; 49(11):1958-62. Wojtanik K et al. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. J Lipid Res. 2009; 50(6):1068-79. Zwerger M et al. Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet. 2013; 22(12):2335-49.",Not Provided,CN517202:not provided,familial partial lipodystrophy (Dunnigan-type),TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories",SCV000885655.1,-,-,"Lipodystrophy, MonogenicDM_all",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000885655,FALSE,FALSE,TRUE,Pathogenic
29525,single nucleotide variant,NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln),4000,LMNA,HGNC:6636,Pathogenic,1,31-Oct-18,11575937,RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299,"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202","Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided",de novo;germline;unknown,germline,GRCh37,NC_000001.10,1,156106776,156106776,G,A,1q22,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992",3,14486,1,156106776,G,A,29525,1:156106776:G:A,Pathogenic,2013-02-08,-,"Lipodystrophy, familial partial, 2",C1720860:Familial partial lipodystrophy 2,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000595606.1,LMNA,-,"Lipodystrophy, MonogenicDM_all",10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000595606,FALSE,FALSE,TRUE,Pathogenic
29966,duplication,NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs),6927,HNF1A,HGNC:11621,Pathogenic,1,6-Nov-17,587776825,RCV000016063;RCV000117225;RCV000016064;RCV000022617;RCV000016062;RCV000490055,"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:ORPHA319276,SNOMED CT:188251003,SNOMED CT:254915003;MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:CN517202","Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided",germline;somatic,germline/somatic,GRCh37,NC_000012.11,12,121432125,121432125,C,CC,12q24.31,"criteria provided, multiple submitters, no conflicts",4,NA,N,OMIM Allelic Variant:142410.0001,3,14927,12,121432117,G,GC,29966,12:121432117:G:GC,Pathogenic,2017-11-06,"The c.872dupC variant in the HNF1A gene has been reported previously in association with maturity-onset diabetes of the young (Simms et al., 2011; Yamagata et al., 1996). The c.872dupC variant causes a frameshift starting with codon Glycine 292, changes this amino acid to an Arginine residue, and creates a premature Stop codon at position 25 of the new reading frame, denoted p.Gly292ArgfsX25. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.872dupC variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.872dupC as a pathogenic variant.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000576668.3,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",11/6/17,46549,414,17,"[0.9998173967217341,1.8260327826591334E-4]",17,SCV000576668,FALSE,TRUE,TRUE,Pathogenic
29966,duplication,NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs),6927,HNF1A,HGNC:11621,Pathogenic,1,6-Nov-17,587776825,RCV000016063;RCV000117225;RCV000016064;RCV000022617;RCV000016062;RCV000490055,"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:ORPHA319276,SNOMED CT:188251003,SNOMED CT:254915003;MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:CN517202","Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided",germline;somatic,germline/somatic,GRCh37,NC_000012.11,12,121432125,121432125,C,CC,12q24.31,"criteria provided, multiple submitters, no conflicts",4,NA,N,OMIM Allelic Variant:142410.0001,3,14927,12,121432117,G,GC,29966,12:121432117:G:GC,Pathogenic,2015-09-09,-,not provided,CN517202:not provided,MODY - from pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613637.2,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",11/6/17,46549,414,17,"[0.9998173967217341,1.8260327826591334E-4]",17,SCV000613637,FALSE,FALSE,TRUE,Pathogenic
29984,single nucleotide variant,NM_000545.6(HNF1A):c.827C>A (p.Ala276Asp),6927,HNF1A,HGNC:11621,Likely pathogenic,1,7-Jul-17,137853245,RCV000016083;RCV000521190,"MedGen:C1838100,OMIM:600496;MedGen:CN517202","Maturity-onset diabetes of the young, type 3;not provided",germline,germline,GRCh37,NC_000012.11,12,121432080,121432080,C,A,12q24.31,"criteria provided, single submitter",2,NA,N,OMIM Allelic Variant:142410.0019,3,14945,12,121432080,C,A,29984,12:121432080:C:A,Likely pathogenic,2017-07-07,"The A276D variant has been reported previously in association with MODY (Bjrkhaug et al., 2003; Bellann-Chantelot et al., 2008). The variant is observed in 1/8770 (0.01%) alleles from individuals of African background in the ExAC dataset (Lek et al., 2016). A276D is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (A276G) and in nearby residues (R271W/G/Q, R272S/H, K273N, K280E, L281P) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, this variant is likely pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617535.1,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",7/7/17,46944,19,2,"[0.9999786980231765,2.1301976823449217E-5]",2,SCV000617535,FALSE,TRUE,TRUE,Likely pathogenic
31173,single nucleotide variant,NM_000162.3(GCK):c.683C>T (p.Thr228Met),2645,GCK,HGNC:4195,Pathogenic,1,12-Jun-17,80356655,RCV000020167;RCV000030923;RCV000498792,"MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline,germline,GRCh37,NC_000007.13,7,44187429,44187429,G,A,7p13,"criteria provided, multiple submitters, no conflicts",4,NA,N,"OMIM Allelic Variant:138079.0003,OMIM Allelic Variant:138079.0011,UniProtKB (protein):P35557#VAR_003705",3,16134,7,44187429,G,A,31173,7:44187429:G:A,Pathogenic,2017-06-12,"The T228M variant has been published previously in association with MODY, including a confirmed de novo occurrence (Stanik et al., 2014; Costantini et al., 2015). The variant has also been observed in the homozygous state in patients with neonatal diabetes mellitus (Stoffel et al., 1992; Njlstad et al., 2001). The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). T228M is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the substrate-binding site that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown T228M nearly eliminates the catalytic activity of the GCK protein (Njlstad et al., 2001; Molnes et al., 2011). Missense variants in the same residue (T228A/K/R) and in nearby residues (I225F/M, V226E/M, G227R/S/C, G229V/D, N231H/S) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000589594.2,GCK,-,"MODY, MODY Extended, MonogenicDM_all",6/12/17,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000589594,FALSE,TRUE,TRUE,Pathogenic
31173,single nucleotide variant,NM_000162.3(GCK):c.683C>T (p.Thr228Met),2645,GCK,HGNC:4195,Pathogenic,1,12-Jun-17,80356655,RCV000020167;RCV000030923;RCV000498792,"MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline,germline,GRCh37,NC_000007.13,7,44187429,44187429,G,A,7p13,"criteria provided, multiple submitters, no conflicts",4,NA,N,"OMIM Allelic Variant:138079.0003,OMIM Allelic Variant:138079.0011,UniProtKB (protein):P35557#VAR_003705",3,16134,7,44187429,G,A,31173,7:44187429:G:A,Pathogenic,2013-10-18,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613451.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",6/12/17,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000613451,FALSE,FALSE,TRUE,Pathogenic
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2018-06-22,"This sequence change replaces arginine with glutamine at codon 3527 of the APOB protein (p.Arg3527Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs5742904, ExAC 0.04%). This variant is a very well known cause of hypercholesterolemia due to APOB deficiency mainly in people of European ancestry (PMID: 24404629). It has been reported to segregate in families affected with hypercholesterolemia (PMID: 2563166, 21868016) and has been reported in multiple affected unrelated individuals (PMID: 9105560, 21059979, 18325181, 18222178, 10388479, 23375686). This variant is also known in the literature as p.Arg3500Gln. ClinVar contains an entry for this variant (Variation ID: 17890). Experimental studies have shown that this missense change disturbs the APOB protein conformation preventing it from binding LDL, therefore disturbing its normal function as inhibitor of the LDL receptor (PMID: 11115503, 15797858). A different missense substitution at this codon (p.Arg3527Trp) is reported to be deleterious (PMID: 7627691). This indicates that the arginine residue is important for APOB protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C1704417;MedGen:CN182502,"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000541940.4,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000541940,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2018-01-11,"The p.Arg3527Gln variant in APOB is a well-established pathogenic variant that is mainly found in individuals of European descent. It has been previously reported in >500 individuals with familial hypercholesterolemia (FH) and segregated with disease in >50 affected relatives (Soria 1989, M_rz 1993, Leren 1997, Ludwig 1990, Bednarska-Makaruk 2001, Horvath 2001, Kalina 2001). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 17890). It has been identified in 53/126056 of European chromosomes, including 1 homozygote, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs5742904). This frequency is low enough to be consistent with the frequency of FH in the general population. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant familial hypercholesterolemia based upon presence in multiple affected individuals and segregation studies. Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews). ACMG/AMP Criteria applied: PS4_strong, PP1_Strong (Richards 2015).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:71,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271309.2,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000271309,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2017-11-07,"The R3527Q pathogenic variant in the APOB gene, also denoted as R3500Q due to the use of alternate nomenclature, has been previously reported in association with apolipoprotein B deficiency and hypercholesterolemia (Soria et al., 1989; Tybjaerg-Hansen et al.,1998; Fisher et al., 1999; Bertolini et al., 2013; Norsworthy et al., 2014; Radovica-Splavina et al., 2015; Braenne et al., 2016). This variant has been shown to segregate with disease in multiple affected relatives from multiple families (Soria et al., 1989; Loux et al., 1993; Chatzistefanidis et al., 2013). Additionally, R3527Q has been reported as a founder mutation in the Old Order Amish population (Shen et al., 2010). This variant is observed in 73/126,056 alleles from individuals of Non-Finnish European ancestry in large population cohorts (Lek et al., 2016). The R3527Q variant is a semi-conservative amino acid substitution, which occurs at a position that is conserved across mammalian species. Moreover, functional studies indicate that the R3527Q variant causes decreased binding of the APOB protein to the LDL receptor (Fisher et al., 1999). Furthermore, a pathogenic missense variant at the same residue (R3527W, also denoted as R3500W due to the use of alternate nomenclature) has also been reported in association with FH (Gaffney et al., 1995; Fisher et al., 1999).",Not Provided,CN517202:not provided,hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000322134.6,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000322134,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2017-05-25,"This c.10580G>A (p.Arg3527Gln) variant in the APOB gene has previously been reported in multiple patients with hypercholesterolemia [PMID 2563166, 23375686, 18325181, 27497240, 24956927, 21059979, 9603795 among others, reported as p.Arg3500Gln]. This variant is the most common cause of hypercholesterolemia due to an APOB variant and is common among Northern European populations. This change disrupts the binding of low density lipoproteins (LDL) onto the LDL receptor. The receptor mediated catabolism is thus disrupted and LDL accumulates in the plasma. The disorder caused by this specific variant is sometimes referred as hypercholesterolemia, due to ligand-defective apo B [MIM 144010]. This variant has been observed in 28 heterozygous individuals from the ExAC database (http://exac.broadinstitute.org/variant/2-21229160-C-T). Arginine at position 3527 of the APOB protein is highly conserved within mammals. While not validated for clinical use, the computer-based algorithms predict this p.Arg3527Gln change to be deleterious. It is thus interpreted as a pathogenic variant.",OMIM:144010,"C1704417:Hypercholesterolemia, autosomal dominant, type B",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839879.1,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000839879,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2016-06-14,"The c.10580G>A (p.Arg3527Gln) variant, also reported as p.Arg3500Gln, is well described in the literature and reported as one of the two most common variants associated with familial hypercholesterolemia, particularly in individuals of European ancestry (Youngblom et al. 2014). Across a selection of the available literature, the p.Arg3527Gln variant has been found in a heterozygous state in 42 patients (Tybjaerg-Hansen et al. 1998; Soria et al. 1989; Saint-Jore et al. 2000; Bednarska-Makaruk et al. 2001; Horvath et al. 2001; Braenne et al. 2016). Four of the studies demonstrated segregation of the variant with disease (Soria et al. 1989; Horvath et al. 2001; Saint-Jore et al. 2000; Braenne et al. 2016). Control data are unavailable for this variant which is reported at a frequency of 0.00081 in the European American population of the Exome Sequencing Project. Functional studies in transgenic mice showed that the variant resulted in defective LDL receptor binding (Boren et al. 2001). Based on the collective evidence, the p.Arg3527Gln variant is classified as pathogenic for familial hypercholesterolemia.",Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000426986.2,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000426986,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Pathogenic,2016-04-18,-,not provided,CN517202:not provided,hypercholesterolemia - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000612386.1,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000612386,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
32929,single nucleotide variant,NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,11-Jul-18,5742904,RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided",germline;maternal;unknown,germline,GRCh37,NC_000002.11,2,21229160,21229160,C,T,2p24,"criteria provided, conflicting interpretations",18,"ACMG2013,ACMG2016",Y,OMIM Allelic Variant:107730.0009,3,17890,2,21229160,C,T,32929,2:21229160:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:20,"Robarts Research Institute,Western University",SCV000484820.1,APOB,-,Low LDL,7/11/18,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000484820,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
44274,single nucleotide variant,NM_000352.4(ABCC8):c.3517G>A (p.Val1173Met),6833,ABCC8,HGNC:59,Likely pathogenic,1,1-Jan-17,141322087,RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000029255;RCV000626670;RCV000626670;RCV000626670,"Human Phenotype Ontology:HP:0001631,MedGen:C0018817,Orphanet:ORPHA1478;Human Phenotype Ontology:HP:0001693,MedGen:C0232180;Human Phenotype Ontology:HP:0001635,MedGen:C0018802;Human Phenotype Ontology:HP:0011968,MedGen:C0232466;Human Phenotype Ontology:HP:0002020,MedGen:C4317146;Human Phenotype Ontology:HP:0001510,MedGen:C0456070;Human Phenotype Ontology:HP:0001943,MedGen:C0020615;Human Phenotype Ontology:HP:0000256,MedGen:C2243051;Human Phenotype Ontology:HP:0000400,MedGen:C0152421;MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;Human Phenotype Ontology:HP:0002643,MedGen:C4281993;Human Phenotype Ontology:HP:0004322,MedGen:C0349588;Human Phenotype Ontology:HP:0001518,MedGen:C0235991",Atrial septal defect;Cardiac shunt;Congestive heart failure;Feeding difficulties;Gastroesophageal reflux;Growth delay;Hypoglycemia;Macrocephalus;Macrotia;Neonatal diabetes mellitus;Neonatal respiratory distress;Short stature;Small for gestational age,germline;unknown,germline,GRCh37,NC_000011.9,11,17426099,17426099,C,T,11p15.1,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,35609,11,17426099,C,T,44274,11:17426099:C:T,Likely pathogenic,2011-08-18,-,Neonatal Diabetes Mellitus,C0158981:Neonatal diabetes mellitus,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000051901.1,ABCC8,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",1/1/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000051901,FALSE,FALSE,FALSE,
44279,single nucleotide variant,NM_000352.4(ABCC8):c.4135C>A (p.Arg1379Ser),6833,ABCC8,HGNC:59,Conflicting interpretations of pathogenicity,1,9-May-18,137852673,RCV000029261;RCV000675131,"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005",Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy,germline;unknown,germline,GRCh37,NC_000011.9,11,17417462,17417462,G,T,11p15.1,"criteria provided, conflicting interpretations",2,NA,N,-,2,35614,11,17417462,G,T,44279,11:17417462:G:T,Likely pathogenic,2011-08-18,-,Neonatal Diabetes Mellitus,C0158981:Neonatal diabetes mellitus,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000051907.1,ABCC8,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",5/9/18,46517,446,3,"[0.9999677537244448,3.2246275555173374E-5]",3,SCV000051907,FALSE,FALSE,FALSE,
44289,single nucleotide variant,NM_000352.4(ABCC8):c.886G>A (p.Gly296Arg),6833,ABCC8,HGNC:59,Conflicting interpretations of pathogenicity,1,9-Nov-17,148529020,RCV000029271;RCV000675093,"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005",Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy,germline;unknown,germline,GRCh37,NC_000011.9,11,17482160,17482160,C,T,11p15.1,"criteria provided, conflicting interpretations",2,NA,N,-,2,35624,11,17482160,C,T,44289,11:17482160:C:T,Likely pathogenic,2011-08-18,-,Neonatal Diabetes Mellitus,C0158981:Neonatal diabetes mellitus,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000051917.1,ABCC8,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",11/9/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000051917,FALSE,FALSE,FALSE,
44479,deletion,NM_001807.4(CEL):c.1785delC (p.Val596Cysfs),1056,CEL,HGNC:1848,Likely pathogenic,1,18-Aug-11,193922638,RCV000029467,"MedGen:C1853297,OMIM:609812","Maturity-onset diabetes of the young, type 8",germline,germline,GRCh37,NC_000009.11,9,135946665,135946665,C,-,9q34.2,"criteria provided, single submitter",1,NA,N,-,2,35815,9,135946657,GC,G,44479,9:135946657:GC:G,Likely pathogenic,2011-08-18,-,MODY8,"C1853297:Maturity-onset diabetes of the young, type 8",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:4,Integrated Genetics/Laboratory Corporation of America,SCV000052117.1,CEL,-,"MODY Extended, MonogenicDM_all",8/18/11,41404,5559,1,"[0.9999879238720897,1.2076127910346827E-5]",1,SCV000052117,FALSE,FALSE,FALSE,
44846,single nucleotide variant,NM_000162.3(GCK):c.1160C>T (p.Ala387Val),2645,GCK,HGNC:4195,Likely pathogenic,1,3-Dec-15,193921338,RCV000029845;RCV000493278,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44185189,44185189,G,A,7p13,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,36182,7,44185189,G,A,44846,7:44185189:G:A,Likely pathogenic,2015-12-03,"The A387V variant has been previously published in association with GCK-MODY (Thomson et al., 2003; Pruhova et al., 2010). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. A387V is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species within the hexokinase domain; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (A387E/T) and in nearby residues (G385R/W/V, L386V, G388D) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000582616.3,GCK,-,"MODY, MODY Extended, MonogenicDM_all",12/3/15,46297,666,1,"[0.9999892001641575,1.0799835842495194E-5]",1,SCV000582616,FALSE,FALSE,FALSE,
44846,single nucleotide variant,NM_000162.3(GCK):c.1160C>T (p.Ala387Val),2645,GCK,HGNC:4195,Likely pathogenic,1,3-Dec-15,193921338,RCV000029845;RCV000493278,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44185189,44185189,G,A,7p13,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,36182,7,44185189,G,A,44846,7:44185189:G:A,Likely pathogenic,2011-08-18,-,MODY2,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:3,Integrated Genetics/Laboratory Corporation of America,SCV000052500.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",12/3/15,46297,666,1,"[0.9999892001641575,1.0799835842495194E-5]",1,SCV000052500,FALSE,FALSE,FALSE,
44852,single nucleotide variant,NM_000162.3(GCK):c.1240A>G (p.Lys414Glu),2645,GCK,HGNC:4195,Likely pathogenic,1,22-May-18,193922272,RCV000029851;RCV000711759,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44185109,44185109,T,C,7p13,"criteria provided, multiple submitters, no conflicts",2,NA,N,UniProtKB (protein):P35557#VAR_003714,2,36188,7,44185109,T,C,44852,7:44185109:T:C,Likely pathogenic,2011-08-18,-,MODY2,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:4,Integrated Genetics/Laboratory Corporation of America,SCV000052506.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",5/22/18,46861,102,1,"[0.9999893301466037,1.0669853396214336E-5]",1,SCV000052506,FALSE,FALSE,FALSE,
44873,single nucleotide variant,NM_000162.3(GCK):c.214G>A (p.Gly72Arg),2645,GCK,HGNC:4195,Pathogenic,1,12-Jul-18,193922289,RCV000029872;RCV000255585,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44192019,44192019,C,T,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,36209,7,44192019,C,T,44873,7:44192019:C:T,Pathogenic,2018-07-12,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842164.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",7/12/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000842164,FALSE,FALSE,FALSE,
44873,single nucleotide variant,NM_000162.3(GCK):c.214G>A (p.Gly72Arg),2645,GCK,HGNC:4195,Pathogenic,1,12-Jul-18,193922289,RCV000029872;RCV000255585,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44192019,44192019,C,T,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,36209,7,44192019,C,T,44873,7:44192019:C:T,Pathogenic,2016-04-04,"The G72R variant has been published previously in association with MODY2 (Lehto et al., 1999; Raimondo et al., 2014; Flanagan et al., 2014). The variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. G72R is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within a connecting region that is conserved across species, and which is critical for glucokinase interaction (Zelent et al., 2011). In silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have shown that G72R results in increased activity compared to wild type, as well as decreased thermal stability of the protein (Sagen et al., 2006; Raimondo et al., 2014). Missense variants in nearby residues (E70K/D, V71I, D73G, S76C/Y/F) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000321712.6,GCK,-,"MODY, MODY Extended, MonogenicDM_all",7/12/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000321712,FALSE,FALSE,FALSE,
44873,single nucleotide variant,NM_000162.3(GCK):c.214G>A (p.Gly72Arg),2645,GCK,HGNC:4195,Pathogenic,1,12-Jul-18,193922289,RCV000029872;RCV000255585,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44192019,44192019,C,T,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,36209,7,44192019,C,T,44873,7:44192019:C:T,Pathogenic,2011-08-18,-,MODY2,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:8,Integrated Genetics/Laboratory Corporation of America,SCV000052527.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",7/12/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000052527,FALSE,FALSE,FALSE,
44881,single nucleotide variant,NM_000162.3(GCK):c.440G>A (p.Gly147Asp),2645,GCK,HGNC:4195,Likely pathogenic,1,18-Aug-11,193922296,RCV000029880,"MedGen:C1841962,OMIM:125851","Maturity-onset diabetes of the young,  type 2",germline,germline,GRCh37,NC_000007.13,7,44190598,44190598,C,T,7p13,"criteria provided, single submitter",1,NA,N,-,2,36217,7,44190598,C,T,44881,7:44190598:C:T,Likely pathogenic,2011-08-18,-,MODY2,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000052535.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000052535,FALSE,FALSE,FALSE,
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Pathogenic,2018-10-31,-,OMIM:125851;OMIM:125853;OMIM:602485;OMIM:606176,"C0011860:Diabetes mellitus type 2;C1833104:Permanent neonatal diabetes mellitus;C1841962:Maturity-onset diabetes of the young, type 2;C1865290:Hyperinsulinemic hypoglycemia familial 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894423.1,-,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000894423,FALSE,FALSE,TRUE,Pathogenic
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Pathogenic,2017-10-11,"The V226M missense variant in the GCK gene has been reported previously in association with MODY (Velho et al., 1997; Pruhova et al., 2010; Vits et al., 2006). This variant has been shown to segregate with disease in many affected individuals from several families in published literature (Henderson et al., 2007) or referred for genetic testing at GeneDx. The V226M variant is observed in 2/111,690 (0.0018%) alleles from individuals of non-Finnish European background in the gnomAD dataset (Lek et al., 2016). This substitution occurs at a position in the hexokinase subdomain that is conserved across species, and functional studies have shown that V226M leads to decreased enzyme activity of the glucokinase protein (Davis et al., 1999). However, another functional study theorized V226M may lead to a milder phenotype in comparison to other GCK pathogenic variants, as it leads to increased stability of the glucokinase protein while simltaneously decreasing its activity (Raimondo et al., 2014). Missense variants in the same codon (V226L/E) have been reported in association with MODY (Borowiec et al., 2012; Pruhova et al., 2010), as have missense variants in nearby residues (M224R/T, I225F/M, G227R/S/C, T228A/M/R/K) in the Human Gene Mutation Database (Stenson et al., 2014), supporting the functional importance of this region of the protein. The V226M variant is reported as pathogenic in ClinVar but additional evidence is not available (Landrum et al., 2016; SCV000594954.1). We interpret V226M as a pathogenic variant.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000322348.6,GCK,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000322348,FALSE,TRUE,TRUE,Pathogenic
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Pathogenic,2017-04-17,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613449.2,GCK,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000613449,FALSE,FALSE,TRUE,Pathogenic
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Likely pathogenic,2016-10-04,-,OMIM:125851,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Molecular Diagnostics Laboratory,M Health: University of Minnesota",SCV000891242.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000891242,FALSE,FALSE,TRUE,Pathogenic
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Pathogenic,2016-07-19,-,"MODY, type II","C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000594954.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000594954,FALSE,FALSE,TRUE,Pathogenic
44907,single nucleotide variant,NM_000162.5(GCK):c.676G>A (p.Val226Met),2645,GCK,HGNC:4195,Pathogenic/Likely pathogenic,1,31-Oct-18,148311934,RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202","Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided",germline;unknown,germline,GRCh37,NC_000007.13,7,44189362,44189362,C,T,7p13,"criteria provided, multiple submitters, no conflicts",6,NA,N,UniProtKB (protein):P35557#VAR_003703,2,36243,7,44189362,C,T,44907,7:44189362:C:T,Pathogenic,2011-08-18,-,MODY2,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:25,Integrated Genetics/Laboratory Corporation of America,SCV000052561.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000052561,FALSE,FALSE,TRUE,Pathogenic
45013,single nucleotide variant,NM_000457.4(HNF4A):c.427A>G (p.Ser143Gly),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,20-Mar-17,193922472,RCV000030019;RCV000484752,"MedGen:C1852093,OMIM:125850;MedGen:CN169374","Maturity-onset diabetes of the young,  type 1;not specified",germline,germline,GRCh37,NC_000020.10,20,43042375,43042375,A,G,20q13.1,"criteria provided, conflicting interpretations",2,NA,N,-,2,36349,20,43042375,A,G,45013,20:43042375:A:G,Likely pathogenic,2011-08-18,-,MODY1,"C1852093:Maturity-onset diabetes of the young, type 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000052674.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",3/20/17,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000052674,TRUE,FALSE,FALSE,
45024,single nucleotide variant,NM_000457.4(HNF4A):c.834G>C (p.Glu278Asp),3172,HNF4A,HGNC:5024,Likely pathogenic,1,18-Aug-11,193922477,RCV000030030,"MedGen:C1852093,OMIM:125850","Maturity-onset diabetes of the young,  type 1",germline,germline,GRCh37,NC_000020.10,20,43048458,43048458,G,C,20q13.1,"criteria provided, single submitter",1,NA,N,-,2,36360,20,43048458,G,C,45024,20:43048458:G:C,Likely pathogenic,2011-08-18,-,MODY1,"C1852093:Maturity-onset diabetes of the young, type 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000052685.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000052685,FALSE,FALSE,FALSE,
45028,single nucleotide variant,NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,21-Dec-16,193922479,RCV000193933;RCV000030034;RCV000517103,"Human Phenotype Ontology:HP:0000842,MedGen:C0020459;MedGen:C1852093,OMIM:125850;MedGen:CN169374","Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified",germline,germline,GRCh37,NC_000020.10,20,43052756,43052756,C,T,20q13.1,"criteria provided, conflicting interpretations",3,NA,N,-,2,36364,20,43052756,C,T,45028,20:43052756:C:T,Uncertain significance,2016-12-21,-,not specified,CN169374:not specified,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613665.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",12/21/16,46938,25,1,"[0.9999893476500916,1.065234990838979E-5]",1,SCV000613665,FALSE,FALSE,FALSE,
45028,single nucleotide variant,NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,21-Dec-16,193922479,RCV000193933;RCV000030034;RCV000517103,"Human Phenotype Ontology:HP:0000842,MedGen:C0020459;MedGen:C1852093,OMIM:125850;MedGen:CN169374","Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified",germline,germline,GRCh37,NC_000020.10,20,43052756,43052756,C,T,20q13.1,"criteria provided, conflicting interpretations",3,NA,N,-,2,36364,20,43052756,C,T,45028,20:43052756:C:T,Likely pathogenic,2011-08-18,-,MODY1,"C1852093:Maturity-onset diabetes of the young, type 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:3,Integrated Genetics/Laboratory Corporation of America,SCV000052689.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",12/21/16,46938,25,1,"[0.9999893476500916,1.065234990838979E-5]",1,SCV000052689,FALSE,FALSE,FALSE,
45074,single nucleotide variant,NM_000209.3(PDX1):c.725C>T (p.Pro242Leu),3651,PDX1,HGNC:6107,Conflicting interpretations of pathogenicity,1,28-Mar-16,193922358,RCV000030083;RCV000455258,"MedGen:C1833382,OMIM:606392;MedGen:CN169374","Maturity-onset diabetes of the young, type 4;not specified",germline,germline,GRCh37,NC_000013.10,13,28498711,28498711,C,T,13q12.2,"criteria provided, conflicting interpretations",2,NA,N,-,2,36411,13,28498711,C,T,45074,13:28498711:C:T,Likely pathogenic,2011-08-18,-,MODY4,"C1833382:Maturity-onset diabetes of the young, type 4",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:8,Integrated Genetics/Laboratory Corporation of America,SCV000052738.1,IPF1,-,"MODY, MODY Extended, MonogenicDM_all",3/28/16,41198,5765,24,"[0.9997087237244526,2.9127627554735667E-4]",24,SCV000052738,FALSE,FALSE,FALSE,
45077,single nucleotide variant,NM_000209.3(PDX1):c.97C>A (p.Pro33Thr),3651,PDX1,HGNC:6107,Conflicting interpretations of pathogenicity,1,10-Jun-16,192902098,RCV000030086;RCV000414508,"MedGen:C1833382,OMIM:606392;MedGen:CN517202","Maturity-onset diabetes of the young, type 4;not provided",germline,germline,GRCh37,NC_000013.10,13,28494372,28494372,C,A,13q12.2,"criteria provided, conflicting interpretations",2,NA,N,-,2,36414,13,28494372,C,A,45077,13:28494372:C:A,Likely pathogenic,2016-06-10,"The P33T variant in the PDX1 gene has been published previously in association with gestational diabetes, MODY, type 2 diabetes, and ketosis-prone diabetes (Gragnoli et al., 2005; Edghill et al., 2011; Haaland et al., 2009). However, the variant was also reported in multiple unaffected family members as well as unaffected controls in these studies. The P33T variant was not observed in approximately 5400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P33T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. While functional studies have indicated that P33T impairs the normal function of the PDX1 protein, this impairment is not complete (Gragnoli et al., 2005). The P33T variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.",Not Provided,CN517202:not provided,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000490700.1,PDX1,-,"MODY, MODY Extended, MonogenicDM_all",6/10/16,38775,8188,96,"[0.998762088974855,0.0012379110251450676]",96,SCV000490700,FALSE,FALSE,FALSE,
45077,single nucleotide variant,NM_000209.3(PDX1):c.97C>A (p.Pro33Thr),3651,PDX1,HGNC:6107,Conflicting interpretations of pathogenicity,1,10-Jun-16,192902098,RCV000030086;RCV000414508,"MedGen:C1833382,OMIM:606392;MedGen:CN517202","Maturity-onset diabetes of the young, type 4;not provided",germline,germline,GRCh37,NC_000013.10,13,28494372,28494372,C,A,13q12.2,"criteria provided, conflicting interpretations",2,NA,N,-,2,36414,13,28494372,C,A,45077,13:28494372:C:A,Uncertain significance,2011-08-18,-,MODY4,"C1833382:Maturity-onset diabetes of the young, type 4",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:13,Integrated Genetics/Laboratory Corporation of America,SCV000052741.1,IPF1,-,"MODY, MODY Extended, MonogenicDM_all",6/10/16,38775,8188,96,"[0.998762088974855,0.0012379110251450676]",96,SCV000052741,FALSE,FALSE,FALSE,
45113,single nucleotide variant,NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,193922566,RCV000030122;RCV000722113;RCV000413322,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11221442,11221442,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369",2,36450,19,11221442,G,A,45113,19:11221442:G:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894172.1,-,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000894172,FALSE,FALSE,TRUE,Pathogenic
45113,single nucleotide variant,NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,193922566,RCV000030122;RCV000722113;RCV000413322,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11221442,11221442,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369",2,36450,19,11221442,G,A,45113,19:11221442:G:A,Pathogenic,2018-09-17,"Variant summary: LDLR c.1055G>A (p.Cys352Tyr) results in a non-conservative amino acid change located in the EGF-like domain and EGF-like calcium-binding domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.1e-06 in 245700 control chromosomes. c.1055G>A has been reported in the literature in multiple individuals affected with Familial Hypercholesterolemia. In one family, a severely affected proband was homozygous for the variant, while the father and paternal grandmother who were heterozygous carriers were unaffected, suggesting incomplete penetrance of the variant (Magana Torres_2014). However, several variants at the same codon have been associated with FH (C352R, C352F, C352S, C352W), as well as the immediately adjacent codons, suggesting the locus is important for gene function. Overall, these data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on LDL receptor function, which showed the variant resulted in <10% of normal activity (Kolansky_2008). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000052777.2,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000052777,FALSE,FALSE,TRUE,Pathogenic
45113,single nucleotide variant,NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,193922566,RCV000030122;RCV000722113;RCV000413322,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11221442,11221442,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369",2,36450,19,11221442,G,A,45113,19:11221442:G:A,Pathogenic,2017-04-11,"This sequence change replaces cysteine with tyrosine at codon 352 of the LDLR protein (p.Cys352Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is present in population databases (rs193922566, ExAC 0.009%). This variant has been reported in the literature segregating with the disease in a family with hypercholesterolemia where the proband was homozygous for this variant (PMID: 25234566), as well as in multiple unrelated individuals affected with hypercholesterolemia (PMID: 1301956, 19717150, 23064986, 22698793, 21722902). This variant is also known as p.Cys331Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 36450). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant has been reported in the literature segregating with the disease in one family and in multiple unrelated affected individuals. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544690.2,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000544690,FALSE,TRUE,TRUE,Pathogenic
45113,single nucleotide variant,NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,193922566,RCV000030122;RCV000722113;RCV000413322,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11221442,11221442,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369",2,36450,19,11221442,G,A,45113,19:11221442:G:A,Likely pathogenic,2016-12-12,"The C352Y likely pathogenic variant in the LDLR gene (also reported as C331Y due to alternate nomenclature) has been reported previously in association with FH (Hobbs et al., 1992; Kolansky et al., 2008; Alonso et al., 2009; Tichy et al., 2012; Magana Torres et al., 2014). Initially, the C352Y variant was reported in several Hispanic individuals with FH (Hobbs et al., 1992; Kolansky et al., 2008; Alonso et al., 2009) and was also subsequently reported in a Czech individual with FH (Tichy et al., 2012). Most recently, the C352Y variant was reported to be homozygous in one individual with severe homozygous FH (Magana Torres et al., 2014). This variant was reported to be heterozygous in both parents, siblings, and the paternal grandmother; however, reduced penetrance was noted as the father and paternal grandmother who were heterozygous for the variant were asymptomatic (Magana Torres et al., 2014). Additionally, the C352Y variant has been reported as a likely pathogenic variant associated with FH by one other clinical laboratory in ClinVar (ClinVar SCV000052777.1; Landrum et al., 2016). The C352Y variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project and was not observed with any significant frequency in the Exome Aggregation Consortium, indicating it is not a common benign variant in these populations. The C352Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved across species and is located in the EGF-like 1 domain. Furthermore, in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (C352S, C352R, C352F, C352W) have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014); however, the pathogenicity of these variants has not been definitively determined.Therefore, this variant is likely pathogenic. In order to definitively determine its clinical significance, additional data is required.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000491200.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000491200,FALSE,FALSE,TRUE,Pathogenic
45113,single nucleotide variant,NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,193922566,RCV000030122;RCV000722113;RCV000413322,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11221442,11221442,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369",2,36450,19,11221442,G,A,45113,19:11221442:G:A,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys340 and Cys352.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540786.1,LDLR,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540786,FALSE,FALSE,TRUE,Pathogenic
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Benign,2018-01-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556781.3,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000556781,TRUE,TRUE,TRUE,Benign
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Benign,2017-06-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000689757.1,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000689757,TRUE,FALSE,TRUE,Benign
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Likely benign,2015-06-17,-,Familial hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia",SCV000257699.2,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000257699,TRUE,FALSE,TRUE,Benign
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Uncertain significance,2011-08-18,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:56,Integrated Genetics/Laboratory Corporation of America,SCV000052778.1,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000052778,TRUE,FALSE,TRUE,Benign
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484782.1,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000484782,TRUE,FALSE,TRUE,Benign
45114,single nucleotide variant,NM_000527.4(LDLR):c.1061-8T>C,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,31-May-18,72658861,RCV000030123;RCV000759074;RCV000245346,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11222182,11222182,T,C,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000154,2,36451,19,11222182,T,C,45114,19:11222182:T:C,Benign,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733818.1,LDLR,-,High LDL,5/31/18,46960,3,426,"[0.9954642248722317,0.004535775127768314]",420,SCV000733818,TRUE,FALSE,TRUE,Benign
45115,single nucleotide variant,NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Mar-16,138315511,RCV000030124;RCV000148563,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11222214,11222214,A,C,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000792,2,36452,19,11222214,A,C,45115,19:11222214:A:C,Likely pathogenic,2011-08-18,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:9,Integrated Genetics/Laboratory Corporation of America,SCV000052779.1,LDLR,-,High LDL,3/25/16,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000052779,FALSE,FALSE,FALSE,
45115,single nucleotide variant,NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Mar-16,138315511,RCV000030124;RCV000148563,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11222214,11222214,A,C,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000792,2,36452,19,11222214,A,C,45115,19:11222214:A:C,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484750.1,LDLR,-,High LDL,3/25/16,46963,0,6,"[0.9999361199241956,6.388007580435663E-5]",6,SCV000484750,FALSE,FALSE,FALSE,
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Likely pathogenic,2018-01-23,"The p.Glu408Lys variant in LDLR (also described as p.Glu387Lys in the literature), has been reported in one individual with early myocardial infarction (Do 2015) and at least 7 individuals with familial hypercholesterolemia (FH), including at least 3 heterozygotes, 3 homozygotes and 1 compound heterozygote with a second pathogenic variant in the LDLR gene (Hobbs 1992, Dedoussis 2004, Widhalm 2007, Taylor 2010). Other clinical laboratories have also reported this variant in ClinVar (Variation ID 36453). In vitro functional studies provide some evidence that the p.Glu408Lys variant may impact ligand recycling as it failed to release ligands in the endosome (Hobbs 1992, Strom 2011). This variant has also been identified in 2/111530 European chromosomes by the Genome Aggregation Database (GnomAD, http://gnomad.broadinstitute.org; dbSNP rs137943601). This frequency is low enough to be consistent with the frequency of FH in the general population. Additionally, other amino acid changes at this position have been reported in individuals with FH (Palcoux 2008, Duscova 2011), suggesting that changes at this position may not be tolerated. In summary, although additional studies are required to fully establish its clinical significance, the p.Glu408Lys variant is likely pathogenic. ACMG/AMP Criteria applied: PS4_moderate, PM2, PS3_supporting, PM5_supporting (Richards 2015).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000711398.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000711398,FALSE,TRUE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:30,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583809.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583809,FALSE,FALSE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 10 , family members = 5 with co-segregation / FH-Algrie-1/Osaka, <2% LDLR Activity / Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503319.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503319,FALSE,FALSE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540803.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540803,FALSE,FALSE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Pathogenic,2016-08-08,"This sequence change replaces glutamic acid with lysine at codon 408 of the LDLR protein (p.Glu408Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs137943601, ExAC 0.002%). This variant has been reported in multiple unrelated individuals and families affected with hypercholesterolemia (PMID: 1301956, 14974088, 17347910, 19843101, 20236128). This variant is also known as FH Algeria-1 or E387K in the literature. ClinVar contains an entry for this variant (Variation ID: 36453). Experimental studies have shown that this missense change is a recycling-defective allele (PMID: 1301956, 21531209). In summary, this variant is rare in population databases, has been observed in many patients with hypercholesterolemia, and has been shown to have a deleterious effect on protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285013.3,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000285013,FALSE,FALSE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Pathogenic,2011-08-25,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268606.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268606,FALSE,FALSE,TRUE,Likely pathogenic
45116,single nucleotide variant,NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,137943601,RCV000030125;RCV000148564,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11223989,11223989,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378",2,36453,19,11223989,G,A,45116,19:11223989:G:A,Pathogenic,2011-08-18,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:14,Integrated Genetics/Laboratory Corporation of America,SCV000052780.1,LDLR,-,High LDL,1/23/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000052780,FALSE,FALSE,TRUE,Likely pathogenic
45119,single nucleotide variant,NM_000527.4(LDLR):c.1381G>A (p.Gly461Ser),3949,LDLR,HGNC:6547,Likely pathogenic,1,18-Aug-11,193922568,RCV000030128,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224233,11224233,G,A,19p13.2,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,-,2,36456,19,11224233,G,A,45119,19:11224233:G:A,Likely pathogenic,2011-08-18,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000052783.1,LDLR,-,High LDL,8/18/11,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000052783,FALSE,FALSE,FALSE,
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Benign,2018-01-26,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556791.3,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000556791,TRUE,TRUE,TRUE,Benign
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Likely benign,2017-06-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000689773.1,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000689773,TRUE,FALSE,TRUE,Benign
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Benign,2016-12-16,"subject mutated among 2600 FH index cases screened = 1/Polymorphisme cf whitall et al J Med Genet, 2002",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503470.1,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000503470,TRUE,FALSE,TRUE,Benign
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Uncertain significance,2011-08-18,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:9,Integrated Genetics/Laboratory Corporation of America,SCV000052788.1,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000052788,TRUE,FALSE,TRUE,Benign
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484792.1,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000484792,TRUE,FALSE,TRUE,Benign
45123,single nucleotide variant,NM_000527.4(LDLR):c.2140+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Jan-18,72658867,RCV000030133;RCV000614028,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11231203,11231203,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000283,2,36460,19,11231203,G,A,45123,19:11231203:G:A,Likely benign,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733830.1,LDLR,-,High LDL,1/26/18,46942,21,472,"[0.9949725192791103,0.005027480720889608]",464,SCV000733830,TRUE,FALSE,TRUE,Benign
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Uncertain significance,2017-11-02,"The V827I variant of uncertain significance in the LDLR gene (also reported as FH-New York 5, and as V806I due to alternate nomenclature) has been published multiple times in association with FH; however, there are conflicting reports concerning its pathogenicity (Hobbs et al., 1992; Lombardi et al., 2000; Zakharova et al., 2005; Tich_ et al., 2012; Bertolini et al., 2013; Vandrovcova et al., 2013; Norsworthy et al., 2014; Durst et al., 2017). Hobbs et al. (1992) originally reported V827I in an American individual with homozygous FH, who also harbored a second variant in the LDLR gene. Lombardi et al. (2000) identified this variant in a cohort of individuals with FH from the Netherlands but did not provided detailed clinical information. The V827I variant was also identified in a 36-year-old Russian female with FH (LDL-C 321 mg/dl) (Zakharova et al., 2005). Vandrocova et al. (2013) identified V827I in a middle-aged proband with elevated total cholesterol (7.9 mmol/l), but also in the proband's adult daughter with normal cholesterol levels (4.6 mmol/l). More recently, V827I was found in 8 Israeli individuals (7 heterozygotes and 1 compound heterozygote) with a mean cholesterol level of 5.4 mmol/L (Durst et al., 2017). Study participants were also genotyped for 6 common LDL-C raising SNPs, and 6/8 V827I carriers had a 6-SNP score above the top quartile cutoff, suggesting that V827I alone is not sufficient to cause the full FH phenotype (Durst et al., 2017). Via whole exome sequencing, Do et al. (2015) identified V287I in 4 patients experiencing myocardial infarction (MI) at an early age, as well as in 5 control individuals with no history of MI. There are conflicting classifications of V827I in ClinVar by other clinical laboratories, ranging from benign to likely pathogenic (SCV000503493.1, SCV000556789.1, SCV000540872.1, SCV000052790.2, SCV000484685.1, SCV000583958.1; Landrum et al., 2016). The V827I variant is observed in approximately 169/10,152 alleles (1.6%) from individuals of Ashkenazi Jewish ancestry, indicating it may be a rare benign variant in this population. The V827I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function.",not specified,CN169374:not specified,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000521002.3,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000521002,FALSE,TRUE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Likely benign,2017-10-30,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556789.3,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000556789,FALSE,TRUE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Benign,2017-08-29,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000689777.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000689777,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Uncertain significance,2017-08-01,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Phosphorus, Inc.",SCV000679811.1,-,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000679811,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583958.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000583958,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Benign,2016-12-16,"subjects mutated among 2600 FH index cases screened = 10 , family member = 1/previously described in association with FH/Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503493.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000503493,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Uncertain significance,2016-12-09,-,MedGen:CN221809,CN517202:not provided,Familial hypercholesterolemia - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697231.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000697231,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Uncertain significance,2016-11-05,Probably not pathogenic - position 827 in NPXY signal is variable - PMID: 1968060,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:11,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540872.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000540872,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Uncertain significance,2015-10-29,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000052790.2,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000052790,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45125,single nucleotide variant,NM_000527.4(LDLR):c.2479G>A (p.Val827Ile),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Nov-17,137853964,RCV000030135;RCV000148585;RCV000058923;RCV000436469,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11240278,11240278,G,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418",2,36462,19,11240278,G,A,45125,19:11240278:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484685.1,LDLR,-,High LDL,11/2/17,46963,0,74,"[0.9992121457317462,7.878542682537317E-4]",74,SCV000484685,FALSE,FALSE,TRUE,"Uncertain significance, Likely benign"
45148,single nucleotide variant,NM_005912.2(MC4R):c.806T>A (p.Ile269Asn),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,14-Mar-17,79783591,RCV000030158;RCV000499660,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN169374",Obesity;not specified,germline,germline,GRCh37,NC_000018.9,18,58038777,58038777,A,T,18q21.3,"criteria provided, conflicting interpretations",3,NA,N,-,2,36486,18,58038777,A,T,45148,18:58038777:A:T,Pathogenic,2014-05-23,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692303.1,MC4R,-,Obesity,3/14/17,46963,0,241,"[0.997434150288525,0.002565849711474991]",237,SCV000692303,TRUE,FALSE,FALSE,
45148,single nucleotide variant,NM_005912.2(MC4R):c.806T>A (p.Ile269Asn),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,14-Mar-17,79783591,RCV000030158;RCV000499660,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN169374",Obesity;not specified,germline,germline,GRCh37,NC_000018.9,18,58038777,58038777,A,T,18q21.3,"criteria provided, conflicting interpretations",3,NA,N,-,2,36486,18,58038777,A,T,45148,18:58038777:A:T,Likely pathogenic,2011-08-18,-,Early Onset Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:5,Integrated Genetics/Laboratory Corporation of America,SCV000052816.1,MC4R,-,Obesity,3/14/17,46963,0,241,"[0.997434150288525,0.002565849711474991]",237,SCV000052816,TRUE,FALSE,FALSE,
45150,single nucleotide variant,NM_005912.2(MC4R):c.896C>A (p.Pro299His),4160,MC4R,HGNC:6932,Pathogenic,1,18-Aug-11,52804924,RCV000030160,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Obesity,germline,germline,GRCh37,NC_000018.9,18,58038687,58038687,G,T,18q21.3,"criteria provided, single submitter",1,NA,N,-,2,36488,18,58038687,G,T,45150,18:58038687:G:T,Pathogenic,2011-08-18,-,Early Onset Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:13,Integrated Genetics/Laboratory Corporation of America,SCV000052818.1,MC4R,-,Obesity,8/18/11,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000052818,FALSE,FALSE,FALSE,
45462,single nucleotide variant,NM_000545.6(HNF1A):c.1424C>T (p.Pro475Leu),6927,HNF1A,HGNC:11621,Likely pathogenic,1,18-Aug-11,193922580,RCV000030481,"MedGen:C1838100,OMIM:600496","Maturity-onset diabetes of the young, type 3",germline,germline,GRCh37,NC_000012.11,12,121435391,121435391,C,T,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,36801,12,121435391,C,T,45462,12:121435391:C:T,Likely pathogenic,2011-08-18,-,MODY3,"C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053151.1,TCF1,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46951,12,2,"[0.9999787011991225,2.1298800877510595E-5]",2,SCV000053151,FALSE,FALSE,FALSE,
45472,single nucleotide variant,NM_000545.6(HNF1A):c.1745A>G (p.His582Arg),6927,HNF1A,HGNC:11621,Likely pathogenic,1,18-Aug-11,193922589,RCV000030491,"MedGen:C1838100,OMIM:600496","Maturity-onset diabetes of the young, type 3",germline,germline,GRCh37,NC_000012.11,12,121437407,121437407,A,G,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,36811,12,121437407,A,G,45472,12:121437407:A:G,Likely pathogenic,2011-08-18,-,MODY3,"C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053161.1,TCF1,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46865,98,4,"[0.9999573242291689,4.267577083111064E-5]",4,SCV000053161,FALSE,FALSE,FALSE,
45483,single nucleotide variant,NM_000545.6(HNF1A):c.467C>T (p.Thr156Met),6927,HNF1A,HGNC:11621,Likely pathogenic,1,18-Aug-11,150513055,RCV000030503,"MedGen:C1838100,OMIM:600496","Maturity-onset diabetes of the young, type 3",germline,germline,GRCh37,NC_000012.11,12,121426776,121426776,C,T,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,36822,12,121426776,C,T,45483,12:121426776:C:T,Likely pathogenic,2011-08-18,-,MODY3,"C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053174.1,TCF1,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46962,1,7,"[0.9999254716579362,7.452834206379626E-5]",7,SCV000053174,FALSE,FALSE,FALSE,
45493,single nucleotide variant,NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly),6927,HNF1A,HGNC:11621,Likely pathogenic,1,26-Oct-16,137853245,RCV000030513;RCV000441328,"MedGen:C1838100,OMIM:600496;MedGen:CN517202","Maturity-onset diabetes of the young, type 3;not provided",germline,germline,GRCh37,NC_000012.11,12,121432080,121432080,C,G,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,36832,12,121432080,C,G,45493,12:121432080:C:G,Likely pathogenic,2016-10-26,"The A276G variant has been published previously in association with MODY (Bellann-Chantelot et al., 2008; Poitou et al., 2012). However, it has also been observed in an unaffected individual (Flannick et al., 2013). The variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (A276D) and in nearby residues (R271W/G/Q, R272S/C/H, K273N, K280E, L281P) have been reported in the Human Gene Mutation Database in association with diabetes and MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000521028.3,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",10/26/16,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000521028,FALSE,FALSE,FALSE,
45493,single nucleotide variant,NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly),6927,HNF1A,HGNC:11621,Likely pathogenic,1,26-Oct-16,137853245,RCV000030513;RCV000441328,"MedGen:C1838100,OMIM:600496;MedGen:CN517202","Maturity-onset diabetes of the young, type 3;not provided",germline,germline,GRCh37,NC_000012.11,12,121432080,121432080,C,G,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,36832,12,121432080,C,G,45493,12:121432080:C:G,Likely pathogenic,2011-08-18,-,MODY3,"C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:5,Integrated Genetics/Laboratory Corporation of America,SCV000053184.1,TCF1,-,"MODY, MODY Extended, MonogenicDM_all",10/26/16,46946,17,1,"[0.9999893494653431,1.0650534656839773E-5]",1,SCV000053184,FALSE,FALSE,FALSE,
45494,single nucleotide variant,NM_000545.6(HNF1A):c.872C>G (p.Pro291Arg),6927,HNF1A,HGNC:11621,Likely pathogenic,1,18-Aug-11,193922606,RCV000030514,"MedGen:C1838100,OMIM:600496","Maturity-onset diabetes of the young, type 3",germline,germline,GRCh37,NC_000012.11,12,121432125,121432125,C,G,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,36833,12,121432125,C,G,45494,12:121432125:C:G,Likely pathogenic,2011-08-18,-,MODY3,"C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:3,Integrated Genetics/Laboratory Corporation of America,SCV000053185.1,TCF1,-,"MODY, MODY Extended, MonogenicDM_all",8/18/11,46829,134,5,"[0.9999466142774777,5.338572252236862E-5]",5,SCV000053185,FALSE,FALSE,FALSE,
45498,single nucleotide variant,NM_000458.3(HNF1B):c.1006C>T (p.His336Tyr),6928,HNF1B,HGNC:11630,Likely pathogenic,1,18-Aug-11,138986885,RCV000030518,"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004","Familial hypoplastic, glomerulocystic kidney",germline,germline,GRCh37,NC_000017.10,17,36091625,36091625,G,A,17q12,"criteria provided, single submitter",1,NA,N,-,2,36837,17,36091625,G,A,45498,17:36091625:G:A,Likely pathogenic,2011-08-18,-,MODY5,"C0431693:Familial hypoplastic, glomerulocystic kidney",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053189.1,TCF2,-,"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes",8/18/11,46962,1,3,"[0.9999680592819726,3.1940718027341254E-5]",3,SCV000053189,FALSE,FALSE,FALSE,
45501,single nucleotide variant,NM_000458.3(HNF1B):c.140C>T (p.Pro47Leu),6928,HNF1B,HGNC:11630,Conflicting interpretations of pathogenicity,1,27-Nov-17,193922483,RCV000030521;RCV000730643,"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004;MedGen:CN517202","Familial hypoplastic, glomerulocystic kidney;not provided",germline,germline,GRCh37,NC_000017.10,17,36104736,36104736,G,A,17q12,"criteria provided, conflicting interpretations",2,NA,N,-,2,36840,17,36104736,G,A,45501,17:36104736:G:A,Likely pathogenic,2011-08-18,-,MODY5,"C0431693:Familial hypoplastic, glomerulocystic kidney",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053192.1,TCF2,-,"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes",11/27/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000053192,TRUE,FALSE,FALSE,
45515,single nucleotide variant,NM_000458.3(HNF1B):c.949G>T (p.Ala317Ser),6928,HNF1B,HGNC:11630,Likely pathogenic,1,18-Aug-11,193922492,RCV000030535,"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004","Familial hypoplastic, glomerulocystic kidney",germline,germline,GRCh37,NC_000017.10,17,36091682,36091682,C,A,17q12,"criteria provided, single submitter",1,NA,N,-,2,36854,17,36091682,C,A,45515,17:36091682:C:A,Likely pathogenic,2011-08-18,-,MODY5,"C0431693:Familial hypoplastic, glomerulocystic kidney",NA,TRUE,NA,"criteria provided, single submitter",clinical testing;curation,germline:2,Integrated Genetics/Laboratory Corporation of America,SCV000053206.1,TCF2,-,"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes",8/18/11,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000053206,FALSE,FALSE,FALSE,
48709,single nucleotide variant,NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,3-Jul-18,144467873,RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided",germline,germline,GRCh37,NC_000002.11,2,21229161,21229161,G,A,2p24,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",Y,-,3,40223,2,21229161,G,A,48709,2:21229161:G:A,Pathogenic,2018-07-03,"This sequence change replaces arginine with tryptophan at codon 3527 of the APOB protein (p.Arg3527Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs144467873, ExAC 0.1%). This variant has been reported in individuals and families affected with hyperlipidemia and apolipoprotein B deficiency (PMID: 7627691, 9191540, 9702952, 22294733, 21376320, 16250003, 11238294). This variant is a common cause of hyperlipidemia in individuals of East Asian ancestry (PMID: 9702952, 27206935), but has also been reported in individuals of other ancestries (PMID: 23936638, 16250003, 23375686, 26415676) This variant is also known as R3500W in the literature. Experimental studies have shown that this sequence change has been shown to affect protein function (PMID: 11238294, 10388479). In addition, ΌA different missense substitution at this codon (p.Arg3527Gln) is reported to be deleterious (PMID: 24234650, 2563166). This indicates that the arginine residue is important for APOB protein function. In summary, this missense variant has been reported in affected individuals and affects a residue which is important for APOB protein function. For these reasons it has been classified as Pathogenic.",MedGen:C1704417;MedGen:CN182502,"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000284754.4,APOB,-,Low LDL,7/3/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000284754,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
48709,single nucleotide variant,NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,3-Jul-18,144467873,RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided",germline,germline,GRCh37,NC_000002.11,2,21229161,21229161,G,A,2p24,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",Y,-,3,40223,2,21229161,G,A,48709,2:21229161:G:A,Pathogenic,2017-07-27,"The p.Arg3527Trp variant (also referred to in the literature as p.Arg3500Trp) in APOB has been reported in at least 33 individuals with familial hypercholesterolemia, the majority of whom are of East Asian ancestry, and segregated with disease in at least 15 affected relatives from 4 families (Gaffney 1995, Choong 1997, Tai 1998, Fisher 1999, Tai 2001, Yang 2007, Hollandt 2012, Chiou 2010, Chiou 2011, Chiou 2012, Bertolini 2013). This variant has been reported in ClinVar (Variation ID 40223) and has also been identified in 22/18848 East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs144467873). This frequency is low enough to be consistent with the frequency of familial hypercholesterolemia (FH) in the general population. In vitro functional studies provide some evidence that the p.Arg3527Trp variant may impact protein function (Gaffney 1995, Fisher 1999, Tai 2001). Additionally, another variant at this position, p.Arg3527Gln, is a well-established pathogenic variant for FH. In summary, this variant meets criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon segregation studies, increased prevalence in affected individuals, and pathogenicity of other variants at this position. Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000712357.1,APOB,-,Low LDL,7/3/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000712357,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
48709,single nucleotide variant,NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,3-Jul-18,144467873,RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided",germline,germline,GRCh37,NC_000002.11,2,21229161,21229161,G,A,2p24,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",Y,-,3,40223,2,21229161,G,A,48709,2:21229161:G:A,Pathogenic,2017-05-24,"The R3527W variant in the APOB gene has been reported previously in association with hypercholesterolemia using alternate nomenclature, R3500W (Gaffney et al., 1995; Tai et al., 1998; Fisher et al., 1999). The R3527W variant is observed in 11/8642 (0.1%) alleles from individuals of East Asian background in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R3527W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. Functional studies demonstrated the R3500W variant reduced APOB capacity for binding, uptake and degradation of LDL (Fisher et al., 1999). Furthermore, a different missense variant affecting the same residue (R3527Q) has been reported in the Human Gene Mutation Database in association with an APOB-related disorder (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret R3527W as a pathogenic variant.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000583115.3,APOB,-,Low LDL,7/3/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000583115,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
48709,single nucleotide variant,NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,3-Jul-18,144467873,RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided",germline,germline,GRCh37,NC_000002.11,2,21229161,21229161,G,A,2p24,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",Y,-,3,40223,2,21229161,G,A,48709,2:21229161:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484822.1,APOB,-,Low LDL,7/3/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000484822,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Likely benign,2017-11-30,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752432.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000752432,FALSE,TRUE,TRUE,Likely benign
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Likely benign,2017-03-30,ACMG Guidelines: Pathogenic (ii),Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583635.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000583635,FALSE,FALSE,TRUE,Likely benign
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Benign,2017-03-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:20,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540896.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000540896,FALSE,FALSE,TRUE,Likely benign
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Benign,2016-12-16,"subjects mutated among 2600 FH index cases screened = 4 , 2 compound heterozygous / Software predictions: Benign",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503105.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000503105,FALSE,FALSE,TRUE,Likely benign
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484686.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000484686,FALSE,FALSE,TRUE,Likely benign
78990,single nucleotide variant,NM_000527.4(LDLR):c.148G>T (p.Ala50Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Nov-17,137853960,RCV000210234;RCV000148578;RCV000058916;RCV000455660,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11210979,11210979,G,T,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979",2,68099,19,11210979,G,T,78990,19:11210979:G:T,Benign,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733812.1,LDLR,-,High LDL,11/30/17,46963,0,43,"[0.9995421927900687,4.5780720993122243E-4]",43,SCV000733812,FALSE,FALSE,TRUE,Likely benign
80399,single nucleotide variant,NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,16-Oct-17,146377316,RCV000497061;RCV000655087;RCV000655087,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1",germline,germline,GRCh37,NC_000002.11,2,21230565,21230565,G,A,2p24,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,-,2,69508,2,21230565,G,A,80399,2:21230565:G:A,Likely pathogenic,2017-10-16,"The p.Arg3059Cys variant in APOB has been reported in 3 individuals with autosomal dominant hypercholesterolemia, and segregated with disease in 8 affected relatives of one family, though 2 other family members had the variant but only had mildly elevated high cholesterol (Motazacker et al. 2012). In vitro functional studies looking at LDL uptake provide some evidence that the p.Arg3059Cys variant may impact APOB function (Motazacker et al. 2012). The variant has been reported by other clinical laboratories in ClinVar (Variation ID 69508) and has also been identified in 2/245754 chromosomes of the general population in gnomAD (http://gnomad.broadinstitute.org; dbSNP rs146377316). Conservation analysis shows a lack of conservation at this amino acid site, though replacement by a cysteine has not been observed across species. In summary, although additional studies are required to fully establish its clinical significance, the p.Arg3059Cys variant is likely pathogenic. (ACMG/AMP codes applied: PP1_Strong, PS3_Moderate). Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000731607.1,APOB,-,Low LDL,10/16/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000731607,FALSE,TRUE,TRUE,"Likely pathogenic, Uncertain significance"
80399,single nucleotide variant,NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys),338,APOB,HGNC:603,Conflicting interpretations of pathogenicity,1,16-Oct-17,146377316,RCV000497061;RCV000655087;RCV000655087,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1",germline,germline,GRCh37,NC_000002.11,2,21230565,21230565,G,A,2p24,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,-,2,69508,2,21230565,G,A,80399,2:21230565:G:A,Uncertain significance,2017-08-30,"This sequence change replaces arginine with cysteine at codon 3059 of the APOB protein (p.Arg3059Cys). The arginine residue is weakly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs146377316, ExAC 0.01%). This variant has been reported to segregate with hypercholesterolemia in a single family (PMID: 22408029). Experimental studies have shown that this missense change causes a large reduction in low density lipoprotein (LDL) uptake (PMID: 22408029). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.",MedGen:C1704417;MedGen:CN182502,"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000777012.1,APOB,-,Low LDL,10/16/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000777012,FALSE,TRUE,TRUE,"Likely pathogenic, Uncertain significance"
171200,single nucleotide variant,NM_000527.4(LDLR):c.757C>T (p.Arg253Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,150673992,RCV000172958;RCV000148562;RCV000162019,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11217303,11217303,C,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000111,UniProtKB (protein):P01130#VAR_013952",2,161261,19,11217303,C,T,171200,19:11217303:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583735.1,LDLR,-,High LDL,3/30/17,46963,0,28,"[0.9997018929795797,2.981070204203309E-4]",28,SCV000583735,FALSE,FALSE,FALSE,
171222,single nucleotide variant,NM_000527.4(LDLR):c.2282C>T (p.Thr761Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,138477254,RCV000237277;RCV000148565;RCV000162013,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11233991,11233991,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000907,2,161262,19,11233991,C,T,171222,19:11233991:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583940.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000583940,FALSE,FALSE,FALSE,
171222,single nucleotide variant,NM_000527.4(LDLR):c.2282C>T (p.Thr761Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,138477254,RCV000237277;RCV000148565;RCV000162013,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11233991,11233991,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000907,2,161262,19,11233991,C,T,171222,19:11233991:C:T,Uncertain significance,2016-12-16,subjects mutated among 2600 FH index cases screened = 2/Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503476.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000503476,FALSE,FALSE,FALSE,
171222,single nucleotide variant,NM_000527.4(LDLR):c.2282C>T (p.Thr761Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,138477254,RCV000237277;RCV000148565;RCV000162013,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11233991,11233991,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000907,2,161262,19,11233991,C,T,171222,19:11233991:C:T,Likely benign,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733832.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000733832,FALSE,FALSE,FALSE,
171207,single nucleotide variant,NM_000527.4(LDLR):c.970G>A (p.Gly324Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Oct-17,72658860,RCV000237236;RCV000148566;RCV000162021;RCV000455308,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221357,11221357,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000640,2,161263,19,11221357,G,A,171207,19:11221357:G:A,Benign,2017-10-05,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556776.3,LDLR,-,High LDL,10/5/17,46961,2,186,"[0.9980196333127489,0.001980366687251123]",186,SCV000556776,TRUE,TRUE,TRUE,Benign
171207,single nucleotide variant,NM_000527.4(LDLR):c.970G>A (p.Gly324Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Oct-17,72658860,RCV000237236;RCV000148566;RCV000162021;RCV000455308,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221357,11221357,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000640,2,161263,19,11221357,G,A,171207,19:11221357:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583771.1,LDLR,-,High LDL,10/5/17,46961,2,186,"[0.9980196333127489,0.001980366687251123]",186,SCV000583771,TRUE,FALSE,TRUE,Benign
171207,single nucleotide variant,NM_000527.4(LDLR):c.970G>A (p.Gly324Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Oct-17,72658860,RCV000237236;RCV000148566;RCV000162021;RCV000455308,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221357,11221357,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000640,2,161263,19,11221357,G,A,171207,19:11221357:G:A,Benign,2016-12-16,subjects mutated among 2600 FH index cases screened = 2 / Software predictions: Damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503271.1,LDLR,-,High LDL,10/5/17,46961,2,186,"[0.9980196333127489,0.001980366687251123]",186,SCV000503271,TRUE,FALSE,TRUE,Benign
171207,single nucleotide variant,NM_000527.4(LDLR):c.970G>A (p.Gly324Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Oct-17,72658860,RCV000237236;RCV000148566;RCV000162021;RCV000455308,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221357,11221357,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000640,2,161263,19,11221357,G,A,171207,19:11221357:G:A,Likely benign,2016-07-25,"Variant summary: The LDLR c.970G>A (p.Gly324Ser) variant involves the alteration of a conserved nucleotide and results in a replacement of a small size and hydrophobic Glycine (G) with a small size and polar Serine (S) located ) within the first of the three cystein-rich repeats of the epidermal growth factor homology domain that also contributes to ligand binding. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 140/120542 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.0131784 (135/10244). This frequency is about 13 times the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant was reported in several Familial Hypercholesterolemia patients, however without strong evidence for pathogenicity. Moreover, in one FH family, the variant was found to co-occur with pathogenic/likely pathogenic variant and not co-segregate with the disease, indicating neutrality of this variant. In addition, a clinical diagnostic laboratory classified the variant as Likely Benign via ClinVar (without evidence to independently evaluate). Taken together, this variant is classified as likely benign.",MedGen:CN221809,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697255.1,LDLR,-,High LDL,10/5/17,46961,2,186,"[0.9980196333127489,0.001980366687251123]",186,SCV000697255,TRUE,FALSE,TRUE,Benign
171219,single nucleotide variant,NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Oct-17,72658865,RCV000211562;RCV000148567;RCV000162003,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227645,11227645,G,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000566,2,161264,19,11227645,G,T,171219,19:11227645:G:T,Uncertain significance,2017-10-25,"This sequence change replaces alanine with serine at codon 606 of the LDLR protein (p.Ala606Ser). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and serine. This variant is present in population databases (rs72658865, ExAC 0.01%). This variant has been reported in many individuals with possible or definite hypercholesterolemia. Currently there is insufficient evidence to conclude whether this variant segregates with disease or not (PMID: 9409298, 9544745, 14974088, 15199436, 16250003, 17765246, 18325082, 24956927, 27765764). This variant is also known as p.Arg585Ser in the literature. ClinVar contains an entry for this variant (Variation ID: 161264). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Tolerated""; PolyPhen-2: ""Possibly Damaging""; Align-GVGD: ""Class C0""). In summary, this variant is a rare missense change with uncertain impact on protein function. While it has been observed in individuals with elevated cholesterol levels, it is also found in the population at an appreciable frequency. In the absence of conclusive segregation or functional evidence, at this time it has been classified as a Variant of Uncertain Significance.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627022.2,LDLR,-,High LDL,10/25/17,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000627022,FALSE,TRUE,TRUE,Uncertain significance
171219,single nucleotide variant,NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Oct-17,72658865,RCV000211562;RCV000148567;RCV000162003,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227645,11227645,G,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000566,2,161264,19,11227645,G,T,171219,19:11227645:G:T,Uncertain significance,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503417.1,LDLR,-,High LDL,10/25/17,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000503417,FALSE,FALSE,TRUE,Uncertain significance
171219,single nucleotide variant,NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Oct-17,72658865,RCV000211562;RCV000148567;RCV000162003,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227645,11227645,G,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000566,2,161264,19,11227645,G,T,171219,19:11227645:G:T,Uncertain significance,2012-08-07,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:3,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268641.1,LDLR,-,High LDL,10/25/17,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000268641,FALSE,FALSE,TRUE,Uncertain significance
171219,single nucleotide variant,NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Oct-17,72658865,RCV000211562;RCV000148567;RCV000162003,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227645,11227645,G,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000566,2,161264,19,11227645,G,T,171219,19:11227645:G:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484684.1,LDLR,-,High LDL,10/25/17,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000484684,FALSE,FALSE,TRUE,Uncertain significance
171224,single nucleotide variant,NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,374045590,RCV000237920;RCV000148570,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11240274,11240274,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001654,UniProtKB (protein):P01130#VAR_072861",2,161265,19,11240274,C,G,171224,19:11240274:C:G,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583956.1,LDLR,-,High LDL,3/30/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583956,FALSE,FALSE,FALSE,
171224,single nucleotide variant,NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,374045590,RCV000237920;RCV000148570,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11240274,11240274,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001654,UniProtKB (protein):P01130#VAR_072861",2,161265,19,11240274,C,G,171224,19:11240274:C:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484701.1,LDLR,-,High LDL,3/30/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484701,FALSE,FALSE,FALSE,
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894165.1,-,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000894165,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2017-11-03,"The p.Glu101Lys variant in LDLR has been reported in the heterozygous state in >30 individuals with familial hypercholesterolemia (FH), in the compound heterozygous state in 1 individual with homozygous FH (Loux 1992, Webb 1992, Garc_a-Garc_a 2001, Mozas 2004, Humphries 2006, Miyakem2009, Taylor 2010, Futema 2013, Do 2015) and segregated with disease in four affected relatives from two families (Webb 1992, Loux 1992). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID# 161266). In vitro functional studies provide some evidence that the p.Glu101Lys variant may impact protein function (Webb 1992). This variant has also been identified in 3/111700 European chromosomes by the genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs144172724). This frequency is low enough to be consistent with the frequency of FH in the general population. Computational prediction tools and conservation analysis suggests that the p.Glu101Lys variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in multiple affected individuals, segregation studies, low frequency in the general population and functional evidence.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000711395.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000711395,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2017-09-07,"The E101K (aka E80K, FH Lancashire) pathogenic variant is part of a negatively charged triplet, Ser-Asp-Glu, located at the carboxyl-terminal end of the LDL-receptor A2 repeat domain in the LDLR gene, and is critical for ligand binding (Schneider et al., 2003). E101K has been published numerous times in unrelated patients from different ethnic backgrounds with FH (Webb et al., 1992; Wang et al., 2001; Mozas et al., 2004; Robles-Osorio et al., 2006; Humphries et al., 2006; Al-Khateeb et al., 201; Futema et al., 2013). Patient protein studies and in vitro analysis support alteration to protein processing and intracellular transport, in the presence of E101K (Webb et al., 1992; Thormaehlen et al., 2015). E101K results in a non-conservative amino acid substitution at a position that is conserved across species. Additionally, this variant is classified as pathogenic/likely pathogenic and reported to segregate with disease by other clinical laboratories in ClinVar (ClinVar SCV000285028.2, SCV000484724.1, SCV000503127.1, SCV000583649.1, SCV000268550.1, ; Landrum et al., 2016). Furthermore, the E101K variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617500.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000617500,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2017-07-11,"This sequence change replaces glutamic acid with lysine at codon 101 of the LDLR protein (p.Glu101Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs144172724, ExAC <0.01%). This variant has been reported in the literature to segregate with disease in two families (PMID: 1301940, 1352322) and also present in multiple individuals affected with hypercholesterolemia (PMID: 1352322, 11668627, 23669246, 18718593, 19843101, 15241806, 20236128, 17142622, 16314194, 11668640). This variant is also known in the literature as E80K. ClinVar contains an entry for this variant (Variation ID: 161266). One experimental study has shown that this missense variant inhibited LDL uptake in Hel-Kyoto cells (PMID: 25647241). In summary, this variant is present at a very low frequency in the general population, has been reported to segregate with disease and is present in multiple individuals with hypercholesterolemia, and has been shown to affected protein function in vitro. For these reasons, it has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285028.3,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000285028,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583649.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583649,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 8 , family members = 12 with co-segregation / FH-Lancashire",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:8,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503127.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503127,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Pathogenic,2008-06-05,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:7,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268550.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268550,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171199,single nucleotide variant,NM_000527.4(LDLR):c.301G>A (p.Glu101Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,144172724,RCV000211583;RCV000148571;RCV000162016,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11213450,11213450,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315",2,161266,19,11213450,G,A,171199,19:11213450:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Robarts Research Institute,Western University",SCV000484724.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484724,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171211,single nucleotide variant,NM_000527.4(LDLR):c.1201C>G (p.Leu401Val),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-18,146200173,RCV000238417;RCV000586642;RCV000148572;RCV000255176,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11223968,11223968,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987",2,161267,19,11223968,C,G,171211,19:11223968:C:G,Likely pathogenic,2018-05-11,"The c.1201C>G (p.Leu401Val) variant in the LDLR gene has been observed in multiple individuals with familial hypercholesteromeia (PMID: 9104431, 21722902, 25461735). In addition, a missense variant at the same residue, p.Leu401His, has been previously reported in other affected individuals (PMID: 7573037, 11810272,15701167). Therefore, this variant in the LDLR gene is classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839994.1,LDLR,-,High LDL,5/11/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000839994,FALSE,FALSE,TRUE,Likely pathogenic
171211,single nucleotide variant,NM_000527.4(LDLR):c.1201C>G (p.Leu401Val),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-18,146200173,RCV000238417;RCV000586642;RCV000148572;RCV000255176,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11223968,11223968,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987",2,161267,19,11223968,C,G,171211,19:11223968:C:G,Likely pathogenic,2017-06-03,"This sequence change replaces leucine with valine at codon 401 of the LDLR protein (p.Leu401Val). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and valine. This variant is present in population databases (rs146200173, ExAC 0.02%). This variant has been reported in individuals affected with hypercholesterolemia (PMID: 9104431, 21722902, 25461735). It is also known as p.Leu380Val in the literature. This variant has been reported in individuals in the Universal Mutation Database (PMID: 12124988) and has an entry in ClinVar (Variation ID: 161267). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant is a rare missense change that has been reported in many affected individuals. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627015.1,LDLR,-,High LDL,5/11/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000627015,FALSE,TRUE,TRUE,Likely pathogenic
171211,single nucleotide variant,NM_000527.4(LDLR):c.1201C>G (p.Leu401Val),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-18,146200173,RCV000238417;RCV000586642;RCV000148572;RCV000255176,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11223968,11223968,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987",2,161267,19,11223968,C,G,171211,19:11223968:C:G,Uncertain significance,2016-12-16,subject mutated among 2600 FH index cases screened = 1 compound heterozygous on LDL Apheresis /FH-Norvege / Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503313.1,LDLR,-,High LDL,5/11/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503313,FALSE,FALSE,TRUE,Likely pathogenic
171211,single nucleotide variant,NM_000527.4(LDLR):c.1201C>G (p.Leu401Val),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-18,146200173,RCV000238417;RCV000586642;RCV000148572;RCV000255176,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11223968,11223968,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987",2,161267,19,11223968,C,G,171211,19:11223968:C:G,Pathogenic,2016-08-25,"The L401V variant in the LDLR gene has been reported previously in the heterozygous state in multiple individuals with familial hypercholesterolemia (Leren et al., 1997; Vaca et al., 2011; Jannes et al., 2015). Note that Leren et al. described L401V using alternate nomenclature L380V (1997). The L401V variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L401V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in the same residue, L401H, was previously reported, using alternate nomenclature L308H and referred to as FH-Pori, in four unrelated individuals of Finnish descent with heterozygous familial hypercholesterolemia (Koivisto et al., 1995), supporting the functional importance of this region of the protein. Therefore, we interpret L401V as a known pathogenic variant.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000322301.6,LDLR,-,High LDL,5/11/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000322301,FALSE,FALSE,TRUE,Likely pathogenic
171211,single nucleotide variant,NM_000527.4(LDLR):c.1201C>G (p.Leu401Val),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-18,146200173,RCV000238417;RCV000586642;RCV000148572;RCV000255176,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11223968,11223968,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987",2,161267,19,11223968,C,G,171211,19:11223968:C:G,Pathogenic,2016-04-28,"Variant summary: The c.1201C>G variant affects a conserved nucleotide, resulting in amino acid change from Leu to Val. 3/4 in-silico tools predict this variant to be damaging (SNPs&GO not captured due to low reliability index). This variant is found in 2/119858 control chromosomes at a frequency of 0.0000167, which does not exceed maximal expected frequency of a pathogenic allele (0.0012508) to exclude pathogenicity. The variant was reported in several FH patients and one study reported the variant to co-segregate with hypercholesterolemia (Leren_JIM_19970) indicating pathogenicity. In addition, a clinical laboratory and a reputable database classify this variant as Likely pathogenic / Disease causing. Taken together, this variant was classified as Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697189.1,LDLR,-,High LDL,5/11/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000697189,FALSE,FALSE,TRUE,Likely pathogenic
171204,single nucleotide variant,NM_000527.4(LDLR):c.862G>A (p.Glu288Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-May-18,368657165,RCV000234348;RCV000148573,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11218112,11218112,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983",2,161268,19,11218112,G,A,171204,19:11218112:G:A,Likely pathogenic,2018-05-01,"This sequence change replaces glutamic acid with lysine at codon 288 of the LDLR protein (p.Glu288Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs368657165, ExAC 0.02%). This variant has been reported in multiple individuals affected with hypercholesterolemia (PMID: 10090484, 11810272, 11857755, 17765246,Ό23375686). Experimental studies have shown that this missense change reduces the protein LDL-binding capacity and decreases LDL internalization (PMID: 21990180). For these reasons, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285035.3,LDLR,-,High LDL,5/1/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000285035,FALSE,TRUE,TRUE,Likely pathogenic
171204,single nucleotide variant,NM_000527.4(LDLR):c.862G>A (p.Glu288Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-May-18,368657165,RCV000234348;RCV000148573,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11218112,11218112,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983",2,161268,19,11218112,G,A,171204,19:11218112:G:A,Likely pathogenic,2017-08-21,"This c.862G>C (p.Glu288Lys) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 21990180, 26927322). Glutamate at position 288 of the LDLR protein is highly evolutionarily conserved. Functional studies have shown that this variant disrupts normal LDLR function by decreasing its internalization and ligand binding capacity (PMID: 21990180). This variant is classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839988.1,LDLR,-,High LDL,5/1/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000839988,FALSE,FALSE,TRUE,Likely pathogenic
171204,single nucleotide variant,NM_000527.4(LDLR):c.862G>A (p.Glu288Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-May-18,368657165,RCV000234348;RCV000148573,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11218112,11218112,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983",2,161268,19,11218112,G,A,171204,19:11218112:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583752.1,LDLR,-,High LDL,5/1/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000583752,FALSE,FALSE,TRUE,Likely pathogenic
171204,single nucleotide variant,NM_000527.4(LDLR):c.862G>A (p.Glu288Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-May-18,368657165,RCV000234348;RCV000148573,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11218112,11218112,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983",2,161268,19,11218112,G,A,171204,19:11218112:G:A,Uncertain significance,2016-12-16,subjects mutated among 2600 FH index cases screened = 2 / previously described in association with FH / Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503246.1,LDLR,-,High LDL,5/1/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000503246,FALSE,FALSE,TRUE,Likely pathogenic
171204,single nucleotide variant,NM_000527.4(LDLR):c.862G>A (p.Glu288Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-May-18,368657165,RCV000234348;RCV000148573,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11218112,11218112,G,A,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983",2,161268,19,11218112,G,A,171204,19:11218112:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Robarts Research Institute,Western University",SCV000484703.1,LDLR,-,High LDL,5/1/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000484703,FALSE,FALSE,TRUE,Likely pathogenic
171198,single nucleotide variant,NM_000527.4(LDLR):c.296C>G (p.Ser99Ter),3949,LDLR,HGNC:6547,Pathogenic,1,6-May-17,377271627,RCV000238369;RCV000148574,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213445,11213445,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001685,2,161269,19,11213445,C,G,171198,19:11213445:C:G,Pathogenic,2017-05-06,"This sequence change creates a premature translational stop signal at codon 99 (p.Ser99*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in many individuals with familial hypercholesterolemia (PMID: 7718019, 9259195, 9698020, 11857755, 23375686). This variant is also known as p.Ser78* and FH-Svartor in the literature. ClinVar contains an entry for this variant (Variation ID: 161269). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544657.2,LDLR,-,High LDL,5/6/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000544657,FALSE,TRUE,TRUE,Pathogenic
171215,single nucleotide variant,NM_000527.4(LDLR):c.1467C>G (p.Tyr489Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Mar-16,370777955,RCV000238307;RCV000148575,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224319,11224319,C,G,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000415,2,161270,19,11224319,C,G,171215,19:11224319:C:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484710.1,LDLR,-,High LDL,3/25/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484710,FALSE,FALSE,FALSE,
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894177.1,-,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000894177,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2018-05-22,"This sequence change replaces glycine with glutamic acid at codon 592 of the LDLR protein (p.Gly592Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs137929307, ExAC 0.009%). This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 15864114,20663204, 21310417), and is a common cause of familial hypercholesterolemia in individuals of European ancestry (PMID: 26238499, 23375686, 21925044), This variant is also known as p.Gly571Glu in the literature. ClinVar contains an entry for this variant (Variation ID: 161271). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544669.4,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000544669,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2018-05-04,"The G592E variant in the LDLR gene, previously reported as G571E due to alternate nomenclature, has been reported many times in association with heterozygous FH and homozygous FH (Hobbs et al., 1992; Chmara et al., 2010; Goldman et al., 2010; Bertolini et al., 2013; Mollaki et al., 2014; Braenne et al., 2016; Gabcova et al., 2017). The G592E variant is observed in 15/126,710 (0.01%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). The G592E variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Functional studies demonstrate that this variant would lead to deficient LDLR protein (Susan-Resiga et al., 2017).",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000582282.4,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000582282,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2017-12-19,"The p.Gly592Glu variant in LDLR has been reported in >200 Caucasian individuals with familial hypercholesterolemia (FH) and segregated with disease in >30 affected relatives from >3 families (Gorski 1998, Miltiadous 2001, Kuhrova 2002, Kublaska 2008, Bourbon 2008, Chmara 2010, Diakou 2011, Tichy 2012, Bertolini 2013, Do 2015, Medeiros 2015, Jannes 2015, Braenne 2015). This variant has also been identified in 15/126710 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs137929307). However, this frequency is low enough to be consistent with the frequency of FH in the general population. Furthermore, in vitro functional studies provide some evidence that the p.Gly592Glu variant may impact protein function (Romano 2011). In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in multiple affected individuals and segregation studies. ACMG/AMP Criteria applied: PS4_Strong, PP1_Strong (Richards 2015).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:16,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271385.2,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000271385,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:8,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583883.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583883,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Likely pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:11,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503412.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503412,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:443,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540837.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000540837,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2016-09-13,"Variant summary: The LDLR c.1775G>A (p.Gly592Glu) variant involves the alteration of a conserved nucleotide. Gly592 is highly conserved across species, and 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 6/121608 control chromosomes at a frequency of 0.0000493, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). This variant has been reported in many FH patients in both heterozygous, compound heterozygous, and homozygous states with evidence of co-segregation in some of the families. Functional studies indicate that the variant of interest has defective LDL receptor activity. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic/likely pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697209.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000697209,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Pathogenic,2010-09-07,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:3,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268637.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268637,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Robarts Research Institute,Western University",SCV000484718.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484718,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171217,single nucleotide variant,NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,137929307,RCV000172964;RCV000587007;RCV000148576;RCV000162001,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227604,11227604,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",22,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403",2,161271,19,11227604,G,A,171217,19:11227604:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733827.1,LDLR,-,High LDL,10/31/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000733827,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171212,single nucleotide variant,NM_000527.4(LDLR):c.1238C>T (p.Thr413Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,368562025,RCV000211581;RCV000148582;RCV000519267,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11224005,11224005,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000967,2,161276,19,11224005,C,T,171212,19:11224005:C:T,Likely pathogenic,2017-10-23,"This c.1238C>T (p.Thr413Met) variant in the LDLR gene has been reported in multiple individuals with familial hypercholesterolemia (PMID: 11857755, 17539906, 19843101, 11668627, 15015036, 25682026) or myocardial infarction (PMID: 25487149). The p.Thr413Met variant occurs within the low-density lipoprotein receptor repeat class B domain of the LDLR protein (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?seqinput=NP_001182729.1 ). The c.1238C>T variant is rare in the general population and threonine at position 413 of the LDLR protein is highly evolutionarily conserved. The c.1238C>T (p.Thr413Met) variant in the LDLR gene is classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839993.1,LDLR,-,High LDL,10/23/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000839993,FALSE,FALSE,TRUE,Likely pathogenic
171212,single nucleotide variant,NM_000527.4(LDLR):c.1238C>T (p.Thr413Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,368562025,RCV000211581;RCV000148582;RCV000519267,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11224005,11224005,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000967,2,161276,19,11224005,C,T,171212,19:11224005:C:T,Likely pathogenic,2017-05-18,"The T413M variant in the LDLR gene has been reported previously in at least 5 unrelated individuals from various ethnic backgrounds with familial hypercholesterolemia (Wang et al., 2001; Bunn et al., 2002; Mihaylov et al., 2004; Wang et al., 2005). Additionally, the T413M variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T413M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Although this substitution occurs at a position that is not conserved, methionine is not tolerated at this position in any species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (E408K, E408V, K411E, L414R, R416W, R416P, R416Q) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret T413M as a likely pathogenic variant.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617508.1,LDLR,-,High LDL,10/23/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000617508,FALSE,TRUE,TRUE,Likely pathogenic
171212,single nucleotide variant,NM_000527.4(LDLR):c.1238C>T (p.Thr413Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,368562025,RCV000211581;RCV000148582;RCV000519267,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11224005,11224005,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000967,2,161276,19,11224005,C,T,171212,19:11224005:C:T,Likely pathogenic,2017-01-03,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540894.1,LDLR,-,High LDL,10/23/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000540894,FALSE,FALSE,TRUE,Likely pathogenic
171212,single nucleotide variant,NM_000527.4(LDLR):c.1238C>T (p.Thr413Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,368562025,RCV000211581;RCV000148582;RCV000519267,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11224005,11224005,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000967,2,161276,19,11224005,C,T,171212,19:11224005:C:T,Uncertain significance,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503321.1,LDLR,-,High LDL,10/23/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503321,FALSE,FALSE,TRUE,Likely pathogenic
171212,single nucleotide variant,NM_000527.4(LDLR):c.1238C>T (p.Thr413Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,368562025,RCV000211581;RCV000148582;RCV000519267,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;unknown,germline,GRCh37,NC_000019.9,19,11224005,11224005,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000967,2,161276,19,11224005,C,T,171212,19:11224005:C:T,Pathogenic,2008-06-05,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:2,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268607.1,LDLR,-,High LDL,10/23/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268607,FALSE,FALSE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Likely pathogenic,2018-04-26,"This sequence change replaces glycine with arginine at codon 478 of the LDLR protein (p.Gly478Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs144614838, ExAC 0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 27206935, 17087781, 23064986, 21376320, 17765246, 17765246, Ό11810272, 17765246). This variant is also known as p.Gly457Arg in the literature. ClinVar contains an entry for this variant (Variation ID: 161277). Different missense substitutions at this codon (p.Gly478Glu and p.Gly478Arg) have been reported in an individuals affected with familial hypercholesterolemia (PMID: 27824480, 28126585). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C15""). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000832839.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000832839,FALSE,TRUE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Likely pathogenic,2017-09-19,"This c.1432G>A (p.Gly478Arg) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 1301956, 7573037, 9763532, 11810272). Functional studies have indicated that the p.Gly478Arg variant LDLR protein has 2-5% receptor activity compared to wild-type LDLR protein (PMID: 1301956). The c.1432G>A variant is extremely rare in the general population and glycine at position 478 of the LDLR protein is highly evolutionarily conserved. The c.1432G>A (p.Gly478Arg) variant in the LDLR gene is classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839985.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000839985,FALSE,FALSE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:8,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583830.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000583830,FALSE,FALSE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Uncertain significance,2016-12-16,"subjects mutated among 2600 FH index cases screened = 2 / FH-New-York-2, 5 to 15% LDLR activity/Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503348.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000503348,FALSE,FALSE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540818.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000540818,FALSE,FALSE,TRUE,Likely pathogenic
171213,single nucleotide variant,NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,26-Apr-18,144614838,RCV000211688;RCV000148583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224284,11224284,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390",2,161277,19,11224284,G,A,171213,19:11224284:G:A,Pathogenic,2008-06-27,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:6,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268615.1,LDLR,-,High LDL,4/26/18,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000268615,FALSE,FALSE,TRUE,Likely pathogenic
171223,single nucleotide variant,NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Nov-17,5928,RCV000237126;RCV000148584;RCV000162024,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11240240,11240240,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864",2,161278,19,11240240,G,A,171223,19:11240240:G:A,Likely benign,2017-11-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752439.1,LDLR,-,High LDL,11/17/17,46963,0,50,"[0.9994676660349637,5.323339650363052E-4]",50,SCV000752439,FALSE,TRUE,TRUE,Likely benign
171223,single nucleotide variant,NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Nov-17,5928,RCV000237126;RCV000148584;RCV000162024,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11240240,11240240,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864",2,161278,19,11240240,G,A,171223,19:11240240:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583953.1,LDLR,-,High LDL,11/17/17,46963,0,50,"[0.9994676660349637,5.323339650363052E-4]",50,SCV000583953,FALSE,FALSE,TRUE,Likely benign
171223,single nucleotide variant,NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Nov-17,5928,RCV000237126;RCV000148584;RCV000162024,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11240240,11240240,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864",2,161278,19,11240240,G,A,171223,19:11240240:G:A,Uncertain significance,2017-01-16,"Variant summary: The LDLR c.2441G>A (p.Arg814Gln) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 34/121530 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.0031712 (33/10406). This frequency is about 3 times the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005), suggesting this is possibly a benign polymorphism found primarily in the populations of African origin. This variant has been reported in multiple affected individuals (mostly with African ethnicities) without strong evidence for causality. In addition, one clinical diagnostic laboratory/database classified this variant as likely benign and another one classified it as VUS, all without evidence for independent evaluation. In vivo study of LDL metabolism showed this variant with a reduced in vivo activity of LDL-R (80% of WT; Arca_1997 and Arca_1994). Taken together, this variant is classified as VUS.",MedGen:CN221809,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697230.1,LDLR,-,High LDL,11/17/17,46963,0,50,"[0.9994676660349637,5.323339650363052E-4]",50,SCV000697230,FALSE,FALSE,TRUE,Likely benign
171223,single nucleotide variant,NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Nov-17,5928,RCV000237126;RCV000148584;RCV000162024,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11240240,11240240,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864",2,161278,19,11240240,G,A,171223,19:11240240:G:A,Likely benign,2016-12-16,"subjects mutated among 2600 FH index cases screened = 3 , family member = 1/previously described in association with FH/Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503489.1,LDLR,-,High LDL,11/17/17,46963,0,50,"[0.9994676660349637,5.323339650363052E-4]",50,SCV000503489,FALSE,FALSE,TRUE,Likely benign
171202,single nucleotide variant,NM_000527.4(LDLR):c.806G>A (p.Gly269Asp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Oct-17,143992984,RCV000210247;RCV000148586;RCV000161966,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11217352,11217352,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000504,2,161279,19,11217352,G,A,171202,19:11217352:G:A,Likely benign,2017-10-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752451.1,LDLR,-,High LDL,10/17/17,46963,0,33,"[0.999648659583076,3.513404169239614E-4]",33,SCV000752451,FALSE,TRUE,TRUE,Likely benign
171202,single nucleotide variant,NM_000527.4(LDLR):c.806G>A (p.Gly269Asp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Oct-17,143992984,RCV000210247;RCV000148586;RCV000161966,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11217352,11217352,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000504,2,161279,19,11217352,G,A,171202,19:11217352:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583743.1,LDLR,-,High LDL,10/17/17,46963,0,33,"[0.999648659583076,3.513404169239614E-4]",33,SCV000583743,FALSE,FALSE,TRUE,Likely benign
171202,single nucleotide variant,NM_000527.4(LDLR):c.806G>A (p.Gly269Asp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Oct-17,143992984,RCV000210247;RCV000148586;RCV000161966,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11217352,11217352,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000504,2,161279,19,11217352,G,A,171202,19:11217352:G:A,Likely benign,2016-12-16,subjects mutated among 2600 FH index cases screened = 3 / FH-Rome-3 / Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503239.1,LDLR,-,High LDL,10/17/17,46963,0,33,"[0.999648659583076,3.513404169239614E-4]",33,SCV000503239,FALSE,FALSE,TRUE,Likely benign
171202,single nucleotide variant,NM_000527.4(LDLR):c.806G>A (p.Gly269Asp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-Oct-17,143992984,RCV000210247;RCV000148586;RCV000161966,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11217352,11217352,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000504,2,161279,19,11217352,G,A,171202,19:11217352:G:A,Benign,2016-03-11,"Variant summary: c.806G>A affects a non-conserved nucleotide, resulting in amino acid change from Gly to Asp. 2/4 in-silico tools predict this variant to be benign (SNPs&GO not captured due to low reliability index). Functional study showed that the LDL uptake, binding capacity of LDL, and LDLR expression of variant were similar to those observed in control cells (Etxebarria_2012), indicating the neutral effect. This variant was found in 24/131566 control chromosomes at a frequency of 0.0001824. This variant has been reported in multiple FH patients without strong evidence for causality. Among the reported patients, variant was reported to co-occur with a deleterious LDLR variant c.1045delC in cis (Mozas_2004) and there is at least one family reported with lack of co-segregation of this variant with disease (Bourbon_2008). In addition, variant has been detected in early-onset myocardial infarction case with comparable allele frequency as in controls and multiple publications listed variant as nonpathogenic/benign (Do_2015, Etxebarre_2012, and Benito-Vicente_2015). Considering all, this variant is classified as Benign.",MedGen:CN221809,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697252.1,LDLR,-,High LDL,10/17/17,46963,0,33,"[0.999648659583076,3.513404169239614E-4]",33,SCV000697252,FALSE,FALSE,TRUE,Likely benign
171206,single nucleotide variant,NM_000527.4(LDLR):c.967G>A (p.Gly323Ser),3949,LDLR,HGNC:6547,Likely pathogenic,1,16-Dec-16,373869746,RCV000238216;RCV000148589,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11221354,11221354,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000623,2,161282,19,11221354,G,A,171206,19:11221354:G:A,Likely pathogenic,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / Software predictions: Damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503269.1,LDLR,-,High LDL,12/16/16,46961,2,3,"[0.9999680586018185,3.194139818146973E-5]",3,SCV000503269,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Likely pathogenic,2017-05-11,"The c.1444G>A (p.Asp482Asn) variant in the LDLR gene has been reported in patients with hypercholesterolemia [PMID 8535447, 23375686, 20236128, 16159606, 21326404; legacy name 461]. This variant was observed in five heterozygous individuals in the ExAC population database (http://exac.broadinstitute.org/variant/19-11224296-G-A). Aspartate at position 482 of the LDLR protein is conserved in mammals and while not clinically validated, computer-based algorithms (SIFT and Polyphen-2) predict this p.Asp482Asn change to be deleterious. This c.1444G>A (p.Asp482Asn) variant is thus classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839981.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000839981,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:9,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583832.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583832,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Pathogenic,2016-12-28,"This sequence change replaces aspartic acid with asparagine at codon 482 of the LDLR protein (p.Asp482Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs139624145, ExAC <0.01%). This variant has been reported in the literature in several unrelated individuals affected with hypercholesterolemia (PMID: 8535447, 23375686, 21310417, 20236128, 16389549). This variant is also known as p.Asp461Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 161284). A different missense substitution at this codon (p.Asp482His) has been determined to be pathogenic (PMID: 21310417, 20236128, 16389549). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544697.2,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000544697,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Pathogenic,2016-12-01,"The D482N variant in the LDLR gene has been reported previously in the heterozygous state in multiple individuals with familial hypercholesterolemia (Taylor et al., 2010; Graham et al., 2005; Laurie et al., 2004). The D482N variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D482N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (D482H, D482Y) have been reported previously in the heterozygous state in individuals with familial hypercholesterolemia (Meshkov et al., 2004; Day et al., 1997). Missense variants at nearby residues (D477N, G478R, L479P, A480V, V481M, W483R, F485R, H485Q, S486G, S486N) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, based on the ACMG recommendations, D482N is interpreted as a known pathogenic sequence change.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000491201.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000491201,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:10,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540819.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540819,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Pathogenic,2008-07-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:4,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268616.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268616,FALSE,FALSE,FALSE,
171214,single nucleotide variant,NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-May-17,139624145,RCV000172963;RCV000148591;RCV000414235,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11224296,11224296,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001428,2,161284,19,11224296,G,A,171214,19:11224296:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484754.1,LDLR,-,High LDL,5/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484754,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Uncertain significance,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782916.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000782916,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Pathogenic,2017-06-05,"Variant summary: The LDLR c.1474G>A (p.Asp492Asn) variant involves the alteration of a conserved nucleotide. 4/5 in silico tools predict a damaging outcome for this variant. This variant was found in 2/121480 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in multiple affected FH patients including heterozygous patients and compound heterozygous patients (Mak_1998, Chiou_2010, Bertolini_2013, Blaha_2015). Variant was shown to segregate with disease in at least one of the reported families (Blaha_2015). Variants involving nearby nucleotides such as c.1474G>C, c.1474delG, c.1475A>G, etc, have been reported in affected individuals suggesting variant of interest is located in a mutiaotn hotspot. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697197.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000697197,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Likely pathogenic,2017-04-26,"This c.1474G>A (p.Asp492Asn) variant has been reported in a 42 year old male patient with familial hypercholesterolemia from a cohort of 30 patients [reported as D471N, FH Graz-1 in PMID 9763532]. This variant was also reported in a patient presenting with a total cholesterol level of 23 mmol/L and xanthomas [PMID 25936317]; this patient also carried a second allele (p.Gly592Glu), which is classified as pathogenic by our laboratory . This variant was further detected in a patient from a cohort of 2,078 patients from Italy [PMID 23375686]; this patient also carried a p.Cys698Trp variant, classified as a variant of unknown significance by our laboratory at this time. Additional variants affecting the same amino acid at position 492 (p.Asp492Gly and p.Asp492His) have been reported in patients with familial hypercholesterolemia [PMID 16250003, 10208479].This variant was reported in 2 heterozygous individuals in the ExAC database (http://exac.broadinstitute.org/variant/19-11224326-G-A). Asparagine at amino acid position 492 of the LDLR protein is highly conserved in mammals. While not validated for clinical use, the computer-based algorithms predict this p.Asp492Asn change to be deleterious. This variant is thus classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839982.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000839982,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:14,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583835.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000583835,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 10 , family members = 5 with unclear co-segregation / previously described in association with FH/Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:10,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503353.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000503353,FALSE,FALSE,FALSE,
171216,single nucleotide variant,NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,373646964,RCV000237459;RCV000590270;RCV000148592;RCV000161989,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11224326,11224326,G,A,19p13.2,"criteria provided, conflicting interpretations",13,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850",2,161285,19,11224326,G,A,171216,19:11224326:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:43,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540820.1,LDLR,-,High LDL,1/2/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",3,SCV000540820,FALSE,FALSE,FALSE,
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Pathogenic,2018-05-17,"This sequence change replaces aspartic acid with glutamic acid at codon 266 of the LDLR protein (p.Asp266Glu). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. This variant has been reported in many unrelated individuals affected with hypercholesterolemia (PMID: 1301956, 23375686, 21310417) and is established as a common cause of disease (PMID: 20663204, 22698793, 26238499). ΌThis variant is also known as p.Asp245Glu in the literature. ClinVar contains an entry for this variant (Variation ID: 161287). A different missense substitution at this codon (p.Asp266Tyr) is reported to be deleterious (PMID: 11196104). This indicates that the asparagine residue is important for LDLR protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544696.4,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000544696,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Pathogenic,2017-11-13,"The p.Asp266Glu variant has been reported in over 100 individuals with familial hypercholesterolemia (FH; Bertolini 2013, Br_nne 2015, Brusgaard 2006, Chmara 2010, Do 2015, Fouchier 2001, Hobbs 1992, Schmidt 2000, Sharifi 2016, Tich_ 2012, Weiss 2000). Some publications refer to this variant as p.Asp245Glu (or p.D266E). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID: 161287) and has been identified in 10/126728 European chromosomes by the Genome Aggregation Database (GnomAD, http://gnomad.broadinstitute.org; dbSNP rs139043155). In vitro functional studies provide some evidence that the p.Asp266Glu variant may impact protein function, resulting in 15-30% LDL receptor activity (Hobbs 1992). Computational prediction tools and conservation analysis suggest that the p.Asp266Glu variant may impact the protein. Another likely pathogenic missense change at the same position (p.Asp266Tyr) has been reported in association to FH (reported as p.Asp245Tyr, Weiss 2000). In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in a large number of affected individuals, low frequency in controls, presence of another pathogenic missense change at the same amino acid position, functional evidence and computational evidence. ACMG/AMP Criteria applied: PS4, PM2, PM5, PP3, PS3_supporting (Richards 2015).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:28,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000711397.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000711397,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Pathogenic,2017-09-11,"The D266E pathogenic variant in the LDLR gene has been published previously, as D245E using alternative nomenclature, in association with FH (Hobbs et al., 1992; Kuhrova et al., 2001; Muller et al., 2004; Chmara et al., 2010; Amhad et al., 2012; Tichy et al., 2012; Stein et al., 2013; Kusters et al., 2013; Lange et al., 2014; Sharifi et al., 2016; Gabcova et al., 2016). Functional studies by Hobbs et al. (1992) demonstrate LDL receptor activity is 15-30% in patients with the D266E variant. The D266E variant results in a conservative amino acid substitution at a position that is conserved across most species. Finally, the D266E variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000234646.4,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000234646,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Likely pathogenic,2017-07-06,"This c.798T>A (p.Asp266Glu) variant has previously been detected in multiple patients with familial hypercholesterolemia [PMID 1301956, 11196104, 25637381, 25487149, 11810272, 16542394, 21310417, also reported as FH Cincinnati-1 (legacy: 245)]. Additional patients with hypercholesterolemia have been reported with variants located at the same amino acid position (p.Asp266Asn, p.Asp266Gly, p.Asp266Tyr and p.Asp266Val). This variant was observed in ten heterozygous individuals in the gnomAD database (http://gnomad.broadinstitute.org/variant/19-11217344-T-A This variant is highly conserved in mammals and computer-based algorithms predict this p.Asp266Glu change to be deleterious. It is thus classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839980.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000839980,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583741.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583741,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 4 , family members = 11 with co-segregation / FH-Cincinnati-1, 15 to 30% LDLR activity / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503238.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503238,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:382,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540759.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000540759,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Likely pathogenic,2015-09-10,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:1,"Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children",SCV000590848.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000590848,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Pathogenic,2008-07-09,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:2,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268586.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268586,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171201,single nucleotide variant,NM_000527.4(LDLR):c.798T>A (p.Asp266Glu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,17-May-18,139043155,RCV000172959;RCV000148594;RCV000162020,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Hypercholesterolaemia;not provided,germline;inherited;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11217344,11217344,T,A,19p13.2,"criteria provided, conflicting interpretations",16,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347",2,161287,19,11217344,T,A,171201,19:11217344:T:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484680.1,LDLR,-,High LDL,5/17/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000484680,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic, Pathogenic"
171218,single nucleotide variant,NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,24-Oct-17,373371572,RCV000237585;RCV000588105;RCV000148597;RCV000518174,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11227612,11227612,C,T,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856",2,161290,19,11227612,C,T,171218,19:11227612:C:T,Likely pathogenic,2017-10-24,"This sequence change replaces arginine with tryptophan at codon 595 of the LDLR protein (p.Arg595Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs373371572, ExAC 0.001%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 11737238, 25461735, 27784735, 16250003, 20538126). ClinVar contains an entry for this variant (Variation ID: 161290). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752411.1,LDLR,-,High LDL,10/24/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000752411,FALSE,TRUE,TRUE,Likely pathogenic
171218,single nucleotide variant,NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,24-Oct-17,373371572,RCV000237585;RCV000588105;RCV000148597;RCV000518174,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11227612,11227612,C,T,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856",2,161290,19,11227612,C,T,171218,19:11227612:C:T,Likely pathogenic,2017-06-16,-,not provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000614004.1,LDLR,-,High LDL,10/24/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000614004,FALSE,FALSE,TRUE,Likely pathogenic
171218,single nucleotide variant,NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,24-Oct-17,373371572,RCV000237585;RCV000588105;RCV000148597;RCV000518174,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11227612,11227612,C,T,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856",2,161290,19,11227612,C,T,171218,19:11227612:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000494601.2,LDLR,-,High LDL,10/24/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000494601,FALSE,FALSE,TRUE,Likely pathogenic
171218,single nucleotide variant,NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,24-Oct-17,373371572,RCV000237585;RCV000588105;RCV000148597;RCV000518174,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11227612,11227612,C,T,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856",2,161290,19,11227612,C,T,171218,19:11227612:C:T,Likely pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503414.1,LDLR,-,High LDL,10/24/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503414,FALSE,FALSE,TRUE,Likely pathogenic
171218,single nucleotide variant,NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,24-Oct-17,373371572,RCV000237585;RCV000588105;RCV000148597;RCV000518174,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11227612,11227612,C,T,19p13.2,"criteria provided, conflicting interpretations",11,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856",2,161290,19,11227612,C,T,171218,19:11227612:C:T,Pathogenic,2016-06-15,"Variant summary: The LDLR c.1783C>T (p.Arg595Trp) variant involves the alteration of a non-conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 1/121410 control chromosomes at a frequency of 0.0000082, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in numerous FH patients from multiple ethnic populations. In addition, p.R595Q and p.R595L have been shown to associate with FH, suggesting Arg595 is a mutation hot spot. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697210.1,LDLR,-,High LDL,10/24/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000697210,FALSE,FALSE,TRUE,Likely pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,2018-01-16,"This sequence change affects an acceptor splice site in intron 9 of the LDLR gene. It is expected to disrupt mRNA splicing and results in an absent or disrupted protein product. This variant is not present in population databases (rs139617694, ExAC no frequency). This variant has been reported to segregate with familial hypercholesterolemia in several families (PMID: 9254862, 25154303). It has also been observed in numerous unrelated individuals with familial hypercholesterolemia (PMID: 10735632, 11668640, 11857755, 15241806, 21382890, 21475731, 22390909). ClinVar contains an entry for this variant (Variation ID: 162499). Experimental studies have shown that this intronic change activates a cryptic acceptor splice site and leads to a deletion of seven nucleotides in exon 10 (PMID: 10090473). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544700.3,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000544700,FALSE,TRUE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:33,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583825.1,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000583825,FALSE,FALSE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 11 , family members = 2 with co-segregation / previously described in association with FH",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:11,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503342.1,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000503342,FALSE,FALSE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,2016-02-09,"The c.1359-1G>A variant in LDLR has been reported in >80 individuals with familial hypercholesterolemia (FH), segregated with disease in 8 affected relatives from 3 families (Peeters 1995, Lombarid 1995 and 2000, Garcia-Garcia 2001, Braenne 2015), and has been identified in 1/8600 European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs139617694). This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Heterozygous loss of LDLR function is an established disease mechanism in familial hypercholesterolemia. In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271383.2,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000271383,FALSE,FALSE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,2014-03-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268613.1,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000268613,FALSE,FALSE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484787.1,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000484787,FALSE,FALSE,TRUE,Pathogenic
172183,single nucleotide variant,NM_000527.4(LDLR):c.1359-1G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,16-Jan-18,139617694,RCV000172962;RCV000149884,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443",Familial hypercholesterolemia;Hypercholesterolaemia,germline,germline,GRCh37,NC_000019.9,19,11224210,11224210,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001405,2,162499,19,11224210,G,A,172183,19:11224210:G:A,Pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733821.1,LDLR,-,High LDL,1/16/18,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000733821,FALSE,FALSE,TRUE,Pathogenic
172489,single nucleotide variant,NM_170707.3(LMNA):c.1634G>A (p.Arg545His),4000,LMNA,HGNC:6636,Conflicting interpretations of pathogenicity,1,23-Apr-18,142191737,RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955,"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374","Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified",germline;maternal,germline,GRCh37,NC_000001.10,1,156107470,156107470,G,A,1q22,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,-,2,163878,1,156107470,G,A,172489,1:156107470:G:A,Likely pathogenic,2017-10-17,"A R545H variant that is likely pathogenic has been identified in the LMNA gene. The R545H variant in the LMNA gene was previously identified in one patient in a cohort of LMNA variant carriers who had known cardiac involvement or a family history of cardiac involvement (van Rijsingen et al., 2013). This variant has also been reported in a patient with lipodystrophy (Chan et al., 2016). Additionally, this variant has been reported in several individuals at GeneDx with various levels of cardiac involvement. The R545H variant is observed in 38/75898 (0.05%) alleles from individuals of European (non-Finnish) ancestry in large population cohorts (Lek et al., 2016). The R545H variant is a conservative amino acid substitution, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Nevertheless, this substitution occurs at a position that is conserved among mammals and is located within the C-terminal tail domain. A variant in the same residue (R545C) has been reported in association with muscular dystrophy (Kandert et al., 2009). Additionally, missense variants in nearby residues (R541C, R541H, R541G) have been reported in the Human Gene Mutation Database in association with LMNA-related disorders (Stenson et al., 2014), further supporting the functional importance of this region of the protein.",Not Provided,CN517202:not provided,cardiac involvement and a patient with lipodystrophy,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000234709.3,LMNA,-,"Lipodystrophy, MonogenicDM_all",4/23/18,44851,2112,4,"[0.9999554079061782,4.45920938217654E-5]",4,SCV000234709,TRUE,TRUE,TRUE,Likely pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Pathogenic,2017-04-03,"This sequence change replaces aspartic acid with glycine at codon 221 of the LDLR protein (p.Asp221Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 15523646,23375686). It is a common cause of familial hypercholesterolemia in individuals of Italian ancestry, though it has been observed in individuals in many other countries (PMID: 11196104, 15241806, 220236128, 2698793, 25461735). This variant is also known as p.Asp200Gly in the literature. ClinVar contains an entry for this variant (Variation ID: 183092). Experimental studies have shown that this missense change has a deleterious effect on LDLR activity (PMID: 25647241). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544638.2,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000544638,FALSE,TRUE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:27,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583715.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000583715,FALSE,FALSE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 12 , family members = 7 with co-segregation / FH-Padua / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:12,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503199.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000503199,FALSE,FALSE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Likely pathogenic,2016-11-05,Asp221 bind structural Ca2+.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:45,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540749.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000540749,FALSE,FALSE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Pathogenic,2016-05-27,"The p.Asp221Gly variant in LDLR has been reported in >75 individuals with familial hypercholesterolemia (FH), including in 4 homozygotes who presented with more severe disease (Hobbs 1992, Chmara 2010, Bertolini 2013). However, not all individuals carrying this variant presented with high cholesterol levels (Bertolini 2013, Thormaehlen 2015). This variant has also been identified in 10/65222 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs373822756). Please note that this frequency is low enough to be consistent with the frequency of FH in the general population. In vitro functional studies provide some evidence that the p.Asp221Gly variant may impact protein function (Thormaehlen 2015). However, these types of assays may not accurately represent biological function. In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in affected individuals, low frequency in the general population, and functional data.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000711396.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000711396,FALSE,FALSE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Pathogenic,2009-12-12,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:3,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268577.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000268577,FALSE,FALSE,TRUE,Pathogenic
181233,single nucleotide variant,NM_000527.4(LDLR):c.662A>G (p.Asp221Gly),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,3-Apr-17,373822756,RCV000211655;RCV000161962,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216244,11216244,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332",2,183092,19,11216244,A,G,181233,19:11216244:A:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484733.1,LDLR,-,High LDL,4/3/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000484733,FALSE,FALSE,TRUE,Pathogenic
181238,single nucleotide variant,NM_000527.4(LDLR):c.829G>A (p.Glu277Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Dec-17,148698650,RCV000210246;RCV000495914;RCV000161968;RCV000610848,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11218079,11218079,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350",2,183097,19,11218079,G,A,181238,19:11218079:G:A,Benign,2017-04-24,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285034.2,LDLR,-,High LDL,12/29/17,46963,0,61,"[0.9993505525626557,6.494474373442923E-4]",61,SCV000285034,TRUE,TRUE,TRUE,Benign
181238,single nucleotide variant,NM_000527.4(LDLR):c.829G>A (p.Glu277Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Dec-17,148698650,RCV000210246;RCV000495914;RCV000161968;RCV000610848,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11218079,11218079,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350",2,183097,19,11218079,G,A,181238,19:11218079:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:18,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583745.1,LDLR,-,High LDL,12/29/17,46963,0,61,"[0.9993505525626557,6.494474373442923E-4]",61,SCV000583745,TRUE,FALSE,TRUE,Benign
181238,single nucleotide variant,NM_000527.4(LDLR):c.829G>A (p.Glu277Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Dec-17,148698650,RCV000210246;RCV000495914;RCV000161968;RCV000610848,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11218079,11218079,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350",2,183097,19,11218079,G,A,181238,19:11218079:G:A,Uncertain significance,2017-03-20,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540898.1,LDLR,-,High LDL,12/29/17,46963,0,61,"[0.9993505525626557,6.494474373442923E-4]",61,SCV000540898,TRUE,FALSE,TRUE,Benign
181238,single nucleotide variant,NM_000527.4(LDLR):c.829G>A (p.Glu277Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Dec-17,148698650,RCV000210246;RCV000495914;RCV000161968;RCV000610848,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11218079,11218079,G,A,19p13.2,"criteria provided, conflicting interpretations",12,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350",2,183097,19,11218079,G,A,181238,19:11218079:G:A,Benign,2016-12-16,"subjects mutated among 2600 FH index cases screened = 15 , family members = 5 / for 14 index cases among 15 this variant is associated with c.1268T>C, p.Ile423Thr that seems to be more deleterious / Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:15,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503243.1,LDLR,-,High LDL,12/29/17,46963,0,61,"[0.9993505525626557,6.494474373442923E-4]",61,SCV000503243,TRUE,FALSE,TRUE,Benign
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Pathogenic,2018-07-05,"This sequence change replaces glycine with serine at codon 343 of the LDLR protein (p.Gly343Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs730882096, ExAC 0.005%). This variant has been reported in numerous individuals affected with familial hypercholesterolemia (PMID: 1301956, 11040093, 11933210, 20506408, 23375686, 22294733, 18096825, 17765246, 15241806, 25461735, 27765764). This variant is also known as G322S or FH-Picardie in the literature. ClinVar contains an entry for this variant (Variation ID: 183106). Experimental studies have shown that this missense change affects protein folding and expression in the cell surface in vitro (PMID: 15100232). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Different missense substitutions at this codon (p.Gly343Asp, p.Gly343Val) have been reported in individuals affected with hypercholesterolemia (PMID: 12436241, 18718593). These variants are also known in the literature as p.Gly322Asp and p.Gly322Val. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000821038.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000821038,FALSE,TRUE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Likely pathogenic,2017-12-04,"The p.Gly343Ser variant in LDLR has been reported in at least 10 individuals with familial hypercholesterolemia (FH); nine patients were heterozygous (Fouchier 2001, Bourbon 2008, Reshef 1996, Thiart 2000, Guardamagna 2009, Mozas 2004, Van Gaal 2001, Salazar 2002) and one individual carried the variant in the compound heterozygous state (Hobbs 1992). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 183106). In vitro functional studies provide evidence that the p.Gly343Ser variant may impact protein function (Hobbs 1992). This variant has been identified in 5/126,580 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/, rs730882096). This frequency is low enough to be consistent with the frequency of FH in the general population Computational prediction tools and conservation analysis suggest that the p.Gly343Ser variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Gly343Ser variant is likely pathogenic. ACMG/AMP Criteria applied: PS4_Moderate, PM2, PP3, PS3_supporting (Richards 2015).",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:7,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000712222.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000712222,FALSE,TRUE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Likely pathogenic,2017-10-05,"The G343S likely pathogenic variant in the LDLR gene (previously reported as G322S and FH Picardie due to the use of alternate nomenclature) has been reported in association with FH across multiple ethnic groups (Reshef et al., 1996; Thiart et al., 2000; Fouchier et al., 2001; Salazar et al., 2002; Bourbon et al., 2008; Junyent et al., 2008; van der Graaf et al., 2011; Kusters et al., 2013; Medeiros et al., 2014; Jannes et al., 2015; Reiman et al., 2016; Sanchez-Hernandez et al., 2016; Gabcova et al., 2016). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The G343S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, functional studies showed decreased LDL receptor activity (Hobbs et al., 1992). Missense variants in the same residue (G343V, G343D, G343C) have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014); however, the pathogenicity of these variants has not been definitively determined.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617505.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000617505,FALSE,TRUE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Pathogenic,2017-05-09,"Variant summary: The LDLR c.1027G>A (p.Gly343Ser) variant involves the alteration of a conserved nucleotide, resulting in a missense substitution that lies within the EGF-like calcium-binding domain, the EGF-like domain, and the Growth factor receptor cysteine-rich domain (InterPro). 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in the large control database ExAC at a frequency of 0.0000246 (3/121826 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). The variant is present in patient cohorts affected with familial hypercholesterolemia (e.g., Bertolini_Arthero_2013; Salazar_HM_2002; Huijgen_HM_2010 amongst others) and is widely considered to be a pathogenic mutation in the literature. A functional study showed that the variant causes a ~50% reduction in LDL receptor protein at the cell surface likely due to protein misfolding, though the receptor that is present at the cell surface is able to bind and release LDL cholesterol properly (Boswell_JBC_2004). In addition, 2 other missense mutations at the Gly343 residue have been identified in patients with familial hypercholesterolemia (p.Gly343Cys [Jelassi_Artherosclerosis_2008] and p.Gly343Asp [Amsellem_HG_2002]), suggesting the residue is a critical amino acid in the development of hypercholesterolemia. Multiple clinical diagnostic laboratories/reputable databases have classified this variant with conflicting interpretations in ClinVar, including uncertain significance, likely pathogenic, and pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697181.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000697181,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:12,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583777.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583777,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 7 , family members = 12 with co-segregation (1 homozygote in a family) / FH-Picardie, 15 to 30% LDLR activity / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:7,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503283.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503283,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Pathogenic,2008-06-09,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268593.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268593,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181247,single nucleotide variant,NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jul-18,730882096,RCV000211596;RCV000587327;RCV000161977,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11221414,11221414,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367",2,183106,19,11221414,G,A,181247,19:11221414:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484753.1,LDLR,-,High LDL,7/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484753,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic, Likely pathogenic"
181265,single nucleotide variant,NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Dec-17,185098634,RCV000238063;RCV000161998,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227549,11227549,C,T,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000232,UniProtKB (protein):P01130#VAR_072851",2,183123,19,11227549,C,T,181265,19:11227549:C:T,Likely pathogenic,2017-12-11,"This sequence change replaces arginine with cysteine at codon 574 of the LDLR protein (p.Arg574Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs185098634, ExAC 0.02%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 11462246, 19446849, 26892515), probable hypercholesterolemia (PMID: 23375686, 20145306), and myocardial infarction (PMID: 25487149). ClinVar contains an entry for this variant (Variation ID: 183123). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Different missense substitutions at this codon (p.Arg574His, p.Arg574Ser, p.Arg574Leu) have been reported in several individuals affected with hypercholesterolemia (PMID: 28028493, 20018285, 22698793). This suggests that the arginine residue is critical for LDLR protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752408.1,LDLR,-,High LDL,12/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000752408,FALSE,TRUE,TRUE,Likely pathogenic
181265,single nucleotide variant,NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Dec-17,185098634,RCV000238063;RCV000161998,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227549,11227549,C,T,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000232,UniProtKB (protein):P01130#VAR_072851",2,183123,19,11227549,C,T,181265,19:11227549:C:T,Uncertain significance,2016-12-16,"subject mutated among 2600 FH index cases screened = 1, family member=1 /FH-Germany/software prediction damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503397.1,LDLR,-,High LDL,12/11/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503397,FALSE,FALSE,TRUE,Likely pathogenic
181268,single nucleotide variant,NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Apr-18,201102492,RCV000211609;RCV000162002,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227613,11227613,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000563,2,183126,19,11227613,G,A,181268,19:11227613:G:A,Pathogenic,2018-04-11,"This sequence change replaces arginine with glutamine at codon 595 of the LDLR protein (p.Arg595Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs201102492, ExAC 0.03%). This variant has been reported in several individuals affected with familial hypercholesterolemia (FH) and myocardial infarction and has been described as a common cause of FH in Finland (PMID: 15359125, 15256764, 16250003, 18718593, 25437892,Ό25487149, 27497240). This variant is also known as p.Arg574Gln and FH-Pogosta in the literature. ClinVar contains an entry for this variant (Variation ID: 183126). Experimental studies have shown that this missense change does not affect LDL uptake in vitro (PMID: 25647241). A different missense substitution at this codon (p.Arg595Trp) has been determined to be pathogenic (PMID: 11737238, 25461735, 27784735, 16250003, 20538126). This suggests that the arginine residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752415.2,LDLR,-,High LDL,4/11/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000752415,FALSE,TRUE,TRUE,Pathogenic
181268,single nucleotide variant,NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Apr-18,201102492,RCV000211609;RCV000162002,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227613,11227613,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000563,2,183126,19,11227613,G,A,181268,19:11227613:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540838.1,LDLR,-,High LDL,4/11/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000540838,FALSE,FALSE,TRUE,Pathogenic
181268,single nucleotide variant,NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Apr-18,201102492,RCV000211609;RCV000162002,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227613,11227613,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000563,2,183126,19,11227613,G,A,181268,19:11227613:G:A,Pathogenic,2010-09-24,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268639.1,LDLR,-,High LDL,4/11/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000268639,FALSE,FALSE,TRUE,Pathogenic
181268,single nucleotide variant,NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,11-Apr-18,201102492,RCV000211609;RCV000162002,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227613,11227613,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000563,2,183126,19,11227613,G,A,181268,19:11227613:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484704.1,LDLR,-,High LDL,4/11/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000484704,FALSE,FALSE,TRUE,Pathogenic
181269,single nucleotide variant,NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Sep-17,139791325,RCV000211563;RCV000162004;RCV000454999,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11230798,11230798,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000258,2,183127,19,11230798,G,A,181269,19:11230798:G:A,Uncertain significance,2017-09-27,"This sequence change replaces glutamic acid with lysine at codon 626 of the LDLR protein (p.Glu626Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs139791325, ExAC 0.08%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in individuals affected with hypercholesterolemia and myocardial infarction (PMID: 16250003, 20828696, 25487149, 25647241). ClinVar contains an entry for this variant (Variation ID: 183127). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C15""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544656.3,LDLR,-,High LDL,9/27/17,46963,0,19,"[0.9997977130932862,2.0228690671379596E-4]",19,SCV000544656,TRUE,TRUE,TRUE,Uncertain significance
181269,single nucleotide variant,NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Sep-17,139791325,RCV000211563;RCV000162004;RCV000454999,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11230798,11230798,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000258,2,183127,19,11230798,G,A,181269,19:11230798:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583902.1,LDLR,-,High LDL,9/27/17,46963,0,19,"[0.9997977130932862,2.0228690671379596E-4]",19,SCV000583902,TRUE,FALSE,TRUE,Uncertain significance
181269,single nucleotide variant,NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Sep-17,139791325,RCV000211563;RCV000162004;RCV000454999,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11230798,11230798,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000258,2,183127,19,11230798,G,A,181269,19:11230798:G:A,Uncertain significance,2015-07-30,-,Familial hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia",SCV000296926.2,LDLR,-,High LDL,9/27/17,46963,0,19,"[0.9997977130932862,2.0228690671379596E-4]",19,SCV000296926,TRUE,FALSE,TRUE,Uncertain significance
181269,single nucleotide variant,NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Sep-17,139791325,RCV000211563;RCV000162004;RCV000454999,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11230798,11230798,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000258,2,183127,19,11230798,G,A,181269,19:11230798:G:A,Pathogenic,2011-05-25,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268644.1,LDLR,-,High LDL,9/27/17,46963,0,19,"[0.9997977130932862,2.0228690671379596E-4]",19,SCV000268644,TRUE,FALSE,TRUE,Uncertain significance
181272,single nucleotide variant,NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,7-Jun-17,368838866,RCV000238415;RCV000162008,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11231159,11231159,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001078,2,183130,19,11231159,G,A,181272,19:11231159:G:A,Uncertain significance,2017-06-07,"Variant summary: The LDLR c.2101G>A (p.Gly701Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). The variant of interest has been found in a large and broad control population from ExAC in 17/137956 control chromosomes at a frequency of 0.0001232, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in patients with hypercholesterolemia, coronary artery disease and/or myocardial infarction (Fouchier _2005, Duskova _2011, Thormaehlen_2015, Khera_2016) without strong evidence for causality. In two case-control studies, this variant was not significantly more enriched in patients with coronary artery disease and/or myocardial infarction than in controls (Thormaehlen_2015, Khera_2016). Based on LDLR uptake and complementation assay, one in vitro study has concluded that its pathogenicity or functional outcome is unclear (Thormaehlen _2015). There are conflicting reports of classification on this variant in ClinVar, likely pathogenic as well as likely benign (both in 2016). Taken together, this variant is currently classified as Variant of Unknown Significance.",MedGen:CN221809,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697222.1,LDLR,-,High LDL,6/7/17,46963,0,15,"[0.9998402998104892,1.5970018951089155E-4]",15,SCV000697222,FALSE,FALSE,FALSE,
181272,single nucleotide variant,NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,7-Jun-17,368838866,RCV000238415;RCV000162008,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11231159,11231159,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001078,2,183130,19,11231159,G,A,181272,19:11231159:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:4,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540860.1,LDLR,-,High LDL,6/7/17,46963,0,15,"[0.9998402998104892,1.5970018951089155E-4]",15,SCV000540860,FALSE,FALSE,FALSE,
181272,single nucleotide variant,NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,7-Jun-17,368838866,RCV000238415;RCV000162008,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11231159,11231159,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001078,2,183130,19,11231159,G,A,181272,19:11231159:G:A,Likely benign,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733828.1,LDLR,-,High LDL,6/7/17,46963,0,15,"[0.9998402998104892,1.5970018951089155E-4]",15,SCV000733828,FALSE,FALSE,FALSE,
181275,single nucleotide variant,NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,14-Jun-16,150104358,RCV000237615;RCV000162012,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11233951,11233951,G,A,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000290,2,183133,19,11233951,G,A,181275,19:11233951:G:A,Uncertain significance,2016-06-14,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000410544.2,LDLR,-,High LDL,6/14/16,46963,0,11,"[0.999882886527692,1.1711347230798714E-4]",11,SCV000410544,FALSE,FALSE,FALSE,
181275,single nucleotide variant,NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,14-Jun-16,150104358,RCV000237615;RCV000162012,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11233951,11233951,G,A,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000290,2,183133,19,11233951,G,A,181275,19:11233951:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484755.1,LDLR,-,High LDL,6/14/16,46963,0,11,"[0.999882886527692,1.1711347230798714E-4]",11,SCV000484755,FALSE,FALSE,FALSE,
181228,single nucleotide variant,NM_000527.4(LDLR):c.502G>A (p.Asp168Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,28-Jun-18,200727689,RCV000211669;RCV000162017,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216084,11216084,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322",2,183136,19,11216084,G,A,181228,19:11216084:G:A,Pathogenic,2018-06-28,"This sequence change replaces aspartic acid with asparagine at codon 168 of the LDLR protein (p.Asp168Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs200727689, ExAC 0.003%). This variant has been reported in numerous unrelated individuals affected with familial hypercholesterolemia (PMID: 9259195, 9678702, 12124988, 15556094, 16205024, 19007590, 22859806, 27784735). This variant is also known as p.Asp147Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 183136). Experimental studies have shown that this missense change causes a significantly reduced affinity to LDL (PMID: 25545329, 25647241). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627039.3,LDLR,-,High LDL,6/28/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000627039,FALSE,TRUE,TRUE,Pathogenic
181228,single nucleotide variant,NM_000527.4(LDLR):c.502G>A (p.Asp168Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,28-Jun-18,200727689,RCV000211669;RCV000162017,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216084,11216084,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322",2,183136,19,11216084,G,A,181228,19:11216084:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 3 , family member = 1 with co-segregation / FH-Sephardic, 2 to 5% LDLR Activity / Software predictions: Conflicting",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503170.1,LDLR,-,High LDL,6/28/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503170,FALSE,FALSE,TRUE,Pathogenic
181228,single nucleotide variant,NM_000527.4(LDLR):c.502G>A (p.Asp168Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,28-Jun-18,200727689,RCV000211669;RCV000162017,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216084,11216084,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322",2,183136,19,11216084,G,A,181228,19:11216084:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540737.1,LDLR,-,High LDL,6/28/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000540737,FALSE,FALSE,TRUE,Pathogenic
181228,single nucleotide variant,NM_000527.4(LDLR):c.502G>A (p.Asp168Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,28-Jun-18,200727689,RCV000211669;RCV000162017,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216084,11216084,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322",2,183136,19,11216084,G,A,181228,19:11216084:G:A,Pathogenic,2014-04-04,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268566.1,LDLR,-,High LDL,6/28/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268566,FALSE,FALSE,TRUE,Pathogenic
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Benign,2017-08-18,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556774.2,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000556774,TRUE,TRUE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Benign,2017-06-22,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000689758.1,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000689758,TRUE,FALSE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Benign,2017-03-22,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:690,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540899.1,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000540899,TRUE,FALSE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Likely benign,2017-03-21,-,not specified,CN169374:not specified,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000614003.1,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000614003,TRUE,FALSE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Benign,2016-12-16,subjects mutated among 2600 FH index cases screened = 201 6 being homozygotes / Software predictions: Benign,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:201,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503308.1,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000503308,TRUE,FALSE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Likely benign,2016-06-14,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000410531.2,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000410531,TRUE,FALSE,TRUE,Benign
181250,single nucleotide variant,NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,18-Aug-17,11669576,RCV000237576;RCV000162023;RCV000241875,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11222300,11222300,G,A,19p13.2,"criteria provided, conflicting interpretations",15,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519",2,183138,19,11222300,G,A,181250,19:11222300:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484696.1,LDLR,-,High LDL,8/18/17,46928,35,4469,"[0.9523845039209001,0.0476154960790999]",3889,SCV000484696,TRUE,FALSE,TRUE,Benign
186816,single nucleotide variant,NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter),6833,ABCC8,HGNC:59,Pathogenic/Likely pathogenic,1,31-Oct-18,72559722,RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895,"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202",Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided,germline;unknown,germline,GRCh37,NC_000011.9,11,17434263,17434263,G,A,11p15.1,"criteria provided, multiple submitters, no conflicts",5,NA,N,-,2,188915,11,17434263,G,A,186816,11:17434263:G:A,Pathogenic,2018-10-31,-,OMIM:125853;OMIM:240800;OMIM:256450;OMIM:606176;OMIM:610374,C0011860:Diabetes mellitus type 2;C0271714:Leucine-induced hypoglycemia;C1833104:Permanent neonatal diabetes mellitus;C1835887:Transient neonatal diabetes mellitus 2;C2931832:Persistent hyperinsulinemic hypoglycemia of infancy,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000893867.1,-,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",10/31/18,46955,8,12,"[0.9998722180811416,1.2778191885848153E-4]",12,SCV000893867,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Uncertain significance,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782952.1,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000782952,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583731.1,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000583731,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Likely benign,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH / Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503229.1,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503229,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Pathogenic,2016-06-28,"Variant summary: The LDLR c.718G>A (p.Glu240Lys) variant involves the alteration of a conserved nucleotide and results in a replacement of a medium size and acidic Glutamic acid (E) with a large size and basic Lysine (K) located in the ligand binding domain of LDLR. 3/4 in silico tools predict a damaging outcome for this substitution (SNPs&GO not captured due to low reliability index). This variant was found in 2/121994 control chromosomes at a frequency of 0.0000164, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). It was reported in several FH patients indicating its pathogenicity. Additionally a functional study of LDLR function in fibroblast monolayers revealed the variant to only have the WT 15-30% LDL receptor activity suggesting the variant to be a partially transport defective allele that impairs transport between ER and Golgi. Furthermore, the variat was found not to fold into a unique disulphide bond structure like the WT does, thus leading to the conclusion that this variant gives rise to a protein folding defect. Moreover, multiple clinical diagnostic laboratories classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697249.1,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000697249,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Pathogenic,2015-09-01,"The E240K mutation in the LDLR gene has been published previously as a disease-causing mutation (reported as E219K in Hobbs et al. due to alternate nomenclature) associated with autosomal dominant hypercholesterolemia (Hobbs et al., 1992; Bertolini et al., 2013). Based on the ACMG recommendations, E240K is interpreted as a known pathogenic sequence change.",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000234645.10,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000234645,FALSE,FALSE,FALSE,
198013,single nucleotide variant,NM_000527.4(LDLR):c.718G>A (p.Glu240Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,22-May-18,768563000,RCV000211564;RCV000586018;RCV000182341,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline,germline,GRCh37,NC_000019.9,19,11217264,11217264,G,A,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343",2,200920,19,11217264,G,A,198013,19:11217264:G:A,Pathogenic,2012-03-01,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268584.1,LDLR,-,High LDL,5/22/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000268584,FALSE,FALSE,FALSE,
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Pathogenic,2017-11-10,"This sequence change replaces histidine with tyrosine at codon 583 of the LDLR protein (p.His583Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is present in population databases (rs730882109, ExAC 0.09%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant is a known familial hypercholesterolemia founder variant in China and it has been reported in multiple unrelated affected individuals and segregating with disease in a family in China and Southeast Asia (PMID: 7903864, 23155708, 27206935, 21376320, 22353362, 28028493, 16205024). This variant is also known as p.His562Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 200921). Experimental studies have shown that this missense change impairs lipoprotein uptake by reducing the number of surface receptors (PMID: 7903864, 21511053). Different missense substitution at this codon (p.His583Gln, p.His583Asp, His583Arg) have been reported in several individuals affected with hypercholesterolemia (PMID: 23375686, 19318025, 22698793). This suggests that the histidine residue is critical for LDLR protein function and that other missense substitutions at this position may be deleterious. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752419.1,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000752419,FALSE,TRUE,TRUE,Pathogenic
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583880.1,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000583880,FALSE,FALSE,TRUE,Pathogenic
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Likely benign,2016-12-16,subject mutated among 2600 FH index cases screened = 1 /previously described in association with FH /Software predictions: Conflicting,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503407.1,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000503407,FALSE,FALSE,TRUE,Pathogenic
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Pathogenic,2015-03-19,"The H583Y c.1747CAC>TAC mutation in the LDLR gene has been published previously as a disease-causing mutation using alternate nomenclature (reported as H562Y) (Sun et al., 1994; Van Hoof et al., 2005). Based on the ACMG recommendations, H583Y is interpreted as a known pathogenic sequence change. The variant is found in ,LDLR panel(s).",Not Provided,CN517202:not provided,Familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000234652.11,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000234652,FALSE,FALSE,TRUE,Pathogenic
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Pathogenic,2010-10-19,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:3,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268636.1,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000268636,FALSE,FALSE,TRUE,Pathogenic
198015,single nucleotide variant,NM_000527.4(LDLR):c.1747C>T (p.His583Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Jan-18,730882109,RCV000211604;RCV000182342,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11227576,11227576,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000234,2,200921,19,11227576,C,T,198015,19:11227576:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484707.1,LDLR,-,High LDL,1/23/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000484707,FALSE,FALSE,TRUE,Pathogenic
196756,single nucleotide variant,NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,7-Dec-17,141502002,RCV000408878;RCV000228895;RCV000182576,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified",germline,germline,GRCh37,NC_000001.10,1,55524222,55524222,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025456,2,201128,1,55524222,C,T,196756,1:55524222:C:T,Benign,2017-12-07,-,MedGen:C1863551,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000291596.3,PCSK9,-,Low LDL,12/7/17,46960,3,122,"[0.9987010221465077,0.0012989778534923339]",122,SCV000291596,FALSE,TRUE,TRUE,"Benign, Uncertain significance"
196756,single nucleotide variant,NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,7-Dec-17,141502002,RCV000408878;RCV000228895;RCV000182576,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified",germline,germline,GRCh37,NC_000001.10,1,55524222,55524222,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025456,2,201128,1,55524222,C,T,196756,1:55524222:C:T,Uncertain significance,2017-03-21,"The R469W variant has been reported in one individual with severe hypercholesterolemia, who was also heterozygous for a variant in the LDLR gene (Allard et al., 2005). Subsequently, an individual with elevated LDL-C was found to harbor this variant in isolation (Wang et al., 2016). The R469W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Nevertheless, this substitution occurs at a position that is not conserved across species, where W469 is wild-type in at least one mammalian species. Additionally, the majority of in silico analyses (2 out of 3) predict this variant likely does not alter the protein structure/function. Though R469W was presumed to be a gain-of-function variant by Hampton et al. (2007), in vitro functional analysis showed no effect on the ability of the PCSK9-encoded protein to bind Annexin A2, a protein responsible for inhibiting PCSK9-endoded protein activity (Ly et al,. 2014). Therefore, the mechanism by which this variant may result in disease is unclear. Furthermore, the Exome Aggregation Consortium reports R469W was observed in 80/10392 (0.8%) alleles from individuals of African background, including two individuals of African background who were homozygous for the variant. Of note, this variant has been reported in individuals of African descent with high LDL, though the association was not statistically significant (Kotowski et al., 2006). It has also been identified in two individuals of African Canadian descent from the general population who also harbored other PCSK9 variants (Mayne et al., 2013). Ultimately, the possibility that this variant may have a mild clinical effect and/or function as a genetic modifier for disease can not be excluded, at this time.",not specified,CN169374:not specified,severe hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000234926.12,PCSK9,-,Low LDL,12/7/17,46960,3,122,"[0.9987010221465077,0.0012989778534923339]",122,SCV000234926,FALSE,TRUE,TRUE,"Benign, Uncertain significance"
196756,single nucleotide variant,NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,7-Dec-17,141502002,RCV000408878;RCV000228895;RCV000182576,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified",germline,germline,GRCh37,NC_000001.10,1,55524222,55524222,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025456,2,201128,1,55524222,C,T,196756,1:55524222:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484814.1,PCSK9,-,Low LDL,12/7/17,46960,3,122,"[0.9987010221465077,0.0012989778534923339]",122,SCV000484814,FALSE,FALSE,TRUE,"Benign, Uncertain significance"
207484,single nucleotide variant,NM_000162.3(GCK):c.370G>A (p.Asp124Asn),2645,GCK,HGNC:4195,Conflicting interpretations of pathogenicity,1,1-Jun-17,759072800,RCV000193215;RCV000518229,"MedGen:C1841962,OMIM:125851;MedGen:CN169374","Maturity-onset diabetes of the young,  type 2;not specified",germline,germline,GRCh37,NC_000007.13,7,44190668,44190668,C,T,7p13,"criteria provided, conflicting interpretations",2,NA,N,-,2,211073,7,44190668,C,T,207484,7:44190668:C:T,Uncertain significance,2017-06-01,-,not specified,CN169374:not specified,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613426.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",6/1/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000613426,FALSE,FALSE,FALSE,
207484,single nucleotide variant,NM_000162.3(GCK):c.370G>A (p.Asp124Asn),2645,GCK,HGNC:4195,Conflicting interpretations of pathogenicity,1,1-Jun-17,759072800,RCV000193215;RCV000518229,"MedGen:C1841962,OMIM:125851;MedGen:CN169374","Maturity-onset diabetes of the young,  type 2;not specified",germline,germline,GRCh37,NC_000007.13,7,44190668,44190668,C,T,7p13,"criteria provided, conflicting interpretations",2,NA,N,-,2,211073,7,44190668,C,T,207484,7:44190668:C:T,Likely pathogenic,2015-01-21,-,"MODY, type II","C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000247467.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",6/1/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000247467,FALSE,FALSE,FALSE,
207832,single nucleotide variant,NM_000525.3(KCNJ11):c.881C>T (p.Thr294Met),3767,KCNJ11,HGNC:6257,Pathogenic/Likely pathogenic,1,18-Aug-17,780957825,RCV000192330;RCV000668887;RCV000668887;RCV000668887,"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582",Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3,germline;unknown,germline,GRCh37,NC_000011.9,11,17408758,17408758,G,A,11p15.1,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,211230,11,17408758,G,A,207832,11:17408758:G:A,Likely pathogenic,2017-08-18,-,OMIM:601820;OMIM:606176;OMIM:610582,C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,Counsyl,SCV000793561.1,KCNJ11,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",8/18/17,46963,0,7,"[0.9999254732448949,7.452675510508272E-5]",7,SCV000793561,FALSE,FALSE,FALSE,
226401,single nucleotide variant,NM_000527.4(LDLR):c.1691A>G (p.Asn564Ser),3949,LDLR,HGNC:6547,Likely pathogenic,1,24-Apr-18,758194385,RCV000210237,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11226874,11226874,A,G,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000225,UniProtKB (protein):P01130#VAR_005400",2,224616,19,11226874,A,G,226401,19:11226874:A:G,Likely pathogenic,2018-04-24,"This sequence change replaces asparagine with serine at codon 564 of the LDLR protein (p.Asn564Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs758194385, ExAC 0.01%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 9654205, 18718593, 20538126, 23375686,Ό28145427).ΌThis variant is also known as N543S in the literature. ClinVar contains an entry for this variant (Variation ID: 224616). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000831365.1,LDLR,-,High LDL,4/24/18,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000831365,FALSE,TRUE,TRUE,Likely pathogenic
226402,single nucleotide variant,NM_000527.4(LDLR):c.1836C>T (p.Ala612=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Jun-17,143872778,RCV000210239;RCV000586569;RCV000456101,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline,germline,GRCh37,NC_000019.9,19,11227665,11227665,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000249,2,224618,19,11227665,C,T,226402,19:11227665:C:T,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583890.1,LDLR,-,High LDL,6/27/17,46963,0,10,"[0.9998935332069927,1.0646679300726103E-4]",10,SCV000583890,TRUE,FALSE,TRUE,Uncertain significance
226402,single nucleotide variant,NM_000527.4(LDLR):c.1836C>T (p.Ala612=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Jun-17,143872778,RCV000210239;RCV000586569;RCV000456101,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline,germline,GRCh37,NC_000019.9,19,11227665,11227665,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000249,2,224618,19,11227665,C,T,226402,19:11227665:C:T,Uncertain significance,2017-01-24,Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This is a silent variant in LDLR. It is classified as DM in HGMD. This variant has been reported in 7 patients with familial hypercholesterolemia in one study (Widhalm 2007). This variant is classified in ClinVar with 1 star as VUS by Mayo Clinic and as Likely Benign by British Heart Foundation. The variant has a Max MAF of 0.03% in ExAC (23 alleles) and 0.03% in gnomAD (43 alleles).,not specified,CN169374:not specified,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000539509.1,LDLR,-,High LDL,6/27/17,46963,0,10,"[0.9998935332069927,1.0646679300726103E-4]",10,SCV000539509,TRUE,TRUE,TRUE,Uncertain significance
226402,single nucleotide variant,NM_000527.4(LDLR):c.1836C>T (p.Ala612=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Jun-17,143872778,RCV000210239;RCV000586569;RCV000456101,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline,germline,GRCh37,NC_000019.9,19,11227665,11227665,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000249,2,224618,19,11227665,C,T,226402,19:11227665:C:T,Likely benign,2016-12-25,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556782.2,LDLR,-,High LDL,6/27/17,46963,0,10,"[0.9998935332069927,1.0646679300726103E-4]",10,SCV000556782,TRUE,FALSE,TRUE,Uncertain significance
226402,single nucleotide variant,NM_000527.4(LDLR):c.1836C>T (p.Ala612=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Jun-17,143872778,RCV000210239;RCV000586569;RCV000456101,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline,germline,GRCh37,NC_000019.9,19,11227665,11227665,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000249,2,224618,19,11227665,C,T,226402,19:11227665:C:T,Uncertain significance,2016-06-14,"The c.1836C>T (p.Ala612Ala) variant has been reported in two studies and is found in a total of eight familial hypercholesterolemia patients in a heterozygous state (Widhalm et al. 2007; Chmara et al. 2010). In silico analysis of this variant predicted no effect on consensus splice sites and overall non-pathogenicity (Chmara et al. 2010; Usifo et al. 2012). Control data are unavailable for this variant, which is reported at a frequency of 0.00034 in the European (Non-Finnish) population of the Exome Aggregation Consortium. The evidence for this variant is limited. The p.Ala612Ala variant is classified as a variant of unknown significance but suspicious for pathogenicity for familial hypercholesterolemia.",Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000410538.2,LDLR,-,High LDL,6/27/17,46963,0,10,"[0.9998935332069927,1.0646679300726103E-4]",10,SCV000410538,TRUE,FALSE,TRUE,Uncertain significance
226402,single nucleotide variant,NM_000527.4(LDLR):c.1836C>T (p.Ala612=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,27-Jun-17,143872778,RCV000210239;RCV000586569;RCV000456101,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374",Familial hypercholesterolemia;not provided;not specified,germline,germline,GRCh37,NC_000019.9,19,11227665,11227665,C,T,19p13.2,"criteria provided, conflicting interpretations",9,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000249,2,224618,19,11227665,C,T,226402,19:11227665:C:T,Uncertain significance,2016-02-29,"Variant summary: The c.1836C>T in LDLR gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.021%. The observed frequency does not exceed the maximum expected allele frequency for a pathogenic LDLR variant of 0.1%, suggesting that it is not a common polymorphism. In addtion, it is unknown whether the control population was cardiographically evaluated or profiled for lipid levels. Therefore, they may or may not represent as true normal population with respect to the silent phenotypes associated with this gene. This variant was found in several affected individuals with premature atherosclerosis and/or hypercholesterolaemia but without strong evidence for casualty. Lastly, the variant of interest has not been reported by reputable databases/clinical laboratories. Taken together, this variant has been classified as a VUS-possibly benign, until more information becomes available.",MedGen:CN221809,CN517202:not provided,premature atherosclerosis and/or hypercholesterolaemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697212.1,LDLR,-,High LDL,6/27/17,46963,0,10,"[0.9998935332069927,1.0646679300726103E-4]",10,SCV000697212,TRUE,FALSE,TRUE,Uncertain significance
226399,single nucleotide variant,NM_000527.4(LDLR):c.941-4G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,12-Jan-18,116405216,RCV000210248;RCV000736080,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11221324,11221324,G,A,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000515,2,224619,19,11221324,G,A,226399,19:11221324:G:A,Benign,2018-01-12,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556777.3,LDLR,-,High LDL,1/12/18,46963,0,399,"[0.9957519749590102,0.004248025040989715]",389,SCV000556777,FALSE,TRUE,TRUE,Benign
226399,single nucleotide variant,NM_000527.4(LDLR):c.941-4G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,12-Jan-18,116405216,RCV000210248;RCV000736080,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11221324,11221324,G,A,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000515,2,224619,19,11221324,G,A,226399,19:11221324:G:A,Benign,2017-07-28,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genome Diagnostics Laboratory,University Medical Center Utrecht",SCV000743852.1,LDLR,-,High LDL,1/12/18,46963,0,399,"[0.9957519749590102,0.004248025040989715]",389,SCV000743852,FALSE,FALSE,TRUE,Benign
226399,single nucleotide variant,NM_000527.4(LDLR):c.941-4G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,12-Jan-18,116405216,RCV000210248;RCV000736080,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11221324,11221324,G,A,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000515,2,224619,19,11221324,G,A,226399,19:11221324:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583767.1,LDLR,-,High LDL,1/12/18,46963,0,399,"[0.9957519749590102,0.004248025040989715]",389,SCV000583767,FALSE,FALSE,TRUE,Benign
226399,single nucleotide variant,NM_000527.4(LDLR):c.941-4G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,12-Jan-18,116405216,RCV000210248;RCV000736080,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11221324,11221324,G,A,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000515,2,224619,19,11221324,G,A,226399,19:11221324:G:A,Likely benign,2015-11-30,-,Familial hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia",SCV000296929.2,LDLR,-,High LDL,1/12/18,46963,0,399,"[0.9957519749590102,0.004248025040989715]",389,SCV000296929,FALSE,FALSE,TRUE,Benign
226399,single nucleotide variant,NM_000527.4(LDLR):c.941-4G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,12-Jan-18,116405216,RCV000210248;RCV000736080,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline;unknown,germline,GRCh37,NC_000019.9,19,11221324,11221324,G,A,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000515,2,224619,19,11221324,G,A,226399,19:11221324:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484780.1,LDLR,-,High LDL,1/12/18,46963,0,399,"[0.9957519749590102,0.004248025040989715]",389,SCV000484780,FALSE,FALSE,TRUE,Benign
226400,single nucleotide variant,NM_000527.4(LDLR):c.1194C>T (p.Ile398=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,13306498,RCV000210233,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223961,11223961,C,T,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001231,2,224620,19,11223961,C,T,226400,19:11223961:C:T,Benign,2018-01-02,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000556771.3,LDLR,-,High LDL,1/2/18,46962,1,134,"[0.9985733145947787,0.0014266854052212426]",134,SCV000556771,FALSE,TRUE,TRUE,Benign
226400,single nucleotide variant,NM_000527.4(LDLR):c.1194C>T (p.Ile398=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,13306498,RCV000210233,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223961,11223961,C,T,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001231,2,224620,19,11223961,C,T,226400,19:11223961:C:T,Benign,2017-07-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000689759.1,LDLR,-,High LDL,1/2/18,46962,1,134,"[0.9985733145947787,0.0014266854052212426]",134,SCV000689759,FALSE,FALSE,TRUE,Benign
226400,single nucleotide variant,NM_000527.4(LDLR):c.1194C>T (p.Ile398=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,13306498,RCV000210233,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223961,11223961,C,T,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001231,2,224620,19,11223961,C,T,226400,19:11223961:C:T,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583803.1,LDLR,-,High LDL,1/2/18,46962,1,134,"[0.9985733145947787,0.0014266854052212426]",134,SCV000583803,FALSE,FALSE,TRUE,Benign
226972,single nucleotide variant,NM_000527.4(LDLR):c.190+4A>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,769446356,RCV000211667;RCV000210581;RCV000523458,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202",Familial hypercholesterolemia;Inborn genetic diseases;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11211025,11211025,A,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000028,2,225097,19,11211025,A,T,226972,19:11211025:A:T,Pathogenic,2017-10-23,"This sequence change falls in intron 2 of the LDLR gene. It does not directly change the encoded amino acid sequence of the LDLR protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs769446356, ExAC 0.02%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 16250003, 27765764, 15199436, 16205024, 21418584). ClinVar contains an entry for this variant (Variation ID: 225097). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that this intronic change results in a reduction in transcripts with this variant compared to wild type and it reduces the amount of surface LDLR and LDL internalization (PMID: 19208450). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752427.1,LDLR,-,High LDL,10/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000752427,FALSE,TRUE,TRUE,"Pathogenic, Likely pathogenic"
226972,single nucleotide variant,NM_000527.4(LDLR):c.190+4A>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,769446356,RCV000211667;RCV000210581;RCV000523458,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202",Familial hypercholesterolemia;Inborn genetic diseases;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11211025,11211025,A,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000028,2,225097,19,11211025,A,T,226972,19:11211025:A:T,Likely pathogenic,2017-08-24,"The c.190+4 A>T likely pathogenic variant in the LDLR gene has been reported in multiple unrelated patients with FH (Fouchier et al., 2005; Punzalan et al., 2005; Al-Khateeb et al., 2011; Wang et al., 2016). The c.190+4 A>T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a nucleotide position that is conserved through mammals. The c.190+4 A>T variant is predicted to destroy the canonical splice donor site in intron 2 and cause abnormal gene splicing. Finally, other splice site variants in the LDLR gene have been reported in HGMD in association with FH (Stenson et al., 2014).",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617499.1,LDLR,-,High LDL,10/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000617499,FALSE,TRUE,TRUE,"Pathogenic, Likely pathogenic"
226972,single nucleotide variant,NM_000527.4(LDLR):c.190+4A>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,769446356,RCV000211667;RCV000210581;RCV000523458,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202",Familial hypercholesterolemia;Inborn genetic diseases;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11211025,11211025,A,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000028,2,225097,19,11211025,A,T,226972,19:11211025:A:T,Uncertain significance,2014-06-25,Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected,MeSH:D030342,C0950123:Inborn genetic diseases,Familial Hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,Ambry Genetics,SCV000263003.4,LDLR,-,High LDL,10/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000263003,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic"
226972,single nucleotide variant,NM_000527.4(LDLR):c.190+4A>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,769446356,RCV000211667;RCV000210581;RCV000523458,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202",Familial hypercholesterolemia;Inborn genetic diseases;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11211025,11211025,A,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000028,2,225097,19,11211025,A,T,226972,19:11211025:A:T,Pathogenic,2010-03-18,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:3,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268537.1,LDLR,-,High LDL,10/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268537,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic"
226972,single nucleotide variant,NM_000527.4(LDLR):c.190+4A>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,23-Oct-17,769446356,RCV000211667;RCV000210581;RCV000523458,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202",Familial hypercholesterolemia;Inborn genetic diseases;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11211025,11211025,A,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000028,2,225097,19,11211025,A,T,226972,19:11211025:A:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484775.1,LDLR,-,High LDL,10/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000484775,FALSE,FALSE,TRUE,"Pathogenic, Likely pathogenic"
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Pathogenic,2017-03-30,ACMG Guidelines: Pathogenic (ii),Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:8,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583627.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583627,FALSE,FALSE,FALSE,
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Pathogenic,2017-01-12,"Variant summary: The LDLR c.81C>G (p.Cys27Trp) variant (alternatively also known as C6W and FH San Francisco) substitutes a Cys residue located in LDL receptor class A repeat which forms ligand binding domain (InterPro, Klancar_2015, Bertolini_2013, Hobbs_1992). The ligand-binding domain contains seven or eight 40-amino acid LDLR class A (cysteine-rich) repeats, each of which contains a coordinated calcium ion and six cysteine residues involved in disulphide bond formation (InterPro, PMID: 6091915). Therefore, this variant is predicted to be deleterious for protein function as it breaks down one of the disulphide bonds. 5/5 in silico tools also predict damaging outcome for this variant. This variant was found in 2/121358 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). In literature, this variant is widely reported as a pathogenic variant found mainly in FH patients of European origin (Klancar_2015, Mollaki_2014,Kolansky_2008, Bertolini_2013, Day_1997, Hobbs_1992). Genotype-phenotype correlation study showed that this variant causes a milder disease (Mollaki_2014). A functional study showed that this variant leads to impaired LDL receptor activity (Hobbs_1992). Multiple reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697253.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000697253,FALSE,FALSE,FALSE,
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Likely benign,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / Software predictions: Damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503098.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503098,FALSE,FALSE,FALSE,
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys27 and Cys39.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540716.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540716,FALSE,FALSE,FALSE,
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Pathogenic,2012-04-16,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268538.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268538,FALSE,FALSE,FALSE,
228117,single nucleotide variant,NM_000527.4(LDLR):c.81C>G (p.Cys27Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,2228671,RCV000211569;RCV000588365,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11210912,11210912,C,G,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304",2,226304,19,11210912,C,G,228117,19:11210912:C:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484735.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484735,FALSE,FALSE,FALSE,
228138,single nucleotide variant,NM_000527.4(LDLR):c.429C>A (p.Cys143Ter),3949,LDLR,HGNC:6547,Pathogenic,1,5-Dec-17,199774121,RCV000211567,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216011,11216011,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001734,2,226325,19,11216011,C,A,228138,19:11216011:C:A,Pathogenic,2017-12-05,"This sequence change creates a premature translational stop signal (p.Cys143*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs199774121, ExAC 0.005%). This variant has been reported to segregate with familial hypercholesterolemia in a single family (PMID: 9212177) and has been reported in several individuals with this condition (PMID: 27831900, 165423944, 21382890). This variant is also known as p.Cys122* in the literature. ClinVar contains an entry for this variant (Variation ID: 226325). Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544658.3,LDLR,-,High LDL,12/5/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000544658,FALSE,TRUE,TRUE,Pathogenic
228138,single nucleotide variant,NM_000527.4(LDLR):c.429C>A (p.Cys143Ter),3949,LDLR,HGNC:6547,Pathogenic,1,5-Dec-17,199774121,RCV000211567,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216011,11216011,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001734,2,226325,19,11216011,C,A,228138,19:11216011:C:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:35,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583677.1,LDLR,-,High LDL,12/5/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583677,FALSE,FALSE,TRUE,Pathogenic
228138,single nucleotide variant,NM_000527.4(LDLR):c.429C>A (p.Cys143Ter),3949,LDLR,HGNC:6547,Pathogenic,1,5-Dec-17,199774121,RCV000211567,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216011,11216011,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001734,2,226325,19,11216011,C,A,228138,19:11216011:C:A,Pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:7,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503157.1,LDLR,-,High LDL,12/5/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503157,FALSE,FALSE,TRUE,Pathogenic
228138,single nucleotide variant,NM_000527.4(LDLR):c.429C>A (p.Cys143Ter),3949,LDLR,HGNC:6547,Pathogenic,1,5-Dec-17,199774121,RCV000211567,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216011,11216011,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001734,2,226325,19,11216011,C,A,228138,19:11216011:C:A,Pathogenic,2016-02-18,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268564.1,LDLR,-,High LDL,12/5/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268564,FALSE,FALSE,TRUE,Pathogenic
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2018-06-25,"This sequence change deletes 3 nucleotides from exon 4 of the LDLR mRNA (c.654_656delTGG). This leads to the deletion of 1 amino acid residue in the LDLR protein (p.Gly219del) but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs758036807, ExAC 0.008%). This variant is a known common cause of familial hypercholesterolemia in Ashkenazi Jewish population from Eastern Europe (PMID:Ό9744476,Ό11309683,Ό1867200), although it has been observed in individuals from other ethnicities (PMID: 17539906, 18096825, 22698793,Ό28104544). This variant is also known as p.G197del and p.Gly218del in the literature. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acid is currently unknown. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285032.3,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000285032,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Likely pathogenic,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782951.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000782951,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2017-07-19,"The c.654_656delTGG pathogenic variant in the LDLR gene, also reported as G197del due to alternate nomenclature, has been reported previously in many individuals from various ethnic backgrounds with a diagnosis of FH (Hobbs et al., 1990; Gudnason et al., 1993; Giesel et al., 1995; Heath et al., 1999; Taylor et al., 2007; Junyent et al., 2008; Tichy et al., 2012; Sharifi et al., 2016). Additionally, this variant is considered a Lithuanian Ashkenazi Jewish founder mutation (Meiner et al., 1991; Gorski et al., 1998; Durst et al., 2001). Furthermore, the c.654_656delTGG variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant results in the in-frame deletion of one amino acid, glycine 219, and does not result in a shift in reading frame or a premature stop codon. Nevertheless, functional studies show that the c.654_656delTGG variant results in slow processing and abnormal rate of transport to the Golgi complex likely due to protein mis-folding (Hobbs et al., 1990).",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000577590.3,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000577590,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2017-05-25,"The c.654_656del (p.Gly219del) variant in the LDLR gene has been detected in multiple cohorts of patients with hypercholesterolemia [PMID 22698793, 18096825, sometimes referred as G197del]. This variant is a founder mutation in the Ashkenazi Jewish population and traces its ancestry to Lithuania [PMID 1867200, 11309683, 9744476]. This variant leads to the deletion of one single amino acid and preserves the reading frame. This variant has been observed in only 5 individuals in the ExAC database (http://exac.broadinstitute.org/variant/19-11216232-ATGG-A). This variant thus classified as pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839990.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000839990,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583714.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000583714,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 3 , family members = 3 with co-segregation / FH-Lithuania, < 5% LDLR Activity",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503197.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000503197,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:20,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540747.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000540747,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2016-03-28,"Variant Summary: The LDLR variant of interest causes an in-frame deletion resulting in the loss of a Glycine at codon 219. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 5/119648 (1/23930), which does not exceed the predicted maximum expected allele frequency for a pathogenic LDLR variant of 1/800. The variant of interest has been reported in multiple affected individuals via publications and has been indicated to be a founder mutation. Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697245.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000697245,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228142,deletion,NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Jun-18,121908027,RCV000211647;RCV000589051;RCV000489033,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;inherited;not applicable,germline,GRCh37,NC_000019.9,19,11216236,11216238,TGG,-,19p13.2,"criteria provided, multiple submitters, no conflicts",14,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005",3,226329,19,11216232,ATGG,A,228142,19:11216232:ATGG:A,Pathogenic,2009-02-12,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268574.1,LDLR,-,High LDL,6/25/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000268574,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894171.1,-,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000894171,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2018-05-21,"This sequence change creates a premature translational stop signal (p.Glu228*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs121908029, ExAC 0.01%). This variant has been reported in multiple unrelated individuals and affected with familial hypercholesterolemia (PMID: 1301956, 11462246, 15359125, 19843101, 21310417,Ό23054246). This variant is also known as p.Glu207* in the literature. ClinVar contains an entry for this variant (Variation ID: 226333). Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627046.3,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000627046,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583726.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000583726,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2017-02-16,"E228X (referred to as Stop207 and FH Morocco) has been reported previously as a novel variant in one individual of Moroccan American ancestry with primary hypercholesterolemia who was homozygous for E228X (Hobbs et al., 1992). E228X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Furthermore, this particular area of the LDLR gene appears to be a mutation hotspot, and other nonsense variants in the LDLR gene have been reported in Human Gene Mutation Database in association with FH (Stenson et al., 2014). Furthermore, the E228X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; Exome Variant Server).In summary, E228X in the LDLR gene is interpreted as a pathogenic variant.",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000680545.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000680545,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 7 , family member = 1 with co-segregation / FH-Morocco, 2% LDLR Activity",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:7,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503219.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000503219,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2016-11-21,"Variant summary: The LDLR c.682G>T (p.Glu228X) variant (alternatively also known as E207X) results in a premature termination codon, predicted to cause a truncated or absent LDLR protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. Functional analyses show that this variant results into NMD causing absent LDLR protein (Charng_2006) and/or extremely low LDL receptor activity (Hobbs_1992). Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. p.Cys276X, p.Val295fsX75). This variant is widely reported in FH patients and is a recurrent pathogenic mutation (Hobbs_1992, Leren_2004, Muller_2004, Charng_2006, Humphries_2006). This variant was found in 2/117006 control chromosomes at a frequency of 0.0000171, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). The heterozygotes in ExAC are likely to represent as subclinical cases or reduced penetrance. Multiple clinical lab/research centers have classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697248.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000697248,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2013-06-27,-,not provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000614010.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000614010,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Pathogenic,2011-08-11,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:5,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268582.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000268582,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228146,single nucleotide variant,NM_000527.4(LDLR):c.682G>T (p.Glu228Ter),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,31-Oct-18,121908029,RCV000211631;RCV000589867;RCV000518828,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202",Familial hypercholesterolemia;Familial hypercholesterolemias;not provided,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",12,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001818,2,226333,19,11216264,G,T,228146,19:11216264:G:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484711.1,LDLR,-,High LDL,10/31/18,46944,19,1,"[0.9999893490115883,1.0650988411724608E-5]",1,SCV000484711,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228147,single nucleotide variant,NM_000527.4(LDLR):c.796G>A (p.Asp266Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,19-Sep-17,875989907,RCV000211615,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11217342,11217342,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000469,2,226334,19,11217342,G,A,228147,19:11217342:G:A,Likely pathogenic,2017-09-19,"This c.796G>A (p.Asp266Asn) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 11810272, 23375686). Multiple different amino acid substitutions affecting aspartic acid at position 266 of the LDLR protein have also been reported in patients with familial hypercholesterolemia (PMID: 1301956, 12417285, 28235710). The c.796G>A variant is extremely rare in the general population and aspartic acid at position 266 of the LDLR protein is highly evolutionarily conserved. The c.796G>A (p.Asp266Asn) variant in the LDLR gene is classified as likely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839983.1,LDLR,-,High LDL,9/19/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000839983,FALSE,FALSE,FALSE,
228147,single nucleotide variant,NM_000527.4(LDLR):c.796G>A (p.Asp266Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,19-Sep-17,875989907,RCV000211615,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11217342,11217342,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000469,2,226334,19,11217342,G,A,228147,19:11217342:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583740.1,LDLR,-,High LDL,9/19/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583740,FALSE,FALSE,FALSE,
228147,single nucleotide variant,NM_000527.4(LDLR):c.796G>A (p.Asp266Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,19-Sep-17,875989907,RCV000211615,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11217342,11217342,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000469,2,226334,19,11217342,G,A,228147,19:11217342:G:A,Likely pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family members = 2 with co-segregation / previously described in association with FH / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503237.1,LDLR,-,High LDL,9/19/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503237,FALSE,FALSE,FALSE,
228147,single nucleotide variant,NM_000527.4(LDLR):c.796G>A (p.Asp266Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,19-Sep-17,875989907,RCV000211615,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11217342,11217342,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000469,2,226334,19,11217342,G,A,228147,19:11217342:G:A,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:10,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540758.1,LDLR,-,High LDL,9/19/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540758,FALSE,FALSE,FALSE,
228147,single nucleotide variant,NM_000527.4(LDLR):c.796G>A (p.Asp266Asn),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,19-Sep-17,875989907,RCV000211615,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11217342,11217342,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",8,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000469,2,226334,19,11217342,G,A,228147,19:11217342:G:A,Pathogenic,2013-02-26,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268585.1,LDLR,-,High LDL,9/19/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268585,FALSE,FALSE,FALSE,
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,2018-05-08,"This sequence change creates a premature translational stop signal at codon 350 (p.Arg350*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). This particular variant has been reported in numerous individuals and families affected with familial Όhypercholesterolemia (PMID: 7709162, 9039985, 22390909, 21382890, 21310417), and has been reported in an individual affected with myocardial infarction (PMID: 25487149). This variant is also known as Arg329* in the literature. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544687.3,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000544687,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,2017-08-25,"The R350X variant (previously reported as R329X due to the use of alternate nomenclature) in the LDLR gene has been reported in association with FH across multiple ethnic groups (Solberg et al., 1994; Day et al., 1997; Maruyama et al., 2004; Kubalska et al., 2008; Chmara et al., 2010; Futema et al., 2012; Jannes et al., 2015; Fan et al., 2015; Hu et al., 2016). This variant is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other nonsense variants in the LDLR gene have been reported in Human Gene Mutation Database in association with FH (Stenson et al., 2014). Furthermore, the R350X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617506.1,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000617506,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 4 , family member = 3 with co-segregation / FH-Fossum",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503287.1,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503287,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:10,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540784.1,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540784,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,2008-06-05,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:8,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268595.1,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268595,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228156,single nucleotide variant,NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter),3949,LDLR,HGNC:6547,Pathogenic,1,8-May-18,769737896,RCV000211692;RCV000520229,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;inherited,germline,GRCh37,NC_000019.9,19,11221435,11221435,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",11,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000147,2,226342,19,11221435,C,T,228156,19:11221435:C:T,Pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen",SCV000733817.1,LDLR,-,High LDL,5/8/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000733817,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228154,single nucleotide variant,NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,761954844,RCV000211666,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11221373,11221373,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362",2,226344,19,11221373,G,A,228154,19:11221373:G:A,Likely benign,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH (linked to ethnicity ?) / Software predictions: Damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503275.1,LDLR,-,High LDL,12/16/16,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000503275,FALSE,FALSE,FALSE,
228154,single nucleotide variant,NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,761954844,RCV000211666,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11221373,11221373,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362",2,226344,19,11221373,G,A,228154,19:11221373:G:A,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys318 and Cys329.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540780.1,LDLR,-,High LDL,12/16/16,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000540780,FALSE,FALSE,FALSE,
228154,single nucleotide variant,NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,761954844,RCV000211666,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11221373,11221373,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362",2,226344,19,11221373,G,A,228154,19:11221373:G:A,Pathogenic,2008-11-17,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:4,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268597.1,LDLR,-,High LDL,12/16/16,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000268597,FALSE,FALSE,FALSE,
228154,single nucleotide variant,NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,761954844,RCV000211666,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable;unknown,germline,GRCh37,NC_000019.9,19,11221373,11221373,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362",2,226344,19,11221373,G,A,228154,19:11221373:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484751.1,LDLR,-,High LDL,12/16/16,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000484751,FALSE,FALSE,FALSE,
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583801.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000583801,FALSE,FALSE,TRUE,Pathogenic
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Pathogenic,2017-03-28,"Variant summary: The LDLR c.1187-10G>A variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a disease-causing outcome for this variant. 5/5 splice prediction tools predict the creation of a cryptic splice site 8bp upstream of the canonical splice site at the exon-intron junction. A functional study that assayed splicing defects via cDNA analysis in a family affected by familial hypercholesterolemia showed that a heterozygous individual expresses both the WT allele as well as the variant allele (which includes the 8bp of retained intronic sequence), and a severely affected homozygous individual who expresses no detectable WT transcript (Sun_Sci Rep_2015). Additionally, another study analyzed residual LDLR activity in B- and T-lymphocytes in FH patients compared to control individuals and found that heterozygous patients have approximately half of LDLR activity of control individuals via flow cytometry experiments (Romano_JLR_2011), which supports the hypothesis that the variant is a null allele. This variant was found in the large control database ExAC at a frequency of 0.0000417 (5/119944 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). In addition, the observations of the variant in the ExAC dataset needs to be cautiously considered due to the cohort containing individuals that could harbor a LDLR phenotype. Furthermore, a publication, Sun_2015, shows the variant to cosegregate with disease in a large FH family, including the proband, who was homozygous for the variant and had a significantly elevated lipid level. Multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697187.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000697187,FALSE,FALSE,TRUE,Pathogenic
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Pathogenic,2017-03-09,"This sequence change falls in intron 8 of the LDLR mRNA. It does not directly change the encoded amino acid sequence of the LDLR protein. This variant is present in population databases (rs765696008, ExAC 0.02%). This variant has been reported in several individuals and families affected with familial hypercholesterolemia (PMID: 11668627, 21865347, 12436241, 20145306, 24075752, 20145306), including in an individual with early severe disease that carried two copies of this variant (PMID: 26077743), Όand has also been reported by the LDLR-UMD database (PMID:Ό12124988 ). ClinVar contains an entry for this variant (Variation ID: 226349). Algorithms developed to predict the effect of sequence changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. An experimental study reported reduced LDLR activity in transformed lymphocytesΌ(PMID: 21865347). In summary, this is a rare variant that has been previously reported in affected individuals and families and has been shown to affect protein function. For these reasons it has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544644.2,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000544644,FALSE,TRUE,TRUE,Pathogenic
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 4 , family member = 2",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503311.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000503311,FALSE,FALSE,TRUE,Pathogenic
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Pathogenic,2008-06-05,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:5,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268602.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000268602,FALSE,FALSE,TRUE,Pathogenic
228162,single nucleotide variant,NM_000527.4(LDLR):c.1187-10G>A,3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,765696008,RCV000211627;RCV000588170,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11223944,11223944,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",10,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000172,2,226349,19,11223944,G,A,228162,19:11223944:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"Robarts Research Institute,Western University",SCV000484784.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000484784,FALSE,FALSE,TRUE,Pathogenic
228164,single nucleotide variant,NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,121908043,RCV000211575,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223983,11223983,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847",2,226351,19,11223983,C,T,228164,19:11223983:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583806.1,LDLR,-,High LDL,3/30/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583806,FALSE,FALSE,FALSE,
228164,single nucleotide variant,NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,121908043,RCV000211575,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223983,11223983,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847",2,226351,19,11223983,C,T,228164,19:11223983:C:T,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 11 , family members = 7 with co-segregation / previously described in association with FH/Software predictions: Benign",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:11,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503317.1,LDLR,-,High LDL,3/30/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503317,FALSE,FALSE,FALSE,
228164,single nucleotide variant,NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,121908043,RCV000211575,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11223983,11223983,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",9,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847",2,226351,19,11223983,C,T,228164,19:11223983:C:T,Pathogenic,2012-07-04,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268604.1,LDLR,-,High LDL,3/30/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268604,FALSE,FALSE,FALSE,
228193,single nucleotide variant,NM_000527.4(LDLR):c.1898G>A (p.Arg633His),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Nov-17,754536745,RCV000211621,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230820,11230820,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001073,2,226380,19,11230820,G,A,228193,19:11230820:G:A,Likely pathogenic,2017-11-28,"The c.1898G>A (p.Arg633His) variant is extremely rare in general population (3 in 246014 by gnomad) and observed in multiple familial hypercholesterolaemia (FH) patients (PMID: 15823288,16250003,19318025). It is predicted to be deleterious by multiple in silica prediction software. The Arg633 is well conserved during evolution. It has been also observed in other clinical labs and reported as pathogenic. At the same position, Arg633Cys variant was observed in multiple FH patient cohort. Based on the above evidences, we interpret this variant as ikely pathogenic.",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000839996.1,LDLR,-,High LDL,11/28/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000839996,FALSE,FALSE,FALSE,
228193,single nucleotide variant,NM_000527.4(LDLR):c.1898G>A (p.Arg633His),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Nov-17,754536745,RCV000211621,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230820,11230820,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001073,2,226380,19,11230820,G,A,228193,19:11230820:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583907.1,LDLR,-,High LDL,11/28/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583907,FALSE,FALSE,FALSE,
228193,single nucleotide variant,NM_000527.4(LDLR):c.1898G>A (p.Arg633His),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Nov-17,754536745,RCV000211621,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230820,11230820,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001073,2,226380,19,11230820,G,A,228193,19:11230820:G:A,Likely pathogenic,2016-02-25,"This sequence change replaces arginine with histidine at codon 633 of the LDLR protein (p.Arg633His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs754536745, ExAC 0.01%). This variant has been reported in the literature in three patients affected with hypercholesterolemia (PMID: 16250003, 19843101, 15823288). This variant is also known in the literature as R612H. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C0""). A different missense substitution at this codon (p.Arg633Cys) is reported to be deleterious (PMID: 9259195, 15241806, 23375686). This variant is also known in the literature as R612C. This indicates that the arginine residue is important for LDLR protein function. In summary, this is a rare missense change that has been reported in patients affected with hypercholesterolemia and is located in a residue important for LDLR protein function. For these reasons, it has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285022.2,LDLR,-,High LDL,11/28/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000285022,FALSE,FALSE,FALSE,
228193,single nucleotide variant,NM_000527.4(LDLR):c.1898G>A (p.Arg633His),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Nov-17,754536745,RCV000211621,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230820,11230820,G,A,19p13.2,"criteria provided, conflicting interpretations",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001073,2,226380,19,11230820,G,A,228193,19:11230820:G:A,Pathogenic,2013-10-30,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268649.1,LDLR,-,High LDL,11/28/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268649,FALSE,FALSE,FALSE,
228195,single nucleotide variant,NM_000527.4(LDLR):c.1955T>C (p.Met652Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Mar-18,875989936,RCV000211590,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230877,11230877,T,C,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000266,2,226382,19,11230877,T,C,228195,19:11230877:T:C,Uncertain significance,2018-03-28,"This sequence change replaces methionine with threonine at codon 652 of the LDLR protein (p.Met652Thr). The methionine residue is weakly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several unrelated individuals affected with hypercholesterolemia (PMID: 20236128, 20809525). ClinVar contains an entry for this variant (Variation ID: 226382). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627024.2,LDLR,-,High LDL,3/28/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000627024,FALSE,TRUE,TRUE,Uncertain significance
228195,single nucleotide variant,NM_000527.4(LDLR):c.1955T>C (p.Met652Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Mar-18,875989936,RCV000211590,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230877,11230877,T,C,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000266,2,226382,19,11230877,T,C,228195,19:11230877:T:C,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583911.1,LDLR,-,High LDL,3/28/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583911,FALSE,FALSE,TRUE,Uncertain significance
228195,single nucleotide variant,NM_000527.4(LDLR):c.1955T>C (p.Met652Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Mar-18,875989936,RCV000211590,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230877,11230877,T,C,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000266,2,226382,19,11230877,T,C,228195,19:11230877:T:C,Likely pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503437.1,LDLR,-,High LDL,3/28/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503437,FALSE,FALSE,TRUE,Uncertain significance
228195,single nucleotide variant,NM_000527.4(LDLR):c.1955T>C (p.Met652Thr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,28-Mar-18,875989936,RCV000211590,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230877,11230877,T,C,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000266,2,226382,19,11230877,T,C,228195,19:11230877:T:C,Pathogenic,2008-06-25,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268651.1,LDLR,-,High LDL,3/28/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000268651,FALSE,FALSE,TRUE,Uncertain significance
228198,single nucleotide variant,NM_000527.4(LDLR):c.2030G>T (p.Cys677Phe),3949,LDLR,HGNC:6547,Likely pathogenic,1,25-Mar-16,875989938,RCV000211595,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231088,11231088,G,T,19p13.2,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000659,2,226385,19,11231088,G,T,228198,19:11231088:G:T,Pathogenic,2008-11-03,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268654.1,LDLR,-,High LDL,3/25/16,46956,7,1,"[0.9999893517335378,1.064826646221995E-5]",1,SCV000268654,FALSE,FALSE,FALSE,
228201,deletion,NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs),3949,LDLR,HGNC:6547,Pathogenic,1,11-May-17,875989940,RCV000211650;RCV000493493,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11233980,11233980,T,-,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000890,2,226388,19,11233979,CT,C,228201,19:11233979:CT:C,Pathogenic,2017-05-11,"This sequence change deletes 1 nucleotide from exon 15 of the LDLR mRNA (c.2271delT), causing a frameshift at codon 759. This creates a premature translational stop signal (p.Leu759Serfs*6) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in individuals with familial hypercholesterolemia (PMID: 16314194, 22089669). ClinVar contains an entry for this variant (Variation ID: 226388). For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627032.1,LDLR,-,High LDL,5/11/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000627032,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228201,deletion,NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs),3949,LDLR,HGNC:6547,Pathogenic,1,11-May-17,875989940,RCV000211650;RCV000493493,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11233980,11233980,T,-,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000890,2,226388,19,11233979,CT,C,228201,19:11233979:CT:C,Pathogenic,2017-05-10,"The c.2271delT variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (Vaca et al., 2011). The c.2271delT variant causes a frameshift starting with codon Leucine 759, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Leu759SerfsX6. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2271delT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.2271delT as a pathogenic variant.",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000582114.3,LDLR,-,High LDL,5/11/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000582114,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
228201,deletion,NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs),3949,LDLR,HGNC:6547,Pathogenic,1,11-May-17,875989940,RCV000211650;RCV000493493,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11233980,11233980,T,-,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000890,2,226388,19,11233979,CT,C,228201,19:11233979:CT:C,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583939.1,LDLR,-,High LDL,5/11/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583939,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
228201,deletion,NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs),3949,LDLR,HGNC:6547,Pathogenic,1,11-May-17,875989940,RCV000211650;RCV000493493,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11233980,11233980,T,-,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000890,2,226388,19,11233979,CT,C,228201,19:11233979:CT:C,Pathogenic,2010-03-26,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:1,"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital",SCV000268661.1,LDLR,-,High LDL,5/11/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000268661,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
230981,single nucleotide variant,NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,552422789,RCV000238261;RCV000223047,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11223984,11223984,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954",2,228798,19,11223984,G,A,230981,19:11223984:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:13,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583807.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583807,FALSE,FALSE,FALSE,
230981,single nucleotide variant,NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,552422789,RCV000238261;RCV000223047,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11223984,11223984,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954",2,228798,19,11223984,G,A,230981,19:11223984:G:A,Uncertain significance,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family members = 3 with unclear co-segregation / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503318.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503318,FALSE,FALSE,FALSE,
230981,single nucleotide variant,NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,552422789,RCV000238261;RCV000223047,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11223984,11223984,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954",2,228798,19,11223984,G,A,230981,19:11223984:G:A,Uncertain significance,2015-12-21,"Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg406Gln variant in LDLR has been reported in 2 individuals with familial hypercholesterolemia (Tosi 2007, Thiart 2000) and has been identified in 1/10248 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs552422789). Computational prediction tools and conservation analysis suggest that the p.Arg406Gln variant may impact the protein. In addition, splicing prediction tools predict this variant results in the generation of a novel 3' splice site. However, the results of these computational tools are not predictive enough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Arg406Gln variant is uncertain.",not specified,CN169374:not specified,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine",SCV000271917.2,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000271917,FALSE,FALSE,FALSE,
243266,single nucleotide variant,NM_000527.4(LDLR):c.12G>A (p.Trp4Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,756039188,RCV000227275,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11200236,11200236,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000357,2,237860,19,11200236,G,A,243266,19:11200236:G:A,Pathogenic,2017-03-30,ACMG Guidelines: Pathogenic (i),Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583622.1,LDLR,-,High LDL,3/30/17,46919,44,1,"[0.9999893433363882,1.0656663611756432E-5]",1,SCV000583622,FALSE,FALSE,FALSE,
243266,single nucleotide variant,NM_000527.4(LDLR):c.12G>A (p.Trp4Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,756039188,RCV000227275,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11200236,11200236,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000357,2,237860,19,11200236,G,A,243266,19:11200236:G:A,Pathogenic,2015-12-20,"This sequence change creates a premature translational stop signal at codon 4 (p.Trp4*). It is expected to result in an absent or disrupted protein product. Truncating variants in LDLR are known to be pathogenic. This particular truncation has been reported in the literature in individuals affected with hypercholesterolemia (PMID: 7903864, 16314194, 20428891, 21376320, 21868016). This variant is also known as W-18X in the literature. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285010.2,LDLR,-,High LDL,3/30/17,46919,44,1,"[0.9999893433363882,1.0656663611756432E-5]",1,SCV000285010,FALSE,FALSE,FALSE,
243273,single nucleotide variant,NM_000527.4(LDLR):c.1586G>A (p.Gly529Asp),3949,LDLR,HGNC:6547,Likely pathogenic,1,25-Mar-16,878854025,RCV000231049,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224438,11224438,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001464,2,237863,19,11224438,G,A,243273,19:11224438:G:A,Likely pathogenic,2015-12-08,"This sequence change replaces glycine with aspartic acid at codon 529 of the LDLR protein (p.Gly529Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. It also falls at the last nucleotide of exon 10 of the LDLR coding sequence. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with familial hypercholesterolemia (PMID: 21722902, 22998978). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Tolerated""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C0""). Nucleotide substitutions at the last nucleotide of the exon are relatively common causes of aberrant splicing (PMID: 17576681). Algorithms developed to predict the effect of nucleotide changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this is a rare missense change that has been reported in affected individuals and has been predicted to have an impact on mRNA splicing. For these reasons, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285014.2,LDLR,-,High LDL,3/25/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000285014,FALSE,FALSE,FALSE,
243275,single nucleotide variant,NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Nov-16,777188764,RCV000228158,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11227550,11227550,G,T,19p13.2,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001502,2,237867,19,11227550,G,T,243275,19:11227550:G:T,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:8,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540833.1,LDLR,-,High LDL,11/5/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000540833,FALSE,FALSE,FALSE,
243275,single nucleotide variant,NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Nov-16,777188764,RCV000228158,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11227550,11227550,G,T,19p13.2,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001502,2,237867,19,11227550,G,T,243275,19:11227550:G:T,Uncertain significance,2016-01-29,"This sequence change replaces arginine with leucine at codon 574 of the LDLR protein (p.Arg574Leu). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and leucine. This variant is present in population databases (rs777188764, ExAC 0.02%). This variant has been reported in an individual affected with hypercholesterolemia. Currently there is insufficient evidence to conclude whether this variant segregates with disease or not (PMID: 22698793). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this is a novel missense change with uncertain impact on protein function that has been reported in one patient. However, the clinical significance of this finding is still unknown. Therefore, it has been classified as a Variant of Uncertain Significance.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285019.2,LDLR,-,High LDL,11/5/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000285019,FALSE,FALSE,FALSE,
243276,single nucleotide variant,NM_000527.4(LDLR):c.1887C>T (p.Phe629=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,8-Jan-18,751234870,RCV000225826,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230809,11230809,C,T,19p13.2,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,-,2,237868,19,11230809,C,T,243276,19:11230809:C:T,Benign,2018-01-08,-,MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285021.3,LDLR,-,High LDL,1/8/18,46963,0,149,"[0.9984136447841918,0.0015863552158081895]",147,SCV000285021,FALSE,TRUE,TRUE,Benign
243276,single nucleotide variant,NM_000527.4(LDLR):c.1887C>T (p.Phe629=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,8-Jan-18,751234870,RCV000225826,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230809,11230809,C,T,19p13.2,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,-,2,237868,19,11230809,C,T,243276,19:11230809:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484765.1,LDLR,-,High LDL,1/8/18,46963,0,149,"[0.9984136447841918,0.0015863552158081895]",147,SCV000484765,FALSE,FALSE,TRUE,Benign
243268,single nucleotide variant,NM_000527.4(LDLR):c.337G>A (p.Glu113Lys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,8-Feb-18,769383881,RCV000232879,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11215919,11215919,G,A,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001704,2,237872,19,11215919,G,A,243268,19:11215919:G:A,Likely pathogenic,2018-02-08,"This sequence change replaces glutamic acid with lysine at codon 113 of the LDLR protein (p.Glu113Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs769383881, ExAC <0.01%). This variant has been reported to segregate with elevated LDL levels in a single family (PMID: 10807540). It has also been reported in several unrelated individuals affected with hypercholesterolemia (PMID: 16250003, 17539906, Invitae). This variant is also known as E92K in the literature. ClinVar contains an entry for this variant (Variation ID: 237872). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Possibly Damaging""; Align-GVGD: ""Class C0""). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000285029.3,LDLR,-,High LDL,2/8/18,46961,2,2,"[0.9999787057345457,2.1294265454313153E-5]",2,SCV000285029,FALSE,TRUE,TRUE,Likely pathogenic
245448,single nucleotide variant,NM_000527.4(LDLR):c.268G>A (p.Asp90Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,15-Jun-18,749038326,RCV000238573;RCV000494304,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213417,11213417,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311",2,251105,19,11213417,G,A,245448,19:11213417:G:A,Pathogenic,2018-06-15,"This sequence change replaces aspartic acid with asparagine at codon 90 of the LDLR protein (p.Asp90Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs749038326, ExAC 0.07%). This variant has been reported in many individuals affected with familial hypercholesterolemia (PMID: 23375686, 16343504, 27206935, 25962062, 21376320, 12436241, 27765764, 15823276, 9763532, 12837857, 9259195, 22390909). This variant is also known as p.Asp69Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 251105). Experimental studies have shown that this missense change affects LDLR subcellular localization and reduces LDLR activity (PMID: 12837857). Several different missense substitutions at this codon (p.Asp90Gly, p.Asp90Ala, p.Asp90Tyr) have been reported in individuals with familial hypercholesterolemia (PMID: 1301956, 19026292, 8347689). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000816377.1,LDLR,-,High LDL,6/15/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000816377,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
245448,single nucleotide variant,NM_000527.4(LDLR):c.268G>A (p.Asp90Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,15-Jun-18,749038326,RCV000238573;RCV000494304,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213417,11213417,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311",2,251105,19,11213417,G,A,245448,19:11213417:G:A,Pathogenic,2017-05-03,"The D90N variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (for examples, see Chang et al., 2003; Norsworthy et al., 2014; Xiang et al., 2017). Functional studies show D90N decreases LDLR on the cell surface and decreases LDL binding and internalization (Chang et al., 2003). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D90N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and is located in the LDL-receptor class A 2 domain (Uniprot). Missense variants at the same residue (D90Y, D90G, D90A, c.270T>A and c.270T>G D90E) have been reported in association with familial hypercholesterolemia, supporting the functional importance of this region of the protein (Hobbs et al., 1992; Rubinsztein et al., 1993; Marduel et al., 2010; Kolansky et al., 2008; Gabcova et al., 2016). Based on the ACMG recommendations, D90N is interpreted as a known pathogenic sequence change.",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000582689.3,LDLR,-,High LDL,6/15/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000582689,FALSE,TRUE,TRUE,"Pathogenic, Pathogenic"
245448,single nucleotide variant,NM_000527.4(LDLR):c.268G>A (p.Asp90Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,15-Jun-18,749038326,RCV000238573;RCV000494304,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213417,11213417,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311",2,251105,19,11213417,G,A,245448,19:11213417:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583645.1,LDLR,-,High LDL,6/15/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000583645,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
245448,single nucleotide variant,NM_000527.4(LDLR):c.268G>A (p.Asp90Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,15-Jun-18,749038326,RCV000238573;RCV000494304,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213417,11213417,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311",2,251105,19,11213417,G,A,245448,19:11213417:G:A,Likely benign,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family members = 2 with co-segregation / other mutations at same codon / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503122.1,LDLR,-,High LDL,6/15/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000503122,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
245448,single nucleotide variant,NM_000527.4(LDLR):c.268G>A (p.Asp90Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,15-Jun-18,749038326,RCV000238573;RCV000494304,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline;not applicable,germline,GRCh37,NC_000019.9,19,11213417,11213417,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311",2,251105,19,11213417,G,A,245448,19:11213417:G:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Robarts Research Institute,Western University",SCV000484708.1,LDLR,-,High LDL,6/15/18,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000484708,FALSE,FALSE,TRUE,"Pathogenic, Pathogenic"
245493,single nucleotide variant,NM_000527.4(LDLR):c.325T>C (p.Cys109Arg),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,140807148,RCV000237408,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11215907,11215907,T,C,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001701,UniProtKB (protein):P01130#VAR_005316",2,251156,19,11215907,T,C,245493,19:11215907:T:C,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:16,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583661.1,LDLR,-,High LDL,3/30/17,46961,2,4,"[0.9999574114690913,4.2588530908626306E-5]",4,SCV000583661,FALSE,FALSE,FALSE,
245493,single nucleotide variant,NM_000527.4(LDLR):c.325T>C (p.Cys109Arg),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,140807148,RCV000237408,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;inherited,germline,GRCh37,NC_000019.9,19,11215907,11215907,T,C,19p13.2,"criteria provided, multiple submitters, no conflicts",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001701,UniProtKB (protein):P01130#VAR_005316",2,251156,19,11215907,T,C,245493,19:11215907:T:C,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys109 and Cys121.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,inherited:14,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540726.1,LDLR,-,High LDL,3/30/17,46961,2,4,"[0.9999574114690913,4.2588530908626306E-5]",4,SCV000540726,FALSE,FALSE,FALSE,
245500,single nucleotide variant,NM_000527.4(LDLR):c.343C>T (p.Arg115Cys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,774723292,RCV000238127,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11215925,11215925,C,T,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001036,2,251162,19,11215925,C,T,245500,19:11215925:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583664.1,LDLR,-,High LDL,3/30/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000583664,FALSE,FALSE,FALSE,
245500,single nucleotide variant,NM_000527.4(LDLR):c.343C>T (p.Arg115Cys),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,774723292,RCV000238127,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11215925,11215925,C,T,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001036,2,251162,19,11215925,C,T,245500,19:11215925:C:T,Uncertain significance,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503143.1,LDLR,-,High LDL,3/30/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000503143,FALSE,FALSE,FALSE,
245598,single nucleotide variant,NM_000527.4(LDLR):c.504C>A (p.Asp168Glu),3949,LDLR,HGNC:6547,Likely pathogenic,1,25-Mar-16,777321035,RCV000238338,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11216086,11216086,C,A,19p13.2,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001133,2,251261,19,11216086,C,A,245598,19:11216086:C:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484741.1,LDLR,-,High LDL,3/25/16,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000484741,FALSE,FALSE,FALSE,
245646,single nucleotide variant,NM_000527.4(LDLR):c.590G>T (p.Cys197Phe),3949,LDLR,HGNC:6547,Likely pathogenic,1,31-Oct-18,376459828,RCV000238173,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11216172,11216172,G,T,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000082,UniProtKB (protein):P01130#VAR_005328",2,251309,19,11216172,G,T,245646,19:11216172:G:T,Likely pathogenic,2018-10-31,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000894169.1,-,-,High LDL,10/31/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000894169,FALSE,FALSE,FALSE,
245672,single nucleotide variant,NM_000527.4(LDLR):c.631C>T (p.His211Tyr),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,25-Apr-18,771917370,RCV000237464,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11216213,11216213,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000711,2,251335,19,11216213,C,T,245672,19:11216213:C:T,Pathogenic,2018-04-25,"This sequence change replaces histidine with tyrosine at codon 211 of the LDLR protein (p.His211Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is present in population databases (rs771917370, ExAC 0.009%). This variant has been reported to segregate with familial hypercholesterolemia in a single family (PMID: 1057090) and has also been reported in an independent individual affected with this condition (PMID: 23064986). This variant is also known as p.His190Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 251335). Experimental studies have shown that this missense change impairs LDLR protein function in vitro (PMID: 21511053). Two different missense substitutions at this codon (p.His221Leu and p.His221Asp) have been reported in individuals affected with familial hypercholesterolemia (PMID: 17347910, 27784735). This suggests that the histidine residue is critical for LDLR protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752404.2,LDLR,-,High LDL,4/25/18,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000752404,FALSE,TRUE,TRUE,Pathogenic
245730,single nucleotide variant,NM_000527.4(LDLR):c.682G>C (p.Glu228Gln),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,15-Aug-17,121908029,RCV000237530,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,C,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340",2,251393,19,11216264,G,C,245730,19:11216264:G:C,Pathogenic,2017-08-15,"This sequence change replaces glutamic acid with glutamine at codon 228 of the LDLR protein (p.Glu228Gln). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is present in population databases (rs121908029, ExAC 0.002%). This variant has been reported in several individuals affected with heterozygous familial hypercholesterolemia (PMID: 8882879, 16250003, 17094996), and one individual with homozygous familial hypercholesterolemia (PMID: 1301956). This variant is also known as p.Glu207Gln in the literature and Tulsa-2. ClinVar contains an entry for this variant (Variation ID: 251393). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. A different missense substitution at this codon (p.Glu228Lys) is reported to be deleterious (PMID: 1301956, 15359125, 18677035, 20736250). This variant is also known as p.Glu207Lys in the literature. This indicates that the glycine residue is important for LDLR protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544665.2,LDLR,-,High LDL,8/15/17,46944,19,4,"[0.9999573960463531,4.2603953646898434E-5]",4,SCV000544665,FALSE,TRUE,TRUE,Pathogenic
245730,single nucleotide variant,NM_000527.4(LDLR):c.682G>C (p.Glu228Gln),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,15-Aug-17,121908029,RCV000237530,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,C,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340",2,251393,19,11216264,G,C,245730,19:11216264:G:C,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583725.1,LDLR,-,High LDL,8/15/17,46944,19,4,"[0.9999573960463531,4.2603953646898434E-5]",4,SCV000583725,FALSE,FALSE,TRUE,Pathogenic
245730,single nucleotide variant,NM_000527.4(LDLR):c.682G>C (p.Glu228Gln),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,15-Aug-17,121908029,RCV000237530,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11216264,11216264,G,C,19p13.2,"criteria provided, multiple submitters, no conflicts",6,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340",2,251393,19,11216264,G,C,245730,19:11216264:G:C,Likely pathogenic,2016-11-05,Disrupt SDE motif. SDE bind structural Ca2+.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540753.1,LDLR,-,High LDL,8/15/17,46944,19,4,"[0.9999573960463531,4.2603953646898434E-5]",4,SCV000540753,FALSE,FALSE,TRUE,Pathogenic
245736,single nucleotide variant,NM_000527.4(LDLR):c.691T>G (p.Cys231Gly),3949,LDLR,HGNC:6547,Likely pathogenic,1,5-Nov-16,746091400,RCV000237108,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11216273,11216273,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000405,UniProtKB (protein):P01130#VAR_005342",2,251397,19,11216273,T,G,245736,19:11216273:T:G,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys216 and Cys231.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540755.1,LDLR,-,High LDL,11/5/16,46839,124,1,"[0.999989325135037,1.0674864962958219E-5]",1,SCV000540755,FALSE,FALSE,FALSE,
245782,single nucleotide variant,NM_000527.4(LDLR):c.769C>T (p.Arg257Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Jun-18,200990725,RCV000237953,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11217315,11217315,C,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836",2,251446,19,11217315,C,T,245782,19:11217315:C:T,Uncertain significance,2018-06-29,"This sequence change replaces arginine with tryptophan at codon 257 of the LDLR protein (p.Arg257Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs200990725, ExAC 0.07%)Ό, and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 11462246, 11933210, 25461735, 25962062, 22353362, 20538126, 16250003, 26343872, 27206935). This variant is also known as p.Arg236Trp in the literature. This variant is reportedly found on the same allele as LDLR p.Asp589Asn (PMID: 16250003, 18325082). ClinVar contains an entry for this variant (Variation ID: 251446). Experimental studies have shown that this missense change does not show significant functional differences in LDLR activity, in contrast to established disease-causing variants (PMID: 25545329). In summary, this variant is a rare missense change that is not predicted to affect protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544695.3,LDLR,-,High LDL,6/29/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000544695,FALSE,TRUE,TRUE,Uncertain significance
245782,single nucleotide variant,NM_000527.4(LDLR):c.769C>T (p.Arg257Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Jun-18,200990725,RCV000237953,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11217315,11217315,C,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836",2,251446,19,11217315,C,T,245782,19:11217315:C:T,Uncertain significance,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782953.1,LDLR,-,High LDL,6/29/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000782953,FALSE,FALSE,TRUE,Uncertain significance
245782,single nucleotide variant,NM_000527.4(LDLR):c.769C>T (p.Arg257Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Jun-18,200990725,RCV000237953,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11217315,11217315,C,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836",2,251446,19,11217315,C,T,245782,19:11217315:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583738.1,LDLR,-,High LDL,6/29/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000583738,FALSE,FALSE,TRUE,Uncertain significance
245782,single nucleotide variant,NM_000527.4(LDLR):c.769C>T (p.Arg257Trp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Jun-18,200990725,RCV000237953,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11217315,11217315,C,T,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836",2,251446,19,11217315,C,T,245782,19:11217315:C:T,Likely benign,2016-12-16,"subjects mutated among 2600 FH index cases screened = 2 / in association with c.1765G>A, p.Asp589Asn / Software predictions: Benign",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503232.1,LDLR,-,High LDL,6/29/18,46963,0,14,"[0.9998509464897898,1.4905351021016544E-4]",14,SCV000503232,FALSE,FALSE,TRUE,Uncertain significance
245891,single nucleotide variant,NM_000527.4(LDLR):c.949G>A (p.Glu317Lys),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,746834464,RCV000237913,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221336,11221336,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000149,2,251567,19,11221336,G,A,245891,19:11221336:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583768.1,LDLR,-,High LDL,3/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000583768,FALSE,FALSE,FALSE,
245935,single nucleotide variant,NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,748300548,RCV000237544,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221432,11221432,C,T,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000964,2,251611,19,11221432,C,T,245935,19:11221432:C:T,Pathogenic,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782905.1,LDLR,-,High LDL,1/2/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000782905,FALSE,FALSE,FALSE,
245935,single nucleotide variant,NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,748300548,RCV000237544,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221432,11221432,C,T,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000964,2,251611,19,11221432,C,T,245935,19:11221432:C:T,Pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family member = 1 with co-segregation",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503285.1,LDLR,-,High LDL,1/2/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503285,FALSE,FALSE,FALSE,
245949,single nucleotide variant,NM_000527.4(LDLR):c.1060+10G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,12710260,RCV000238168,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221457,11221457,G,A,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000880,2,251625,19,11221457,G,A,245949,19:11221457:G:A,Uncertain significance,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782906.1,LDLR,-,High LDL,1/2/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000782906,FALSE,FALSE,FALSE,
245949,single nucleotide variant,NM_000527.4(LDLR):c.1060+10G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,2-Jan-18,12710260,RCV000238168,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221457,11221457,G,A,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000880,2,251625,19,11221457,G,A,245949,19:11221457:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 6 , family member = 1",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503290.1,LDLR,-,High LDL,1/2/18,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000503290,FALSE,FALSE,FALSE,
245980,single nucleotide variant,NM_000527.4(LDLR):c.1090T>C (p.Cys364Arg),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,1-Jun-18,879254787,RCV000238003,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11222219,11222219,T,C,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001355,UniProtKB (protein):P01130#VAR_005373",2,251657,19,11222219,T,C,245980,19:11222219:T:C,Pathogenic,2018-06-01,"This sequence change replaces cysteine with arginine at codon 364 of the LDLR protein (p.Cys364Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in multiple individuals affected with hypercholesterolemia (PMID: 1301956, 23375686, 26723464, 21722902, 25461735, 16314194, 10978268, 15556094). This variant is also known in the literature as Cys343Arg and FH Mexico-3. ClinVar contains an entry for this variant (Variation ID: 251657). This variant affects a cysteine residue located within an epidermal-growth-factor (EGF)_ܒlike domain of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 3495735, 4750422). In addition, missense substitutions within the LDLR EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Several different missense substitution at this codon (p.Cys364Phe, p.Cys364Ser, p.Cys364Tyr) have been reported in individuals affected with hypercholesterolemia (PMID: 11196104, 21310417, 28379029). This suggests that the cysteine residue is critical for LDLR protein function. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000752428.2,LDLR,-,High LDL,6/1/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000752428,FALSE,TRUE,TRUE,Pathogenic
245988,single nucleotide variant,NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jun-18,768430352,RCV000237712,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11222232,11222232,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844",2,251665,19,11222232,G,A,245988,19:11222232:G:A,Pathogenic,2018-06-05,"This sequence change replaces cysteine with tyrosine at codon 368 of the LDLR protein (p.Cys368Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is present in population databases (rs768430352, ExAC 0.002%). This variant has been observed in several individuals affected with familial hypercholesterolemia (PMID: 1310940, 23064986, 21722902, 25461735,Ό26081744). This variant is also known as p.Cys347Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 251665). This variant affects a cysteine residue located within an epidermal-growth-factor (EGF)_ܒlike domain of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 3495735, 4750422). In addition, missense substitutions within the LDLR EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. The p.Cys368 amino acid residue in LDLR has been determined to be clinically significant (PMID:Ό9452094, 27765764). This suggests that variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000824206.1,LDLR,-,High LDL,6/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000824206,FALSE,TRUE,TRUE,Pathogenic
245988,single nucleotide variant,NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jun-18,768430352,RCV000237712,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11222232,11222232,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844",2,251665,19,11222232,G,A,245988,19:11222232:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583789.1,LDLR,-,High LDL,6/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583789,FALSE,FALSE,TRUE,Pathogenic
245988,single nucleotide variant,NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,5-Jun-18,768430352,RCV000237712,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11222232,11222232,G,A,19p13.2,"criteria provided, conflicting interpretations",8,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844",2,251665,19,11222232,G,A,245988,19:11222232:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 3 , family members = 3 with co-segregation / previously described in association with FH / Software predictions: Damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503297.1,LDLR,-,High LDL,6/5/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503297,FALSE,FALSE,TRUE,Pathogenic
246061,single nucleotide variant,NM_000527.4(LDLR):c.1241T>G (p.Leu414Arg),3949,LDLR,HGNC:6547,Likely pathogenic,1,25-Mar-16,748554592,RCV000238583,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224008,11224008,T,G,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000372,UniProtKB (protein):P01130#VAR_005379",2,251747,19,11224008,T,G,246061,19:11224008:T:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484747.1,LDLR,-,High LDL,3/25/16,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484747,FALSE,FALSE,FALSE,
246066,single nucleotide variant,NM_000527.4(LDLR):c.1247G>A (p.Arg416Gln),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,13-Dec-16,773658037,RCV000237115;RCV000437123,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11224014,11224014,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000379,UniProtKB (protein):P01130#VAR_005380",2,251752,19,11224014,G,A,246066,19:11224014:G:A,Pathogenic,2016-12-13,"The R416Q variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (Thiart et al., 1998; Fouchier et al., 2001; Hollants et al., 2012; Huijgen et al., 2012). The R416Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R416Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same codon (R416W, R416P, R416L) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this codon. We interpret R416Q as a pathogenic variant",Not Provided,CN517202:not provided,familial hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000520999.3,LDLR,-,High LDL,12/13/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000520999,FALSE,FALSE,FALSE,
246089,single nucleotide variant,NM_000527.4(LDLR):c.1301C>T (p.Thr434Met),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Mar-16,745343524,RCV000237891,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224068,11224068,C,T,19p13.2,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000979,2,251775,19,11224068,C,T,246089,19:11224068:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484722.1,LDLR,-,High LDL,3/25/16,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000484722,FALSE,FALSE,FALSE,
246112,single nucleotide variant,NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,879254871,RCV000238528,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224109,11224109,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000730,2,251798,19,11224109,C,T,246112,19:11224109:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583823.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583823,FALSE,FALSE,FALSE,
246112,single nucleotide variant,NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,879254871,RCV000238528,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224109,11224109,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000730,2,251798,19,11224109,C,T,246112,19:11224109:C:T,Pathogenic,2016-12-16,subject mutated among 2600 FH index cases screened = 1,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503336.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503336,FALSE,FALSE,FALSE,
246190,single nucleotide variant,NM_000527.4(LDLR):c.1503G>A (p.Ala501=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,368889457,RCV000237830,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11224355,11224355,G,A,19p13.2,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000208,2,251876,19,11224355,G,A,246190,19:11224355:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:6,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583840.1,LDLR,-,High LDL,3/30/17,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000583840,FALSE,FALSE,FALSE,
246200,single nucleotide variant,NM_000527.4(LDLR):c.1529C>T (p.Thr510Met),3949,LDLR,HGNC:6547,Likely pathogenic,1,5-Nov-16,755154048,RCV000237591,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11224381,11224381,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000900,2,251886,19,11224381,C,T,246200,19:11224381:C:T,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540811.1,LDLR,-,High LDL,11/5/16,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000540811,FALSE,FALSE,FALSE,
246223,single nucleotide variant,NM_000527.4(LDLR):c.1586+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Apr-17,781362878,RCV000237174;RCV000587894,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11224443,11224443,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001463,2,251909,19,11224443,G,A,246223,19:11224443:G:A,Uncertain significance,2017-04-25,"Variant summary: The LDLR c.1586+5G>A variant involves the alteration of a conserved intronic nucleotide that is 5 nucleotides away from the exon-intron junction. 4/5 splice prediction tools predict a significant impact on normal splicing and ESE finder predicts that the variant may cause an SRp55 ESE site to be introduced at the locus. One functional study has shown that the variant causes two aberrant splicing transcripts in several heterozygous patient cell lines and that the variant segregates with disease within two families, although several family members are discordant. This study also showed that LDL receptor was not properly trafficked to the cell surface in transfected COS7 cells (Jensen_CG_1999). However, a second functional study also detected aberrant splicing, but assessed LDL receptor protein function in heterozygous patient-derived lymphoblast cell lines and found that ~75% or greater of LDLR was at the cell surface and LDL was internalized similarly to controls, suggesting the variant transcripts do not have a significant biological impact (Holla_MGM_2009). Additionally, several studies have cited the variant in hypercholesterolemia patients, though cosegregation data is lacking in most cases. Based on the literature data, the variant may represent a mild mutation and may have a potentiated effect in compound heterozygosity with a truly pathogenic mutation, but have a less severe impact in heterozygous patients. This variant was found in the large control database ExAC at a frequency of 0.000034 (4/117662 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005). Multiple clinical diagnostic laboratories/reputable databases have classified this variant with conflicting interpretations, including likely pathogenic and uncertain significance. Taken together, this variant is classified as VUS until more conclusive family segregation data and/or control data can be assessed.",MedGen:CN221809,CN517202:not provided,hypercholesterolemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697204.1,LDLR,-,High LDL,4/25/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000697204,FALSE,FALSE,FALSE,
246223,single nucleotide variant,NM_000527.4(LDLR):c.1586+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Apr-17,781362878,RCV000237174;RCV000587894,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11224443,11224443,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001463,2,251909,19,11224443,G,A,246223,19:11224443:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:3,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583852.1,LDLR,-,High LDL,4/25/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583852,FALSE,FALSE,FALSE,
246223,single nucleotide variant,NM_000527.4(LDLR):c.1586+5G>A,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Apr-17,781362878,RCV000237174;RCV000587894,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202",Familial hypercholesterolemia;not provided,germline,germline,GRCh37,NC_000019.9,19,11224443,11224443,G,A,19p13.2,"criteria provided, conflicting interpretations",6,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_001463,2,251909,19,11224443,G,A,246223,19:11224443:G:A,Uncertain significance,2016-12-16,subjects mutated among 2600 FH index cases screened = 2,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503370.1,LDLR,-,High LDL,4/25/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503370,FALSE,FALSE,FALSE,
246297,single nucleotide variant,NM_000527.4(LDLR):c.1721G>A (p.Arg574His),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,3-Jul-18,777188764,RCV000237135,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11227550,11227550,G,A,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_000233,UniProtKB (protein):P01130#VAR_072852",2,251996,19,11227550,G,A,246297,19:11227550:G:A,Likely pathogenic,2018-07-03,"This sequence change replaces arginine with histidine at codon 574 of the LDLR protein (p.Arg574His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs777188764, ExAC 0.01%). This variant has been observed in individuals affected with familial hypercholesterolemia (PMID: 20018285, 25461735, Invitae). ClinVar contains an entry for this variant (Variation ID: 251996). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Variants that disrupt the p.Arg574 amino acid residue in LDLR have been observed in affected individuals (PMID:Ό11462246, 19446849, 26892515, 20018285, 25461735, Invitae). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000836468.1,LDLR,-,High LDL,7/3/18,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000836468,FALSE,TRUE,TRUE,Likely pathogenic
246373,single nucleotide variant,NM_000527.4(LDLR):c.1846-10G>T,3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,29-Aug-17,368243304,RCV000237306;RCV000599958,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11230758,11230758,G,T,19p13.2,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000252,2,252072,19,11230758,G,T,246373,19:11230758:G:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484791.1,LDLR,-,High LDL,8/29/17,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484791,TRUE,FALSE,FALSE,
246378,single nucleotide variant,NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,747134711,RCV000237217,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230777,11230777,T,C,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000570,2,252083,19,11230777,T,C,246378,19:11230777:T:C,Uncertain significance,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503426.1,LDLR,-,High LDL,12/16/16,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000503426,FALSE,FALSE,FALSE,
246378,single nucleotide variant,NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,747134711,RCV000237217,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230777,11230777,T,C,19p13.2,"criteria provided, conflicting interpretations",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000570,2,252083,19,11230777,T,C,246378,19:11230777:T:C,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484688.1,LDLR,-,High LDL,12/16/16,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484688,FALSE,FALSE,FALSE,
246397,single nucleotide variant,NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr),3949,LDLR,HGNC:6547,Likely pathogenic,1,30-Mar-17,879255066,RCV000237476,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230801,11230801,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000259,2,252101,19,11230801,G,A,246397,19:11230801:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583903.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583903,FALSE,FALSE,FALSE,
246397,single nucleotide variant,NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr),3949,LDLR,HGNC:6547,Likely pathogenic,1,30-Mar-17,879255066,RCV000237476,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230801,11230801,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",4,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000259,2,252101,19,11230801,G,A,246397,19:11230801:G:A,Likely pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503429.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503429,FALSE,FALSE,FALSE,
246432,single nucleotide variant,NM_000527.4(LDLR):c.1966C>A (p.His656Asn),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,16-Dec-16,762815611,RCV000237688,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230888,11230888,C,A,19p13.2,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000267,2,252136,19,11230888,C,A,246432,19:11230888:C:A,Likely pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family members = 5 with co-segregation / previously described in association with FH",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503441.1,LDLR,-,High LDL,12/16/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503441,FALSE,FALSE,FALSE,
246458,single nucleotide variant,NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg),3949,LDLR,HGNC:6547,Likely pathogenic,1,16-Dec-16,150021927,RCV000238269,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11231057,11231057,T,C,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000576,2,252163,19,11231057,T,C,246458,19:11231057:T:C,Likely pathogenic,2016-12-16,subject mutated among 2600 FH index cases screened = 1/software prediction damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503449.1,LDLR,-,High LDL,12/16/16,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000503449,FALSE,FALSE,FALSE,
246458,single nucleotide variant,NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg),3949,LDLR,HGNC:6547,Likely pathogenic,1,16-Dec-16,150021927,RCV000238269,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;unknown,germline,GRCh37,NC_000019.9,19,11231057,11231057,T,C,19p13.2,"criteria provided, multiple submitters, no conflicts",7,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000576,2,252163,19,11231057,T,C,246458,19:11231057:T:C,Likely pathogenic,2016-11-05,Disrupt disulfide bridge between Cys667 and Cys681.,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540851.1,LDLR,-,High LDL,12/16/16,46963,0,5,"[0.9999467666034964,5.323339650363052E-5]",5,SCV000540851,FALSE,FALSE,FALSE,
246486,single nucleotide variant,NM_000527.4(LDLR):c.2050G>A (p.Ala684Thr),3949,LDLR,HGNC:6547,Likely pathogenic,1,16-Dec-16,774730452,RCV000237554,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11231108,11231108,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000754,2,252192,19,11231108,G,A,246486,19:11231108:G:A,Likely pathogenic,2016-12-16,subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH (linked to ethnicity ?)/software prediction damaging,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503453.1,LDLR,-,High LDL,12/16/16,46962,1,4,"[0.9999574123759636,4.258762403645501E-5]",4,SCV000503453,FALSE,FALSE,FALSE,
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Likely pathogenic,2017-10-09,"This sequence change replaces proline with leucine at codon 699 of the LDLR protein (p.Pro699Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs201573863, ExAC 0.01%) but has not been reported in the literature in individuals with a LDLR-related disease. This variant has been reported in numerous individuals affected with familial hypercholesterolemia (PMID: 21642693, 7489239, 23375686, 22390909, 21310417, 26892515) . This variant is also known as Pro678Leu in the literature. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000544654.3,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000544654,FALSE,TRUE,TRUE,Likely pathogenic
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583929.1,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000583929,FALSE,FALSE,TRUE,Likely pathogenic
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Likely pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1 , family members = 3 with co-segregation / previously described in association with FH/software prediction damaging",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503463.1,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000503463,FALSE,FALSE,TRUE,Likely pathogenic
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Likely pathogenic,2016-11-05,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:2,"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation",SCV000540843.1,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000540843,FALSE,FALSE,TRUE,Likely pathogenic
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Pathogenic,2016-02-26,"Variant summary: c.2096C>T affects a conserved nucleotide, resulting in amino acid change from Pro to Leu. 5/5 in-silico tools predict this variant to be damaging. This variant was found in 2/120866 control chromosomes at a frequency of 0.0000165, which does not significantly exceed maximal expected frequency of a pathogenic allele (0.0012508). This variant has been reported in multiple FH patients (including homozygous and heterozygous FH patients). Some of the families showed co-segregation of the variant with disease (Schuster _1995). Taken together, this variant was classified as a Pathogenic.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697211.1,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000697211,FALSE,FALSE,TRUE,Likely pathogenic
246513,single nucleotide variant,NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,9-Oct-17,201573863,RCV000237906;RCV000589820,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline;unknown,germline,GRCh37,NC_000019.9,19,11231154,11231154,C,T,19p13.2,"criteria provided, conflicting interpretations",10,"ACMG2013,ACMG2016",N,"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955",2,252219,19,11231154,C,T,246513,19:11231154:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484739.1,LDLR,-,High LDL,10/9/17,46962,1,6,"[0.9999361185639453,6.388143605468251E-5]",6,SCV000484739,FALSE,FALSE,TRUE,Likely pathogenic
246576,single nucleotide variant,NM_000527.4(LDLR):c.2343G>T (p.Glu781Asp),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,25-Mar-16,761683856,RCV000237385,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11238715,11238715,G,T,19p13.2,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,LDLR @ LOVD:LDLR_000981,2,252290,19,11238715,G,T,246576,19:11238715:G:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484720.1,LDLR,-,High LDL,3/25/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000484720,FALSE,FALSE,FALSE,
256754,single nucleotide variant,NM_000527.4(LDLR):c.1167G>A (p.Thr389=),3949,LDLR,HGNC:6547,Conflicting interpretations of pathogenicity,1,30-Mar-17,139066906,RCV000495926;RCV000249917,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374",Familial hypercholesterolemia;not specified,germline,germline,GRCh37,NC_000019.9,19,11222296,11222296,G,A,19p13.2,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,-,2,256365,19,11222296,G,A,256754,19:11222296:G:A,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583796.1,LDLR,-,High LDL,3/30/17,46963,0,19,"[0.9997977130932862,2.0228690671379596E-4]",19,SCV000583796,FALSE,FALSE,FALSE,
260011,single nucleotide variant,NM_000545.6(HNF1A):c.779C>T (p.Thr260Met),6927,HNF1A,HGNC:11621,Pathogenic,1,16-Feb-18,886039544,RCV000255526,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000012.11,12,121432032,121432032,C,T,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,265436,12,121432032,C,T,260011,12:121432032:C:T,Pathogenic,2018-02-16,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000844429.1,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",2/16/18,46957,6,1,"[0.9999893519603041,1.0648039695891987E-5]",1,SCV000844429,FALSE,FALSE,FALSE,
260011,single nucleotide variant,NM_000545.6(HNF1A):c.779C>T (p.Thr260Met),6927,HNF1A,HGNC:11621,Pathogenic,1,16-Feb-18,886039544,RCV000255526,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000012.11,12,121432032,121432032,C,T,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,265436,12,121432032,C,T,260011,12:121432032:C:T,Pathogenic,2016-02-23,"The T260M pathogenic variant in the HNF1A gene has been published previously in association with MODY (Lehto et al., 1997; Awa et al., 2011; Yorifuji et al., 2012). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. T260M is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, transfection studies have shown that T260M significantly inhibits the normal regulatory effects of HNF1A, and causes increased bile acid synthesis (Ekholm et al., 2013). Missense variants in nearby residues (N257T, V259D/F, E261K, R263C/H/L) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000322330.6,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",2/16/18,46957,6,1,"[0.9999893519603041,1.0648039695891987E-5]",1,SCV000322330,FALSE,FALSE,FALSE,
260609,single nucleotide variant,NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,25-Jul-17,148195424,RCV000256274;RCV000417261,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55518374,55518374,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025452,2,265933,1,55518374,C,T,260609,1:55518374:C:T,Uncertain significance,2017-07-25,"Variant of Uncertain Significance due to insufficient evidence: This variant is a missense variant located in the catalytic peptidase domain in the PCSK9 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact the RNA splicing. To our knowledge, functional assays have not been performed for this variant. This variant has been reported in individuals with hypercholesterolemia (PMID 15358785, 16465619, 17765244), as well as in an individual with hypocholesterolemia (PMID 16424354). It has also been identified in 71/118874 chromosomes by the Exome Aggregation Consortium (ExAC) general population database.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Color,SCV000690989.1,PCSK9,-,Low LDL,7/25/17,46949,14,63,"[0.9993290591918891,6.709408081109288E-4]",63,SCV000690989,FALSE,FALSE,FALSE,
260609,single nucleotide variant,NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,25-Jul-17,148195424,RCV000256274;RCV000417261,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55518374,55518374,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025452,2,265933,1,55518374,C,T,260609,1:55518374:C:T,Uncertain significance,2016-12-16,"subjects mutated among 2600 FH index cases screened = 2, family member = 1 / Software predictions: Damaging",OMIM:603776,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503510.1,PCSK9,-,Low LDL,7/25/17,46949,14,63,"[0.9993290591918891,6.709408081109288E-4]",63,SCV000503510,FALSE,FALSE,FALSE,
260609,single nucleotide variant,NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,25-Jul-17,148195424,RCV000256274;RCV000417261,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55518374,55518374,C,T,1p32.3,"criteria provided, conflicting interpretations",5,"ACMG2013,ACMG2016",N,UniProtKB (protein):Q8NBP7#VAR_025452,2,265933,1,55518374,C,T,260609,1:55518374:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484816.1,PCSK9,-,Low LDL,7/25/17,46949,14,63,"[0.9993290591918891,6.709408081109288E-4]",63,SCV000484816,FALSE,FALSE,FALSE,
275130,deletion,NM_001807.4(CEL):c.2181delT (p.Val728Cysfs),1056,CEL,HGNC:1848,Likely pathogenic,1,26-Aug-16,780419796,RCV000365428,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000009.11,9,135947061,135947061,T,-,9q34.2,"criteria provided, single submitter",1,NA,N,-,2,290893,9,135947060,CT,C,275130,9:135947060:CT:C,Likely pathogenic,2016-08-26,-,not provided,CN517202:not provided,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics",SCV000345559.4,CEL,-,"MODY Extended, MonogenicDM_all",8/26/16,46130,833,19,"[0.9997940602644699,2.0593973553002386E-4]",17,SCV000345559,FALSE,FALSE,FALSE,
281418,single nucleotide variant,NM_174936.3(PCSK9):c.94G>A (p.Glu32Lys),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,14-Jun-16,564427867,RCV000331053;RCV000370400,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003",Familial hypercholesterolemia;Familial hypobetalipoproteinemia,germline,germline,GRCh37,NC_000001.10,1,55505604,55505604,G,A,1p32.3,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,-,2,297692,1,55505604,G,A,281418,1:55505604:G:A,Likely pathogenic,2016-06-14,"Mabuchi et al. (2014) investigated a cohort of 1096 Japanese familial hypercholesterolemia patients and identified the c.94G>A (p.Glu32Lys) variant in two homozygotes and 62 heterozygotes, and in nine patients who were double heterozygotes for the p.Glu32Lys variant as well as a variant in the LDLR gene. The authors also reported that the levels of LDL-cholesterol in homozygotes and double heterozygotes of the p.Glu32Lys variant were significantly higher (p<0.001) than p.Glu32Lys heterozygotes, which were in turn significantly higher (p<0.001) than in unaffected family members. In addition, the variant was shown to segregate with a phenotype of elevated LDL-cholesterol levels by Mabuchi et al. (2014) and Noguchi et al. (2010) in unrelated families, although the phenotype was milder than that of heterozygotes with a mutation in the LDLR gene. Control data are unavailable for the p.Glu32Lys variant, which is reported at a frequency of 0.00155 in the East Asian population of the Exome Aggregation Consortium but this is based on two alleles only and hence the variant is presumed rare. Based on the evidence, the p.Glu32Lys variant is classified as likely pathogenic for familial hypercholesterolemia.",Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000358214.2,PCSK9,-,Low LDL,6/14/16,45906,1057,3,"[0.9999673245327408,3.267546725918181E-5]",3,SCV000358214,FALSE,FALSE,FALSE,
347739,single nucleotide variant,NM_005912.2(MC4R):c.494G>A (p.Arg165Gln),4160,MC4R,HGNC:6932,Likely pathogenic,1,14-Jun-16,747681609,RCV000332082,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Obesity,germline,germline,GRCh37,NC_000018.9,18,58039089,58039089,C,T,18q21.32,"criteria provided, single submitter",1,NA,N,UniProtKB (protein):P32245#VAR_038644,2,327713,18,58039089,C,T,347739,18:58039089:C:T,Likely pathogenic,2016-06-14,"The c.494G>A (p.Arg165Gln) variant has been reported in at least four studies in a heterozygous state in a total of 18 patients with severe early-onset obesity, severe obesity, or juvenile onset obesity (Farooqi et al. 2000; Farooqi et al. 2003; Ma et al. 2004; Larsen et al. 2005). In one family, the p.Arg165Gln variant was detected in both the affected father and affected son. The p.Arg165Gln variant was absent from 2,070 control alleles but is reported at a frequency of 0.00005 in the European (Non-Finnish) population of the Exome Aggregation Consortium. In vitro functional studies demonstrated that the p.Arg165Gln variant was expressed but defective in trafficking to the cell surface and was retained intracellularly. The variant was also shown to have impaired ligand-stimulated ERK 1/2 activation, a partial cAMP response when stimulated with alpha-MSH, and to exhibit a 17-fold decrease in affinity to NDP-MSH as a result of a markedly reduced ligand binding capacity (Nijenhuis et al. 2003; Yeo et al. 2003; He et al. 2014). The Arg165 residue is conserved across thirty species (St_ubert et al. 2007). Based on the evidence, the p.Arg165Gln variant is classified as likely pathogenic for obesity.",Obesity,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Illumina Clinical Services Laboratory,Illumina",SCV000409977.2,MC4R,-,Obesity,6/14/16,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000409977,FALSE,FALSE,FALSE,
354097,single nucleotide variant,NM_000527.4(LDLR):c.1868T>C (p.Ile623Thr),3949,LDLR,HGNC:6547,Likely pathogenic,1,-,141155833,RCV000408811,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11230790,11230790,T,C,19p13.2,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,-,2,369855,19,11230790,T,C,354097,19:11230790:T:C,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Robarts Research Institute,Western University",SCV000484770.1,LDLR,-,High LDL,NA,46963,0,3,"[0.9999680599620978,3.194003790217831E-5]",3,SCV000484770,FALSE,FALSE,FALSE,
354078,single nucleotide variant,NM_000527.4(LDLR):c.165C>G (p.Gly55=),3949,LDLR,HGNC:6547,Likely pathogenic,1,-,150644181,RCV000408777,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11210996,11210996,C,G,19p13.2,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,-,2,369857,19,11210996,C,G,354078,19:11210996:C:G,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484772.1,LDLR,-,High LDL,NA,46963,0,7,"[0.9999254732448949,7.452675510508272E-5]",7,SCV000484772,FALSE,FALSE,FALSE,
354091,single nucleotide variant,NM_000527.4(LDLR):c.1060+9C>T,3949,LDLR,HGNC:6547,Likely pathogenic,1,-,540073140,RCV000408891,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11221456,11221456,C,T,19p13.2,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,-,2,369861,19,11221456,C,T,354091,19:11221456:C:T,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484783.1,LDLR,-,High LDL,NA,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000484783,FALSE,FALSE,FALSE,
354066,single nucleotide variant,NM_174936.3(PCSK9):c.1251C>A (p.His417Gln),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,16-Dec-16,143275858,RCV000408779;RCV000417285,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55523779,55523779,C,A,1p32.3,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,-,2,369875,1,55523779,C,A,354066,1:55523779:C:A,Likely benign,2016-12-16,subjects mutated among 2600 FH index cases screened = 2 / One index case is double heterozygote with moderate phenotype / Software predictions: Conflicting,OMIM:603776,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503516.1,PCSK9,-,Low LDL,12/16/16,46963,0,36,"[0.9996167195451738,3.8328045482613975E-4]",36,SCV000503516,FALSE,FALSE,FALSE,
354066,single nucleotide variant,NM_174936.3(PCSK9):c.1251C>A (p.His417Gln),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,16-Dec-16,143275858,RCV000408779;RCV000417285,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55523779,55523779,C,A,1p32.3,"criteria provided, conflicting interpretations",2,"ACMG2013,ACMG2016",N,-,2,369875,1,55523779,C,A,354066,1:55523779:C:A,Likely pathogenic,NA,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Robarts Research Institute,Western University",SCV000484815.1,PCSK9,-,Low LDL,12/16/16,46963,0,36,"[0.9996167195451738,3.8328045482613975E-4]",36,SCV000484815,FALSE,FALSE,FALSE,
360376,single nucleotide variant,NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,763147599,RCV000417321,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11227603,11227603,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,-,2,373769,19,11227603,G,A,360376,19:11227603:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583882.1,LDLR,-,High LDL,3/30/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000583882,FALSE,FALSE,FALSE,
360376,single nucleotide variant,NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg),3949,LDLR,HGNC:6547,Pathogenic/Likely pathogenic,1,30-Mar-17,763147599,RCV000417321,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11227603,11227603,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,-,2,373769,19,11227603,G,A,360376,19:11227603:G:A,Likely pathogenic,2016-12-16,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503411.1,LDLR,-,High LDL,3/30/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503411,FALSE,FALSE,FALSE,
362713,single nucleotide variant,NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,138947766,RCV000417240,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11227559,11227559,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,-,2,375821,19,11227559,G,A,362713,19:11227559:G:A,Pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583871.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583871,FALSE,FALSE,FALSE,
362713,single nucleotide variant,NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter),3949,LDLR,HGNC:6547,Pathogenic,1,30-Mar-17,138947766,RCV000417240,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11227559,11227559,G,A,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,-,2,375821,19,11227559,G,A,362713,19:11227559:G:A,Pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 5 , family members = 4 with co-segregation / Other nonsens mutation at same codon with < 2% LDLR Activity",OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:5,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503401.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503401,FALSE,FALSE,FALSE,
362654,single nucleotide variant,NM_174936.3(PCSK9):c.385G>A (p.Asp129Asn),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,16-Dec-16,778738291,RCV000497232;RCV000417258,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55509693,55509693,G,A,1p32.3,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,-,2,375844,1,55509693,G,A,362654,1:55509693:G:A,Likely pathogenic,2016-12-16,"subjects mutated among 2600 FH index cases screened = 2, family members = 2, with co-segregation / Software predictions: Conflicting",OMIM:603776,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503504.1,PCSK9,-,Low LDL,12/16/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000503504,FALSE,FALSE,FALSE,
362650,single nucleotide variant,NM_174936.3(PCSK9):c.103G>T (p.Asp35Tyr),255738,PCSK9,HGNC:20001,Pathogenic,1,16-Dec-16,764603059,RCV000417231,"MedGen:C1863551,OMIM:603776","Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55505613,55505613,G,T,1p32.3,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,-,2,375848,1,55505613,G,T,362650,1:55505613:G:T,Pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1, family member = 1 / functionnal testing (PMID:22683120) / Software predictions: Conflicting",OMIM:603776,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503512.1,PCSK9,-,Low LDL,12/16/16,45987,976,1,"[0.9999891273620806,1.0872637919412009E-5]",1,SCV000503512,FALSE,FALSE,FALSE,
362653,single nucleotide variant,NM_174936.3(PCSK9):c.323T>G (p.Leu108Arg),255738,PCSK9,HGNC:20001,Pathogenic/Likely pathogenic,1,23-Feb-17,1057519691,RCV000587518;RCV000417273,"MedGen:C0020445;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemias;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55509631,55509631,T,G,1p32.3,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,-,2,375849,1,55509631,T,G,362653,1:55509631:T:G,Likely pathogenic,2017-02-23,"Variant summary: The PCSK9 c.323T>G (p.Leu108Arg) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant. This variant is absent in 121160 control chromosomes. This variant has been reported in one FH family with unequivocal co-segregation evidence (found in 4 affected members, not found in 3 unaffected members). In vitro study showed that p.L108R had a clear and significant gain-of-function effect. Taken together, this variant is classified as likely pathogenic until additional FH families are reported to carry this variant.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000699992.1,PCSK9,-,Low LDL,2/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000699992,FALSE,FALSE,FALSE,
362653,single nucleotide variant,NM_174936.3(PCSK9):c.323T>G (p.Leu108Arg),255738,PCSK9,HGNC:20001,Pathogenic/Likely pathogenic,1,23-Feb-17,1057519691,RCV000587518;RCV000417273,"MedGen:C0020445;MedGen:C1863551,OMIM:603776","Familial hypercholesterolemias;Hypercholesterolemia, autosomal dominant, 3",germline,germline,GRCh37,NC_000001.10,1,55509631,55509631,T,G,1p32.3,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,-,2,375849,1,55509631,T,G,362653,1:55509631:T:G,Pathogenic,2016-12-16,"subject mutated among 2600 FH index cases screened = 1, family member = 1 / functionnal testing (PMID:22683120) / Software predictions: Benign",OMIM:603776,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Centre de G_n_tique Mol_culaire et Chromosomique, Unit_ de g_n_tique de l'Ob_sit_ et des Dyslipid_mies,APHP, GH Hpitaux Universitaires Piti_-Salptrire / Charles-Foix",SCV000503513.1,PCSK9,-,Low LDL,2/23/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000503513,FALSE,FALSE,FALSE,
376001,single nucleotide variant,NM_000458.3(HNF1B):c.1108G>A (p.Gly370Ser),6928,HNF1B,HGNC:11630,Conflicting interpretations of pathogenicity,1,5-Jul-18,113042313,RCV000429473,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000017.10,17,36070609,36070609,C,T,17q12,"criteria provided, conflicting interpretations",2,NA,N,-,2,379811,17,36070609,C,T,376001,17:36070609:C:T,Pathogenic,2015-06-01,"The G370S variant in the HNF1B gene has been reported previously in association with maturity-onsetdiabetes of the young type 5/ renal cysts and diabetes syndrome (Bellann-Chantelot et al., 2005; Poitou etal., 2012). The G370S substitution was not observed with any significant frequency in approximately 6,500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project andwas not observed in the homozygous state in any individual within these populations. Although, in silicoanalysis is inconsistent in its predictions as to whether or not the variant is damaging to the proteinstructure/function, the G370S variant is a non-conservative amino acid substitution, which occurs at aposition that is conserved in mammals. Based on the available data, we interpret G370S as pathogenic variant.",Not Provided,CN517202:not provided,"MODY type 5, renal cysts and diabetes syndrome",TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000517254.3,HNF1B,-,"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes",7/5/18,46963,0,26,"[0.9997231863381811,2.7681366181887867E-4]",26,SCV000517254,TRUE,FALSE,FALSE,
371260,single nucleotide variant,NM_052968.4(APOA5):c.289C>T (p.Gln97Ter),116519,APOA5,HGNC:17288,Pathogenic,1,1-Feb-17,201079485,RCV000428946,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000011.9,11,116661656,116661656,G,A,11q23.3,"criteria provided, single submitter",1,NA,N,-,2,381733,11,116661656,G,A,371260,11:116661656:G:A,Pathogenic,2017-02-01,"The Q97X variant in the APOA5 gene has been reported previously in association with hyperchylomicronemia and hypertriglyceridemia, when seen in the heterozygous and homozygous state with homozygous individuals having more severe disease (Priore Oliva et al., 2008; Charrire et al., 2009; Dussaillant et al., 2012; Chokshi et al., 2014). Functional studies done with patient cells showed LPL activity level was reduced by about 50% in Q97X heterozygotes and more than 90% in the Q97X homozygote (Charrire et al., 2009). This variant is predicted to cause loss of normal protein function through protein truncation. The Q97X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret Q97X as a pathogenic variant.",Not Provided,CN517202:not provided,hyperchylomicronemia and hypertriglyceridemia,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000521319.3,APOA5,-,High triglycerides,2/1/17,46943,20,7,"[0.9999254414928743,7.455850712566304E-5]",7,SCV000521319,FALSE,TRUE,TRUE,Pathogenic
380272,single nucleotide variant,NM_000162.3(GCK):c.128G>A (p.Arg43His),2645,GCK,HGNC:4195,Likely pathogenic,1,21-Dec-17,764232985,RCV000445457;RCV000711763,MedGen:C3888631;MedGen:CN517202,Monogenic diabetes;not provided,germline,germline,GRCh37,NC_000007.13,7,44192980,44192980,C,T,7p13,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,393453,7,44192980,C,T,380272,7:44192980:C:T,Likely pathogenic,2017-12-21,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842157.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",12/21/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000842157,FALSE,FALSE,FALSE,
380272,single nucleotide variant,NM_000162.3(GCK):c.128G>A (p.Arg43His),2645,GCK,HGNC:4195,Likely pathogenic,1,21-Dec-17,764232985,RCV000445457;RCV000711763,MedGen:C3888631;MedGen:CN517202,Monogenic diabetes;not provided,germline,germline,GRCh37,NC_000007.13,7,44192980,44192980,C,T,7p13,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,393453,7,44192980,C,T,380272,7:44192980:C:T,Likely pathogenic,2016-07-22,"The c.128G>A variant in codon 43 (exon 2) of the glucokinase gene, GCK, results in the substitution of Arginine to Histidine. This variant has been reported in the literature in patients with a clinical picture consistent with Maturity-Onset Diabetes of the Young, Type 2 (MODY2, also called GCK-MODY) (22611063, 22493702, 11942313), with evidence of co-segregation with diabetes in two separate families (22611063, 22493702). Different amino acid substitutions at this residue, Arg43Ser and Arg43Cys, have also been reported in patients with MODY2 (17573900, 19358091, 25015100). Functional studies suggest that the Arg43His and Arg43Cys substitutions result proteins with decreased stability compared to wild-type (22611063, 25015100). Additionally, multiple lines of computational evidence (SIFT, Polyphen, MutationTaster, LRT, FATHMM, SVM, LR, CADD, GERP) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. ACMG Criteria = PS3, PP1, PP3",Monogenic diabetes,C3888631:Monogenic diabetes,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"Translational Genomics Laboratory,University of Maryland School of Medicine",SCV000537123.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",12/21/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000537123,FALSE,FALSE,FALSE,
389422,single nucleotide variant,NM_174936.3(PCSK9):c.1394C>T (p.Ser465Leu),255738,PCSK9,HGNC:20001,Conflicting interpretations of pathogenicity,1,5-Dec-17,778849441,RCV000508822;RCV000460891;RCV000454751,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374","Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified",germline,germline,GRCh37,NC_000001.10,1,55524211,55524211,C,T,1p32.3,"criteria provided, conflicting interpretations",3,"ACMG2013,ACMG2016",N,-,2,403292,1,55524211,C,T,389422,1:55524211:C:T,Likely pathogenic,2017-12-05,"This sequence change replaces serine with leucine at codon 465 of the PCSK9 protein (p.Ser465Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in multiple unrelated individuals affected with hypercholesterolemia (PMID:Ό26374825) and was shown to segregate with hypercholesterolemia in a small family (PMID: 24607922). ClinVar contains an entry for this variant (Variation ID: 403292). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C0""). In summary, this variant has been observed in individuals with hypercholesterolemia and is absent from population databases. In the absence of conclusive segregation evidence, at this time this variant has been classified as Likely Pathogenic.",MedGen:C1863551,"C1863551:Hypercholesterolemia, autosomal dominant, 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000543410.3,PCSK9,-,Low LDL,12/5/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000543410,TRUE,TRUE,TRUE,Likely pathogenic
408541,single nucleotide variant,NM_000545.6(HNF1A):c.685C>T (p.Arg229Ter),6927,HNF1A,HGNC:11621,Pathogenic,1,13-Mar-17,769086289,RCV000483162,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000012.11,12,121431481,121431481,C,T,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,420064,12,121431481,C,T,408541,12:121431481:C:T,Pathogenic,2017-03-13,"The R229X variant in the HNF1A gene has been reported previously in association with MODY (Kaisaki et al., 1997). This variant has also been reported in an individual with liver adenomatosis and a family history of diabetes (Bacq et al., 2003). The R229X variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret R229X as a pathogenic variant.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000568551.3,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",3/13/17,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000568551,FALSE,TRUE,TRUE,Pathogenic
415104,single nucleotide variant,NM_000162.3(GCK):c.571C>T (p.Arg191Trp),2645,GCK,HGNC:4195,Pathogenic,1,7-Nov-17,1085307455,RCV000754816;RCV000490143,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44189576,44189576,G,A,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,426122,7,44189576,G,A,415104,7:44189576:G:A,Pathogenic,2017-11-07,"The c.571C>T variant in codon 191 (exon 6) of the glucokinase gene, GCK, results in the substitution of Arginine to Tryptophan. Missense mutations in GCK, including ones in exon 6, have been reported in patients with Maturity-Onset Diabetes of the Young, Type 2 (MODY2, also called GCK-MODY) (19790256). The c.571C>T variant was not observed in the NHLBI Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium databases; however, the c.571C>T variant was previously identified in individuals with a MODY2 phenotype of Korean, Norwegian, Belgian, Brazilian, French, Japanese, Italian, and British descent (16632067, 18399931, 16965331, 23295292, 18411240, 22060211, 11508276, 10753050) . Other amino acid substitutions at this residue, p.Arg191Gln and p.Arg191Leu, have been found in individuals with a MODY2 phenotype (19790256, 11508276, 16444761, 19309449). Additionally, multiple lines of computational evidence (LRT, MutationTaster, FATHMM, MetaSVM, MetalR, Provean, GERP, CADD) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. The c.571C>T variant is located within the small domain of the protein, a region considered to be a mutational hotspot (18382660). ACMG criteria = PS4, PM1, PM2, PP1-mod, PP3",MedGen:C1841962,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Translational Genomics Laboratory,University of Maryland School of Medicine",SCV000882466.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",11/7/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000882466,FALSE,FALSE,TRUE,Pathogenic
415104,single nucleotide variant,NM_000162.3(GCK):c.571C>T (p.Arg191Trp),2645,GCK,HGNC:4195,Pathogenic,1,7-Nov-17,1085307455,RCV000754816;RCV000490143,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44189576,44189576,G,A,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,426122,7,44189576,G,A,415104,7:44189576:G:A,Pathogenic,2017-10-23,-,not provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613442.2,GCK,-,"MODY, MODY Extended, MonogenicDM_all",11/7/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000613442,FALSE,FALSE,TRUE,Pathogenic
415104,single nucleotide variant,NM_000162.3(GCK):c.571C>T (p.Arg191Trp),2645,GCK,HGNC:4195,Pathogenic,1,7-Nov-17,1085307455,RCV000754816;RCV000490143,"MedGen:C1841962,OMIM:125851;MedGen:CN517202","Maturity-onset diabetes of the young,  type 2;not provided",germline,germline,GRCh37,NC_000007.13,7,44189576,44189576,G,A,7p13,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,426122,7,44189576,G,A,415104,7:44189576:G:A,Pathogenic,2017-05-02,"The R191W variant has been published previously in association with MODY (Vits et al., 2006; Sagen et al., 2008; Caetano et al., 2012). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). R191W is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the hexokinase small domain that is conserved across species; the small domain is a hotspot for GCK variants (Tinto et al., 2008). In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (R191L/Q) and in nearby residues (R186G/Q, D187Y, A188P/T/V, I189T, R192S, G193W/R) have been reported in the Human Gene Mutation Database in association with diabetes and MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000576488.3,GCK,-,"MODY, MODY Extended, MonogenicDM_all",11/7/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000576488,FALSE,TRUE,TRUE,Pathogenic
424291,single nucleotide variant,NM_000527.4(LDLR):c.82G>A (p.Glu28Lys),3949,LDLR,HGNC:6547,Likely pathogenic,1,30-Mar-17,551747280,RCV000495866,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11210913,11210913,G,A,19p13.2,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,-,2,430745,19,11210913,G,A,424291,19:11210913:G:A,Likely pathogenic,2017-03-30,ACMG Guidelines: Pathogenic (i),Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583628.1,LDLR,-,High LDL,3/30/17,46963,0,77,"[0.9991802056938441,8.1979430615591E-4]",77,SCV000583628,FALSE,FALSE,FALSE,
424341,single nucleotide variant,NM_000527.4(LDLR):c.2260G>T (p.Gly754Trp),3949,LDLR,HGNC:6547,Likely pathogenic,1,30-Mar-17,559239150,RCV000495862,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11233969,11233969,G,T,19p13.2,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,-,2,430797,19,11233969,G,T,424341,19:11233969:G:T,Likely pathogenic,2017-03-30,-,Familial Hypercholesterolemia,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:4,"U4M - Lille University & CHRU Lille,Universit_ Lille 2 - CHRU de Lille",SCV000583937.1,LDLR,-,High LDL,3/30/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000583937,FALSE,FALSE,FALSE,
425956,single nucleotide variant,NM_000545.6(HNF1A):c.1135C>G (p.Pro379Ala),6927,HNF1A,HGNC:11621,Pathogenic/Likely pathogenic,1,31-Oct-18,754729248,RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000497653,"MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:C3160732,OMIM:144700;MedGen:CN517202","Diabetes mellitus type 1;Diabetes mellitus type 2;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;Renal cell carcinoma, nonpapillary;not provided",germline;unknown,germline,GRCh37,NC_000012.11,12,121434371,121434371,C,G,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,431970,12,121434371,C,G,425956,12:121434371:C:G,Pathogenic,2018-10-31,-,OMIM:125853;OMIM:142330;OMIM:144700;OMIM:222100;OMIM:600496;OMIM:612520,"C0011854:Diabetes mellitus type 1;C0011860:Diabetes mellitus type 2;C1838100:Maturity-onset diabetes of the young, type 3;C1840646:Hepatic adenomas, familial;C2675866:Diabetes mellitus, insulin-dependent, 20;C3160732:Renal cell carcinoma, nonpapillary",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,"Fulgent Genetics,Fulgent Genetics",SCV000893280.1,-,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46953,10,29,"[0.9996911805422444,3.0881945775562794E-4]",27,SCV000893280,FALSE,FALSE,TRUE,Likely pathogenic
425956,single nucleotide variant,NM_000545.6(HNF1A):c.1135C>G (p.Pro379Ala),6927,HNF1A,HGNC:11621,Pathogenic/Likely pathogenic,1,31-Oct-18,754729248,RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000497653,"MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:C3160732,OMIM:144700;MedGen:CN517202","Diabetes mellitus type 1;Diabetes mellitus type 2;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;Renal cell carcinoma, nonpapillary;not provided",germline;unknown,germline,GRCh37,NC_000012.11,12,121434371,121434371,C,G,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,431970,12,121434371,C,G,425956,12:121434371:C:G,Likely pathogenic,2017-06-23,"The P379A variant has been published previously in association with MODY (Bellann-Chantelot et al., 2008; Colclough et al., 2013; Ekholm et al., 2013). The variant is observed in 7/11394 (0.061%) alleles from individuals of Latino background in the ExAC dataset (Lek et al., 2016). P379A is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown P379A increases the activation of the CYP7A1 promoter compared to wild-type (Ekholm et al., 2013). In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000589586.2,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",10/31/18,46953,10,29,"[0.9996911805422444,3.0881945775562794E-4]",27,SCV000589586,FALSE,TRUE,TRUE,Likely pathogenic
429373,single nucleotide variant,NM_000545.6(HNF1A):c.29C>T (p.Thr10Met),6927,HNF1A,HGNC:11621,Likely pathogenic,1,13-Feb-15,774637975,RCV000500944,"MedGen:C1838100,OMIM:600496","Maturity-onset diabetes of the young, type 3",germline,germline,GRCh37,NC_000012.11,12,121416600,121416600,C,T,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,435422,12,121416600,C,T,429373,12:121416600:C:T,Likely pathogenic,2015-02-13,-,"MODY, type III","C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000595133.1,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",2/13/15,46933,30,7,"[0.9999254256067159,7.457439328404321E-5]",7,SCV000595133,FALSE,FALSE,FALSE,
429378,deletion,NM_000545.6(HNF1A):c.864delG (p.Pro291Glnfs),6927,HNF1A,HGNC:11621,Pathogenic,1,23-Dec-16,762703502,RCV000502914;RCV000723679,"MedGen:C1838100,OMIM:600496;MedGen:CN517202","Maturity-onset diabetes of the young, type 3;not provided",germline,germline,GRCh37,NC_000012.11,12,121432117,121432117,G,-,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,435424,12,121432114,CG,C,429378,12:121432114:CG:C,Pathogenic,2016-12-23,-,not provided,CN517202:not provided,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:2,"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics",SCV000700603.2,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",12/23/16,46569,394,7,"[0.9999248427065215,7.515729347849427E-5]",7,SCV000700603,FALSE,FALSE,FALSE,
429378,deletion,NM_000545.6(HNF1A):c.864delG (p.Pro291Glnfs),6927,HNF1A,HGNC:11621,Pathogenic,1,23-Dec-16,762703502,RCV000502914;RCV000723679,"MedGen:C1838100,OMIM:600496;MedGen:CN517202","Maturity-onset diabetes of the young, type 3;not provided",germline,germline,GRCh37,NC_000012.11,12,121432117,121432117,G,-,12q24.31,"criteria provided, multiple submitters, no conflicts",2,NA,N,-,2,435424,12,121432114,CG,C,429378,12:121432114:CG:C,Pathogenic,2016-04-08,-,"MODY, type III","C1838100:Maturity-onset diabetes of the young, type 3",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000595137.1,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",12/23/16,46569,394,7,"[0.9999248427065215,7.515729347849427E-5]",7,SCV000595137,FALSE,FALSE,FALSE,
430076,single nucleotide variant,NM_005912.2(MC4R):c.449C>T (p.Thr150Ile),4160,MC4R,HGNC:6932,Likely pathogenic,1,18-Oct-16,766665118,RCV000582643;RCV000503229,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047","Obesity;Obesity, autosomal dominant",germline,germline,GRCh37,NC_000018.9,18,58039134,58039134,G,A,18q21.32,"criteria provided, single submitter",2,NA,N,-,2,435829,18,58039134,G,A,430076,18:58039134:G:A,Likely pathogenic,2016-10-18,-,"Obesity, autosomal dominant","CN233047:Obesity, autosomal dominant",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000595718.1,MC4R,-,Obesity,10/18/16,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000595718,FALSE,FALSE,FALSE,
430076,single nucleotide variant,NM_005912.2(MC4R):c.449C>T (p.Thr150Ile),4160,MC4R,HGNC:6932,Likely pathogenic,1,18-Oct-16,766665118,RCV000582643;RCV000503229,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047","Obesity;Obesity, autosomal dominant",germline,germline,GRCh37,NC_000018.9,18,58039134,58039134,G,A,18q21.32,"criteria provided, single submitter",2,NA,N,-,2,435829,18,58039134,G,A,430076,18:58039134:G:A,Pathogenic,2014-05-13,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692299.1,MC4R,-,Obesity,10/18/16,46963,0,8,"[0.9999148265655942,8.517343440580883E-5]",8,SCV000692299,FALSE,FALSE,FALSE,
430078,single nucleotide variant,NM_005912.2(MC4R):c.181G>A (p.Glu61Lys),4160,MC4R,HGNC:6932,Pathogenic/Likely pathogenic,1,30-Aug-16,370479598,RCV000583759;RCV000501559;RCV000518806,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202","Obesity;Obesity, autosomal dominant;not provided",germline,germline,GRCh37,NC_000018.9,18,58039402,58039402,C,T,18q21.32,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,435831,18,58039402,C,T,430078,18:58039402:C:T,Pathogenic,2016-08-30,-,not provided,CN517202:not provided,Obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000614059.1,MC4R,-,Obesity,8/30/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000614059,FALSE,FALSE,FALSE,
430078,single nucleotide variant,NM_005912.2(MC4R):c.181G>A (p.Glu61Lys),4160,MC4R,HGNC:6932,Pathogenic/Likely pathogenic,1,30-Aug-16,370479598,RCV000583759;RCV000501559;RCV000518806,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202","Obesity;Obesity, autosomal dominant;not provided",germline,germline,GRCh37,NC_000018.9,18,58039402,58039402,C,T,18q21.32,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,435831,18,58039402,C,T,430078,18:58039402:C:T,Likely pathogenic,2015-10-26,-,"Obesity, autosomal dominant","CN233047:Obesity, autosomal dominant",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000595720.1,MC4R,-,Obesity,8/30/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000595720,FALSE,FALSE,FALSE,
430078,single nucleotide variant,NM_005912.2(MC4R):c.181G>A (p.Glu61Lys),4160,MC4R,HGNC:6932,Pathogenic/Likely pathogenic,1,30-Aug-16,370479598,RCV000583759;RCV000501559;RCV000518806,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202","Obesity;Obesity, autosomal dominant;not provided",germline,germline,GRCh37,NC_000018.9,18,58039402,58039402,C,T,18q21.32,"criteria provided, multiple submitters, no conflicts",3,NA,N,-,2,435831,18,58039402,C,T,430078,18:58039402:C:T,Pathogenic,2013-12-19,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692297.1,MC4R,-,Obesity,8/30/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000692297,FALSE,FALSE,FALSE,
428116,single nucleotide variant,NM_015869.4(PPARG):c.581G>A (p.Arg194Gln),5468,PPARG,HGNC:9236,Likely pathogenic,1,8-Aug-16,148195788,RCV000499572,"MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083",Familial partial lipodystrophy 3,germline,germline,GRCh37,NC_000003.11,3,12434213,12434213,G,A,3p25.2,"criteria provided, single submitter",1,NA,N,-,2,436397,3,12434213,G,A,428116,3:12434213:G:A,Likely pathogenic,2016-08-08,-,"Lipodystrophy, familial partial, type 3",C1720861:Familial partial lipodystrophy 3,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000596559.1,PPARG,-,"Lipodystrophy, MonogenicDM_all",8/8/16,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000596559,FALSE,FALSE,FALSE,
428125,deletion,NM_015869.4(PPARG):c.1361del (p.Pro454Leufs),5468,PPARG,HGNC:9236,Pathogenic,1,22-Jul-16,770557781,RCV000503538,"MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083",Familial partial lipodystrophy 3,germline,germline,GRCh37,NC_000003.11,3,12475487,12475487,C,-,3p25.2,"criteria provided, single submitter",1,NA,N,-,2,436405,3,12475484,AC,A,428125,3:12475484:AC:A,Pathogenic,2016-07-22,-,"Lipodystrophy, familial partial, type 3",C1720861:Familial partial lipodystrophy 3,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Genetic Services Laboratory, University of Chicago",SCV000596567.1,PPARG,-,"Lipodystrophy, MonogenicDM_all",7/22/16,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000596567,FALSE,FALSE,FALSE,
431955,single nucleotide variant,NM_000527.4(LDLR):c.1723C>T (p.Leu575Phe),3949,LDLR,HGNC:6547,Likely pathogenic,1,2-Jan-18,1205480064,RCV000505222,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline;not applicable,germline,GRCh37,NC_000019.9,19,11227552,11227552,C,T,19p13.2,"criteria provided, multiple submitters, no conflicts",2,"ACMG2013,ACMG2016",N,-,2,438324,19,11227552,C,T,431955,19:11227552:C:T,Likely pathogenic,2018-01-02,-,OMIM:143890,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Robarts Research Institute,Western University",SCV000782924.1,LDLR,-,High LDL,1/2/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000782924,FALSE,FALSE,FALSE,
434210,duplication,NM_000527.4(LDLR):c.337dup (p.Glu113Glyfs),3949,LDLR,HGNC:6547,Pathogenic,1,6-Feb-17,752191968,RCV000508965,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000",Familial hypercholesterolemia,germline,germline,GRCh37,NC_000019.9,19,11215919,11215919,na,na,19p13.2,"criteria provided, single submitter",2,"ACMG2013,ACMG2016",N,-,2,440560,19,11215918,C,CG,434210,19:11215918:C:CG,Pathogenic,2017-02-06,"This sequence change inserts 1 nucleotide in exon 4 of the LDLR mRNA (c.337dupG), causing a frameshift at codon 113. This creates a premature translational stop signal (p.Glu113Glyfs*17) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in individuals with hypercholesterolemia (PMID: 16314194). This variant is also known as c.338insG in the literature. For these reasons, this variant has been classified as Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627036.1,LDLR,-,High LDL,2/6/17,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000627036,FALSE,TRUE,TRUE,Pathogenic
434303,single nucleotide variant,NM_000527.4(LDLR):c.1586+5G>C,3949,LDLR,HGNC:6547,Likely pathogenic,1,30-May-17,781362878,RCV000508837;RCV000586202,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11224443,11224443,G,C,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,-,2,440652,19,11224443,G,C,434303,19:11224443:G:C,Likely pathogenic,2017-05-30,"This sequence change falls in intron 10 of the LDLR gene. It does not directly change the encoded amino acid sequence of the LDLR protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with hypercholesterolemia (PMID: 17964958, Invitae). This sequence change has been reported in an individual in the Universal Mutation Database (PMID: 12124988). Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.",MedGen:C0020445,C0745103:Familial hypercholesterolemia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000627020.1,LDLR,-,High LDL,5/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000627020,FALSE,TRUE,TRUE,Likely pathogenic
434303,single nucleotide variant,NM_000527.4(LDLR):c.1586+5G>C,3949,LDLR,HGNC:6547,Likely pathogenic,1,30-May-17,781362878,RCV000508837;RCV000586202,"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445",Familial hypercholesterolemia;Familial hypercholesterolemias,germline,germline,GRCh37,NC_000019.9,19,11224443,11224443,G,C,19p13.2,"criteria provided, multiple submitters, no conflicts",3,"ACMG2013,ACMG2016",N,-,2,440652,19,11224443,G,C,434303,19:11224443:G:C,Likely pathogenic,2016-04-06,"Variant summary: c.1586+5G>C affects a conserved nucleotide, resulting in an intronic change. Mutation taster predicts this variant to be disease-causing. 5/5 programs in Alamut predict a loss (or weakening effect) of the canonical splicing donor site and ESE finder predicts changes of binding motifs for RNA splicing enhancers. This variant was not found in 117702 control chromosomes. This variant has been reported in multiple FH pts with evidence of segregation (Yang_JFormosMedAssoc_2008a). Taken together, this variant was classified as Likely Pathogenic until more information becomes available.",MedGen:CN118841,C0020445:Familial hypercholesterolemias,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Integrated Genetics/Laboratory Corporation of America,SCV000697203.1,LDLR,-,High LDL,5/30/17,46963,0,4,"[0.9999574132827971,4.2586717202904415E-5]",4,SCV000697203,FALSE,FALSE,TRUE,Likely pathogenic
441107,single nucleotide variant,NM_000162.4(GCK):c.682A>G (p.Thr228Ala),2645,GCK,HGNC:4195,Likely pathogenic,1,3-Nov-17,1332966015,RCV000516688,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000007.13,7,44187430,44187430,T,C,7p13,"criteria provided, single submitter",1,NA,N,-,2,447413,7,44187430,T,C,441107,7:44187430:T:C,Likely pathogenic,2017-11-03,-,not provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000613450.2,GCK,-,"MODY, MODY Extended, MonogenicDM_all",11/3/17,46961,2,1,"[0.9999893528672729,1.0647132727156576E-5]",1,SCV000613450,FALSE,FALSE,FALSE,
444937,single nucleotide variant,NM_000545.6(HNF1A):c.812G>A (p.Arg271Gln),6927,HNF1A,HGNC:11621,Pathogenic,1,14-Aug-17,779184183,RCV000519064,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000012.11,12,121432065,121432065,G,A,12q24.31,"criteria provided, single submitter",1,NA,N,-,2,449403,12,121432065,G,A,444937,12:121432065:G:A,Pathogenic,2017-08-14,"The R271Q variant has been reported previously in association with MODY (Tonooka et al., 2002; Bitterman et al., 2016). The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). R271Q is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown R271Q results in increased DNA binding ability, reduced transactivation activities, and abnormal cytoplasmic distribution (Balamurugan et al.; 2016). Missense variants in the same residue (R271W/G) and in nearby residues (N266S/K, W267R/S, F268L/S, A269P/D, R272S/H, K273N, A276D/G) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic.",Not Provided,CN517202:not provided,MODY,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,GeneDx,SCV000617534.1,HNF1A,-,"MODY, MODY Extended, MonogenicDM_all",8/14/17,46959,4,1,"[0.9999893524138078,1.0647586192210225E-5]",1,SCV000617534,FALSE,TRUE,TRUE,Pathogenic
485792,single nucleotide variant,NM_005912.2(MC4R):c.161T>C (p.Leu54Pro),4160,MC4R,HGNC:6932,Pathogenic,1,4-May-17,376439188,RCV000582060,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Obesity,germline,germline,GRCh37,NC_000018.9,18,58039422,58039422,A,G,18q21.32,no assertion criteria provided,1,NA,N,-,2,492861,18,58039422,A,G,485792,18:58039422:A:G,Pathogenic,2017-05-04,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692296.1,MC4R,-,Obesity,5/4/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000692296,FALSE,FALSE,FALSE,
485791,single nucleotide variant,NM_005912.2(MC4R):c.757G>A (p.Val253Ile),4160,MC4R,HGNC:6932,Pathogenic,1,4-Mar-14,187152753,RCV000582762,"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Obesity,germline,germline,GRCh37,NC_000018.9,18,58038826,58038826,C,T,18q21.32,no assertion criteria provided,1,NA,N,-,2,492862,18,58038826,C,T,485791,18:58038826:C:T,Pathogenic,2014-03-04,-,MedGen:C0028754,C0028754:Obesity,NA,TRUE,NA,no assertion criteria provided,clinical testing,germline:na,"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital",SCV000692302.1,MC4R,-,Obesity,3/4/14,46963,0,7,"[0.9999254732448949,7.452675510508272E-5]",7,SCV000692302,FALSE,FALSE,FALSE,
511752,single nucleotide variant,NM_000237.3(LPL):c.590G>A (p.Arg197His),4023,LPL,HGNC:6677,Pathogenic,1,26-Apr-16,372668179,RCV000623537,"MeSH:D030342,MedGen:C0950123",Inborn genetic diseases,germline,germline,GRCh37,NC_000008.10,8,19811679,19811679,G,A,8p21.3,"criteria provided, single submitter",1,NA,N,-,2,521082,8,19811679,G,A,511752,8:19811679:G:A,Pathogenic,2016-04-26,Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected,MeSH:D030342,C0950123:Inborn genetic diseases,NA,TRUE,Kept because pubmed articles referenced are all relevant to phenotype,"criteria provided, single submitter",clinical testing,germline:1,Ambry Genetics,SCV000741513.1,LPL,-,High triglycerides,4/26/16,46963,0,12,"[0.9998722398483912,1.2776015160871325E-4]",12,SCV000741513,FALSE,FALSE,FALSE,
540034,single nucleotide variant,NM_005912.2(MC4R):c.749T>A (p.Leu250Gln),4160,MC4R,HGNC:6932,Conflicting interpretations of pathogenicity,1,10-Mar-17,772393451,RCV000664153;RCV000709739,"MedGen:C3888631;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001",Monogenic diabetes;Obesity,germline;unknown,germline,GRCh37,NC_000018.9,18,58038834,58038834,A,T,18q21.32,"criteria provided, conflicting interpretations",2,NA,N,-,2,549551,18,58038834,A,T,540034,18:58038834:A:T,Likely pathogenic,2017-03-10,"This c.749T>A (p.Leu250Gln) has previously been reported in multiple patients presenting with obesity [PMID 10903341, 16507637, 18559663, 12690102]. Functional assays showed that the receptor displayed high constitutive activity [PMID 12690102, 16611215, 16507637, 23791567]. However, cell surface expression level of the p.Leu250Gln mutant was decreased by about half of wild type [PMID 12690102, 16507637]. Thus the mechanism of pathogenicity of this variant in unclear at this time. This variant is conserved in mammals. This variant has been observed in one heterozygous individual from the ExAC database (http://exac.broadinstitute.org/variant/18-58038834-A-T). While not validated for clinical use, the computer-based algorithms predict this p.Leu250Gln change to be deleterious. It is thus interpreted as a likely pathogenic variant.",OMIM:601665,C0028754:Obesity,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine",SCV000840006.1,MC4R,-,Obesity,3/10/17,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000840006,FALSE,FALSE,FALSE,
546170,duplication,NM_000525.3(KCNJ11):c.1064dup (p.Leu356Thrfs),3767,KCNJ11,HGNC:6257,Likely pathogenic,1,27-Nov-17,1337406718,RCV000671033;RCV000671033;RCV000671033,"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582",Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3,unknown,unknown,GRCh37,NC_000011.9,11,17408574,17408574,T,TA,11p15.1,"criteria provided, single submitter",1,NA,N,-,2,555247,11,17408574,T,TA,546170,11:17408574:T:TA,Likely pathogenic,2017-11-27,-,OMIM:601820;OMIM:606176;OMIM:610582,C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia,NA,TRUE,NA,"criteria provided, single submitter",clinical testing,unknown:na,Counsyl,SCV000795972.1,KCNJ11,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",11/27/17,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000795972,FALSE,FALSE,FALSE,
560798,single nucleotide variant,NM_000384.2(APOB):c.4503T>G (p.Tyr1501Ter),338,APOB,HGNC:603,Pathogenic,1,10-May-18,-1,RCV000700300;RCV000700300,"MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558","Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1",germline,germline,GRCh37,NC_000002.11,2,21235237,21235237,A,C,2p24.1,"criteria provided, single submitter",1,"ACMG2013,ACMG2016",N,-,2,577519,2,21235237,A,C,560798,2:21235237:A:C,Pathogenic,2018-05-10,"This sequence change creates a premature translational stop signal (p.Tyr1501*) in the APOB gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs368825685, ExAC 0.001%). This variant has been observed in individuals affected withΌhypobetalipoproteinemiaΌ(PMID: 8468533, 24507775). Loss-of-function variants in APOB are known to be pathogenic (PMID: 20032471). For these reasons, this variant has been classified as Pathogenic.",MedGen:C1704417;MedGen:CN182502,"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Invitae,SCV000829049.1,APOB,-,Low LDL,5/10/18,46963,0,1,"[0.9999893533206993,1.0646679300726104E-5]",1,SCV000829049,FALSE,TRUE,TRUE,Pathogenic
577178,single nucleotide variant,NM_000352.4(ABCC8):c.4136G>A (p.Arg1379His),6833,ABCC8,HGNC:59,Likely pathogenic,1,28-Sep-17,-1,RCV000710386,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000011.9,11,17417461,17417461,C,T,11p15.1,"criteria provided, single submitter",1,NA,N,-,2,585346,11,17417461,C,T,577178,11:17417461:C:T,Likely pathogenic,2017-09-28,-,not provided,CN517202:not provided,neonatal diabetes - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000840596.1,ABCC8,-,"MODY Extended, MonogenicDM_all, Neonatal Diabetes",9/28/17,46495,468,1,"[0.9999892461555006,1.075384449940854E-5]",1,SCV000840596,FALSE,FALSE,FALSE,
577863,single nucleotide variant,NM_000457.4(HNF4A):c.998G>A (p.Arg333His),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,22-Nov-17,1375557127,RCV000754815;RCV000711966,"MedGen:C1852093,OMIM:125850;MedGen:CN517202","Maturity-onset diabetes of the young,  type 1;not provided",germline,germline,GRCh37,NC_000020.10,20,43052763,43052763,G,A,20q13.12,"criteria provided, conflicting interpretations",2,NA,N,-,2,586023,20,43052763,G,A,577863,20:43052763:G:A,Uncertain significance,2017-11-22,-,not provided,CN517202:not provided,MODY - based on pubmed articles,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842377.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",11/22/17,46948,15,1,"[0.9999893499190594,1.0650080940615148E-5]",1,SCV000842377,FALSE,FALSE,FALSE,
577863,single nucleotide variant,NM_000457.4(HNF4A):c.998G>A (p.Arg333His),3172,HNF4A,HGNC:5024,Conflicting interpretations of pathogenicity,1,22-Nov-17,1375557127,RCV000754815;RCV000711966,"MedGen:C1852093,OMIM:125850;MedGen:CN517202","Maturity-onset diabetes of the young,  type 1;not provided",germline,germline,GRCh37,NC_000020.10,20,43052763,43052763,G,A,20q13.12,"criteria provided, conflicting interpretations",2,NA,N,-,2,586023,20,43052763,G,A,577863,20:43052763:G:A,Pathogenic,2017-10-19,"The c.923G>A variant in codon 308 (exon 10) of the Hepatocyte Nuclear Factor 4-Alpha gene, HNF4A, results in the substitution of Arginine to Histidine. Missense mutations in the HNF4A gene, including ones in exon 10, have been reported previously in patients with a clinical picture consistent with Maturity-Onset Diabetes of the Young, Type 1 (MODY1) (23348805). The c.923G>A variant was not observed in the NHLBI Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium databases; however, the c.923G>A variant has been previously identified in multiple individuals with a diagnosis of MODY1 (10768098, 24947580, 26059258), with evidence of co-segregation in three families (24947580, K. Colclough, personal communication, January 3rd, 2017). Different amino acid substitutions at Arg308 (Arg308Cys and Arg308Ser) have been identified in patients with a strong MODY1 phenotype and have shown co-segregation in one family (K. Colclough, personal communication, January 3rd, 2017). Additionally, multiple lines of computational evidence (SIFT, Polyphen, MutationTaster, FATHMM, MetaSVM, MetalR, Provean, GERP, CADD) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. The c.923G>A variant is located in the ligand-binding domain of the protein, a region of the protein that has minimal benign variation among individuals in population databases and in the literature (23485969, 16917892). ACMG criteria = PP1-strong, PM1, PM2, PM5, PP3",MedGen:C1852093,"C1852093:Maturity-onset diabetes of the young, type 1",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,"Translational Genomics Laboratory,University of Maryland School of Medicine",SCV000882465.1,HNF4A,-,"MODY, MODY Extended, MonogenicDM_all",11/22/17,46948,15,1,"[0.9999893499190594,1.0650080940615148E-5]",1,SCV000882465,FALSE,FALSE,FALSE,
577690,single nucleotide variant,NM_005912.2(MC4R):c.913C>T (p.Arg305Trp),4160,MC4R,HGNC:6932,Likely pathogenic,1,8-Sep-17,-1,RCV000712270,MedGen:CN517202,not provided,germline,germline,GRCh37,NC_000018.9,18,58038670,58038670,G,A,18q21.32,"criteria provided, single submitter",1,NA,N,-,2,586138,18,58038670,G,A,577690,18:58038670:G:A,Likely pathogenic,2017-09-08,-,not provided,CN517202:not provided,Obesity,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:na,Athena Diagnostics Inc,SCV000842720.1,MC4R,-,Obesity,9/8/17,46963,0,2,"[0.9999787066413985,2.1293358601452207E-5]",2,SCV000842720,FALSE,FALSE,FALSE,
611361,single nucleotide variant,NM_000162.5(GCK):c.45+1G>T,2645,GCK,HGNC:4195,Pathogenic,1,17-Aug-17,-1,RCV000760157,"MedGen:C1841962,OMIM:125851","Maturity-onset diabetes of the young,  type 2",germline,germline,GRCh37,NC_000007.13,7,44228507,44228507,C,A,7p13,"criteria provided, single submitter",1,NA,N,-,2,619964,7,44228507,C,A,611361,7:44228507:C:A,Pathogenic,2017-08-17,-,OMIM:125851,"C1841962:Maturity-onset diabetes of the young, type 2",NA,TRUE,NA,"criteria provided, single submitter",clinical testing,germline:1,"Molecular Diagnostics Laboratory,M Health: University of Minnesota",SCV000889974.1,GCK,-,"MODY, MODY Extended, MonogenicDM_all",8/17/17,46962,1,1,"[0.9999893530939908,1.0646906009113752E-5]",1,SCV000889974,FALSE,FALSE,FALSE,
